##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.1-745-gba91191
##SAMPLE=<ID=NA12878_03,Gender=n/a,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##DESCRIPTION=genotype=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=ExAC_sub=Sub-population allele frequenciens for populations AFR,AMR,EAS,NFE,SAS of ExAC project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=PolyPhen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=anno_high_impact=Variant annotated to have high impact by SnpEff.
##FILTER=anno_omim=Variant annotated with information from OMIM.
##FILTER=anno_pathogenic_clinvar=Variant annotated to be pathogenic by ClinVar.
##FILTER=anno_pathogenic_hgmd=Variant annotated to be pathogenic by HGMD.
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=low_DP=Depth less than 20.
##FILTER=low_MQM=Mean mapping quality of alternate allele less than Q50.
##FILTER=low_QUAL=Variant quality less than Q30.
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=pred_pathogenic=Variant predicted to be pathogenic by one or more tools (conservation or effect prediction).
##FILTER=pred_pathogenic_3=Variant predicted to be pathogenic by three or more tools (conservation or effect prediction).
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	ExAC_sub	gnomAD	phyloP	Sift	MetaLR	PolyPhen2	FATHMM	CADD	OMIM	ClinVar	HGMD	COSMIC	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info
chr1	27682481	27682481	G	A	het	off-target	QUAL=2181;DP=169;AF=0.51;MQM=60	MAP3K6	intron	MAP3K6:ENST00000357582:intron:MODIFIER:exon27/28:c.3711+36C>T:,MAP3K6:ENST00000374040:intron:MODIFIER:exon26/27:c.3687+36C>T:,MAP3K6:ENST00000493901:intron:MODIFIER:exon28/29:c.3711+36C>T:		rs12569127	0.1903	0.2656	4554,3529,231	0.2200,0.1972,0.1175,0.3292,0.1619	0.2659											n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a pLI=0.00)
chr1	27686063	27686063	G	C	hom	off-target	QUAL=6115;DP=198;AF=1.00;MQM=60	MAP3K6	intron	MAP3K6:ENST00000357582:intron:MODIFIER:exon17/28:c.2320-50C>G:,MAP3K6:ENST00000374040:intron:MODIFIER:exon16/27:c.2296-50C>G:,MAP3K6:ENST00000493901:intron:MODIFIER:exon18/29:c.2320-50C>G:		rs7521552	0.9880	0.9939	58800,32412,4752	0.9651,0.9974,1.0000,0.9957,0.9969	0.9944											n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a pLI=0.00)
chr1	27687466	27687466	G	T	het		QUAL=9743;DP=738;AF=0.52;MQM=60	MAP3K6	missense	MAP3K6:ENST00000357582:missense:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys,MAP3K6:ENST00000374040:missense:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys,MAP3K6:ENST00000493901:missense:MODERATE:exon15/30:c.1866C>A:p.Asn622Lys		rs35659744	0.1220	0.2622	3300,2798,11	0.0647,0.1470,0.1118,0.3407,0.1776	0.2263	0.0290	T,T,T,T,.	T,T	B,B,.	T,T,T,.	10.76		403071 [benign DISEASE=not_specified]; 		COSM1559293, COSM1559292	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a pLI=0.00)
chr1	27690359	27690359	T	C	het	off-target	QUAL=1451;DP=111;AF=0.53;MQM=60	MAP3K6	intron	MAP3K6:ENST00000357582:intron:MODIFIER:exon5/28:c.864+49A>G:,MAP3K6:ENST00000374040:intron:MODIFIER:exon4/27:c.840+49A>G:,MAP3K6:ENST00000493901:intron:MODIFIER:exon6/29:c.864+49A>G:	MIRb	rs4307592	0.2196	0.2976	1551,1146,215	0.3180,0.2439,0.1188,0.3428,0.1714	0.2989											n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a pLI=0.00)
chr1	27690644	27690644	A	G	het	off-target	QUAL=637;DP=88;AF=0.35;MQM=60	MAP3K6	intron	MAP3K6:ENST00000357582:intron:MODIFIER:exon4/28:c.695+51T>C:,MAP3K6:ENST00000374040:intron:MODIFIER:exon3/27:c.671+51T>C:,MAP3K6:ENST00000493901:intron:MODIFIER:exon5/29:c.695+51T>C:		rs12727507	0.3548	0.3309	7323,4186,2129	0.6736,0.2328,0.1166,0.3619,0.1994	0.4164											n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a pLI=0.00)
chr1	45796269	45796269	G	C	hom	off-target;low_DP;anno_omim	QUAL=264;DP=10;AF=1.00;MQM=60	MUTYH	intron	MUTYH:ENST00000450313:intron:MODIFIER:exon14/15:c.1477-40C>G:,MUTYH:ENST00000528332:intron:MODIFIER:exon5/6:c.520-40C>G:,MUTYH:ENST00000529984:intron:MODIFIER:exon5/6:c.478-40C>G:,MUTYH:ENST00000372104:intron:MODIFIER:exon15/16:c.1393-40C>G:,MUTYH:ENST00000448481:intron:MODIFIER:exon14/15:c.1426-40C>G:,MUTYH:ENST00000456914:intron:MODIFIER:exon14/15:c.1393-40C>G:,MUTYH:ENST00000354383:intron:MODIFIER:exon14/15:c.1396-40C>G:,MUTYH:ENST00000355498:intron:MODIFIER:exon14/15:c.1393-40C>G:,MUTYH:ENST00000372098:intron:MODIFIER:exon14/15:c.1468-40C>G:,MUTYH:ENST00000372110:intron:MODIFIER:exon14/15:c.1438-40C>G:,MUTYH:ENST00000372115:intron:MODIFIER:exon14/15:c.1435-40C>G:,MUTYH:ENST00000488731:intron:MODIFIER:exon5/6:c.478-40C>G:,MUTYH:ENST00000372100:intron:MODIFIER:exon14/15:c.1426-40C>G:,MUTYH:ENST00000531105:intron:MODIFIER:exon2/2:c.116-1160C>G:,MUTYH:ENST00000528013:intron:MODIFIER:exon14/15:c.1435-40C>G:		rs3219493	0.9353	0.9245	35987,19433,3346	0.9582,0.9562,0.8938,0.9153,0.9160	0.9359							604933 [MUTYH (provisional) Adenomas,multiple colorectal,608456|Gastric cancer,somatic,613659|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas,132600];	439920 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MUTYH (inh=AR+AD pLI=0.00)
chr1	45797505	45797505	C	G	het	anno_omim	QUAL=3120;DP=233;AF=0.52;MQM=60	MUTYH	missense,intron	MUTYH:ENST00000450313:missense:MODERATE:exon12/16:c.1014G>C:p.Gln338His,MUTYH:ENST00000372104:missense:MODERATE:exon13/17:c.930G>C:p.Gln310His,MUTYH:ENST00000448481:missense:MODERATE:exon12/16:c.963G>C:p.Gln321His,MUTYH:ENST00000456914:missense:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:ENST00000354383:missense:MODERATE:exon12/16:c.933G>C:p.Gln311His,MUTYH:ENST00000355498:missense:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:ENST00000372098:missense:MODERATE:exon12/16:c.1005G>C:p.Gln335His,MUTYH:ENST00000372110:missense:MODERATE:exon12/16:c.975G>C:p.Gln325His,MUTYH:ENST00000372115:missense:MODERATE:exon12/16:c.972G>C:p.Gln324His,MUTYH:ENST00000372100:missense:MODERATE:exon12/16:c.963G>C:p.Gln321His,MUTYH:ENST00000528013:missense:MODERATE:exon12/16:c.972G>C:p.Gln324His,MUTYH:ENST00000528332:intron:MODIFIER:exon3/6:c.230-277G>C:,MUTYH:ENST00000529984:intron:MODIFIER:exon3/6:c.188-277G>C:,MUTYH:ENST00000488731:intron:MODIFIER:exon3/6:c.188-277G>C:,MUTYH:ENST00000531105:intron:MODIFIER:exon2/2:c.116-2396G>C:		rs3219489	0.3135	0.2967	4266,1586,319	0.2846,0.5312,0.4303,0.2600,0.2448	0.2891	0.0510	T,T,T,T,T,T,T,T,T,T,T,T	T	B,B,B,B,B,B,B	T,T,T,T,T,T,T,T,T,T,T	6.04	604933 [MUTYH (provisional) Adenomas,multiple colorectal,608456|Gastric cancer,somatic,613659|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas,132600];	41767 [benign DISEASE=hereditary_cancer-predisposing_syndrome,carcinoma_of_colon,myh-associated_polyposis,not_specified,not_provided]; 	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH]; 	COSM3751252	n/a (AF>5%)	n/a (AF>5%)					MUTYH (inh=AR+AD pLI=0.00)
chr1	45798555	45798555	T	C	hom	off-target;anno_omim	QUAL=5837;DP=190;AF=1.00;MQM=60	MUTYH	intron	MUTYH:ENST00000450313:intron:MODIFIER:exon6/15:c.504+35A>G:,MUTYH:ENST00000528332:intron:MODIFIER:exon2/6:c.158-49A>G:,MUTYH:ENST00000529984:intron:MODIFIER:exon2/6:c.116-49A>G:,MUTYH:ENST00000372104:intron:MODIFIER:exon7/16:c.420+35A>G:,MUTYH:ENST00000448481:intron:MODIFIER:exon6/15:c.453+35A>G:,MUTYH:ENST00000456914:intron:MODIFIER:exon6/15:c.420+35A>G:,MUTYH:ENST00000354383:intron:MODIFIER:exon6/15:c.423+35A>G:,MUTYH:ENST00000355498:intron:MODIFIER:exon6/15:c.420+35A>G:,MUTYH:ENST00000372098:intron:MODIFIER:exon6/15:c.495+35A>G:,MUTYH:ENST00000372110:intron:MODIFIER:exon6/15:c.465+35A>G:,MUTYH:ENST00000372115:intron:MODIFIER:exon6/15:c.462+35A>G:,MUTYH:ENST00000488731:intron:MODIFIER:exon2/6:c.116-49A>G:,MUTYH:ENST00000372100:intron:MODIFIER:exon6/15:c.453+35A>G:,MUTYH:ENST00000531105:intron:MODIFIER:exon2/2:c.115+1508A>G:,MUTYH:ENST00000528013:intron:MODIFIER:exon6/15:c.462+35A>G:		rs3219487	0.9371	0.9255	52022,27990,4842	0.9653,0.9565,0.8881,0.9159,0.9161	0.9393							604933 [MUTYH (provisional) Adenomas,multiple colorectal,608456|Gastric cancer,somatic,613659|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas,132600];	257529 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MUTYH (inh=AR+AD pLI=0.00)
chr1	62713224	62713224	C	G	hom		QUAL=1165;DP=37;AF=1.00;MQM=60	KANK4	missense	KANK4:ENST00000371153:missense:MODERATE:exon9/10:c.2803G>C:p.Val935Leu,KANK4:ENST00000317477:missense:MODERATE:exon3/4:c.217G>C:p.Val73Leu,KANK4:ENST00000371150:missense:MODERATE:exon6/7:c.871G>C:p.Val291Leu,KANK4:ENST00000354381:missense:MODERATE:exon8/9:c.919G>C:p.Val307Leu		rs2941679	0.9862	0.9744	57571,31015,5111	0.9931,0.9882,0.9998,0.9649,0.9732	0.9755	0.6980	T,T,T,T	T	B,B	T,T,T,T	15.02					n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62713246	62713246	G	A	het		QUAL=1311;DP=117;AF=0.44;MQM=60	KANK4	synonymous	KANK4:ENST00000371153:synonymous:LOW:exon9/10:c.2781C>T:p.His927His,KANK4:ENST00000317477:synonymous:LOW:exon3/4:c.195C>T:p.His65His,KANK4:ENST00000371150:synonymous:LOW:exon6/7:c.849C>T:p.His283His,KANK4:ENST00000354381:synonymous:LOW:exon8/9:c.897C>T:p.His299His		rs10889315	0.3189	0.3896	9671,6170,528	0.3238,0.3193,0.1617,0.4282,0.4052	0.3902										COSM426544	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62728784	62728784	A	G	hom	pred_pathogenic	QUAL=38237;DP=1208;AF=1.00;MQM=60	KANK4	missense,5'UTR	KANK4:ENST00000371153:missense:MODERATE:exon7/10:c.2519T>C:p.Val840Ala,KANK4:ENST00000371150:missense:MODERATE:exon4/7:c.587T>C:p.Val196Ala,KANK4:ENST00000354381:missense:MODERATE:exon6/9:c.635T>C:p.Val212Ala,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-68T>C:		rs2666472	0.7159	0.7444	33236,17884,1580	0.5590,0.8652,0.8406,0.7393,0.7058	0.7543	2.8390	T,T,T	T	B,B	T,T,T	8.63				COSM4144131	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62728838	62728838	T	C	hom	pred_pathogenic	QUAL=35339;DP=1140;AF=1.00;MQM=60	KANK4	missense,5'UTR	KANK4:ENST00000371153:missense:MODERATE:exon7/10:c.2465A>G:p.His822Arg,KANK4:ENST00000371150:missense:MODERATE:exon4/7:c.533A>G:p.His178Arg,KANK4:ENST00000354381:missense:MODERATE:exon6/9:c.581A>G:p.His194Arg,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-122A>G:		rs2258470	0.7163	0.7426	33613,18068,1595	0.5557,0.8631,0.8400,0.7377,0.7031	0.7543	3.3070	T,T,T	T	B,B	T,T,T	5.14					n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62728861	62728861	T	C	hom		QUAL=35802;DP=1143;AF=1.00;MQM=60	KANK4	synonymous,5'UTR	KANK4:ENST00000371153:synonymous:LOW:exon7/10:c.2442A>G:p.Lys814Lys,KANK4:ENST00000371150:synonymous:LOW:exon4/7:c.510A>G:p.Lys170Lys,KANK4:ENST00000354381:synonymous:LOW:exon6/9:c.558A>G:p.Lys186Lys,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-145A>G:		rs2260581	0.7163	0.7426	33625,18069,1593	0.5555,0.8632,0.8404,0.7381,0.7021	0.7546											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62728918	62728918	G	A	hom		QUAL=5593;DP=187;AF=1.00;MQM=60	KANK4	synonymous,5'UTR_premature_start_codon_gain,5'UTR	KANK4:ENST00000371153:synonymous:LOW:exon7/10:c.2385C>T:p.Pro795Pro,KANK4:ENST00000371150:synonymous:LOW:exon4/7:c.453C>T:p.Pro151Pro,KANK4:ENST00000354381:synonymous:LOW:exon6/9:c.501C>T:p.Pro167Pro,KANK4:ENST00000317477:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-202C>T:,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-202C>T:		rs2262110	0.7161	0.7437	33830,18192,1608	0.5579,0.8642,0.8428,0.7390,0.7018	0.7547											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62729015	62729015	G	A	hom	off-target	QUAL=7385;DP=225;AF=1.00;MQM=60	KANK4	5'UTR,intron	KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-299C>T:,KANK4:ENST00000371153:intron:MODIFIER:exon6/9:c.2320-32C>T:,KANK4:ENST00000371150:intron:MODIFIER:exon3/6:c.388-32C>T:,KANK4:ENST00000354381:intron:MODIFIER:exon5/8:c.436-32C>T:		rs2262106	0.7095	0.7535	25643,13969,1095	0.5568,0.8693,0.8500,0.7537,0.7094	0.7562											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62732421	62732421	T	C	het	pred_pathogenic	QUAL=11266;DP=890;AF=0.52;MQM=60	KANK4	missense	KANK4:ENST00000371153:missense:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala,KANK4:ENST00000371150:missense:MODERATE:exon3/7:c.370A>G:p.Thr124Ala,KANK4:ENST00000354381:missense:MODERATE:exon5/9:c.418A>G:p.Thr140Ala		rs11207949	0.3055	0.2850	6079,2111,253	0.2204,0.5009,0.5904,0.2458,0.1437	0.2960	2.3800	T,T,T	T	B,B	T,T,T	9.25					n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62733939	62733939	G	A	het	off-target	QUAL=1676;DP=152;AF=0.46;MQM=60	KANK4	splice_region&intron	KANK4:ENST00000371153:splice_region&intron:LOW:exon5/9:c.2231+20C>T:,KANK4:ENST00000371150:splice_region&intron:LOW:exon2/6:c.299+20C>T:,KANK4:ENST00000354381:splice_region&intron:LOW:exon4/8:c.347+20C>T:		rs11207950	0.4669	0.4324	11564,5648,1676	0.5725,0.3344,0.2575,0.4179,0.5751	0.4444											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62738904	62738904	T	C	hom		QUAL=2015;DP=76;AF=0.99;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.1872A>G:p.Pro624Pro,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-1643A>G:		rs7516290	0.8005	0.7470	30811,15109,3422	0.8585,0.8482,0.8452,0.6919,0.7515	0.7708											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62739198	62739198	G	A	het		QUAL=1755;DP=140;AF=0.49;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.1578C>T:p.Ser526Ser,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-1937C>T:		rs17855078	0.2506	0.3085	6308,3987,186	0.1824,0.2071,0.1259,0.3422,0.4063	0.3046											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62740065	62740065	A	G	het		QUAL=1450;DP=128;AF=0.48;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.711T>C:p.Gly237Gly,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-2804T>C:		rs12127930	0.4822	0.4516	12895,6511,1987	0.6178,0.3435,0.2531,0.4415,0.5673	0.4849										COSM4144132	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62740446	62740446	T	C	hom		QUAL=7384;DP=239;AF=1.00;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.330A>G:p.Pro110Pro,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-3185A>G:		rs2666506	0.8045	0.7448	33966,15906,3719	0.8589,0.8464,0.8634,0.6890,0.7427	0.7700											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62740449	62740449	T	C	hom		QUAL=7384;DP=239;AF=1.00;MQM=60	KANK4	synonymous,intron	KANK4:ENST00000371153:synonymous:LOW:exon3/10:c.327A>G:p.Ser109Ser,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-3188A>G:		rs2666507	0.7810	0.7374	33241,15890,3051	0.7772,0.8431,0.8635,0.6888,0.7424	0.7454											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	62740781	62740781	A	-	het	off-target	QUAL=265;DP=121;AF=0.20;MQM=60	KANK4	intron	KANK4:ENST00000371153:intron:MODIFIER:exon2/9:c.17-22delT:,KANK4:ENST00000354381:intron:MODIFIER:exon2/8:c.17-3520delT:		rs761923018	0.0000	0.1967	0,0,0	0.1666,0.2430,0.1925,0.1970,0.2526	0.1147											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	78578177	78578177	T	C	het		QUAL=4972;DP=413;AF=0.46;MQM=60	GIPC2	intron	GIPC2:ENST00000370759:intron:MODIFIER:exon3/5:c.608-6900T>C:		rs6666954	0.4489	0.3224	6753,2474,1523	0.6061,0.2521,0.6258,0.2826,0.2755	0.3769											n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a pLI=0.00)
chr1	120458004	120458004	A	T	het	anno_omim	QUAL=1768;DP=133;AF=0.55;MQM=60	NOTCH2	synonymous	NOTCH2:ENST00000256646:synonymous:LOW:exon34/34:c.7341T>A:p.Gly2447Gly		rs6685892	0.1925	0.1293	1431,359,637	0.3428,0.0850,0.0281,0.1014,0.1881	0.1687							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];	261705 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120465385	120465385	C	T	het	pred_pathogenic;pred_pathogenic_3;anno_omim	QUAL=89;DP=563;AF=0.33;MQM=60	NOTCH2	missense	NOTCH2:ENST00000256646:missense:MODERATE:exon27/34:c.4876G>A:p.Glu1626Lys			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000	6.0720	D	T	D	T	35.00	600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				0	155					NOTCH2 (inh=AD pLI=1.00)
chr1	120471857	120471857	C	T	het	off-target;anno_omim	QUAL=525;DP=29;AF=0.69;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon22/33:c.3656-22G>A:		rs2493392	0.1925	0.1290	1405,346,625	0.3423,0.0850,0.0283,0.1008,0.1889	0.1687							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120477998	120477998	C	A	het	off-target;low_DP;anno_omim	QUAL=286;DP=19;AF=0.63;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon22/33:c.3655+97G>T:		rs2453056	0.3013	0.1872	2978,490,1358	0.5366,0.1847,0.0953,0.1223,0.3002	0.2426							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120478285	120478285	T	C	het	off-target;anno_omim	QUAL=11662;DP=892;AF=0.51;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon21/33:c.3523-58A>G:		rs5025718	0.6044	0.0000	0,0,0	0,0,0,0,0	0.6698							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120484421	120484421	G	A	het	off-target;anno_omim	QUAL=762;DP=65;AF=0.49;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon17/33:c.2753-44C>T:		rs2493420	0.2714	0.1844	2345,431,880	0.4523,0.1869,0.0988,0.1253,0.3045	0.2168							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120496119	120496119	A	T	het	off-target;anno_omim	QUAL=7154;DP=639;AF=0.45;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon14/33:c.2365+47T>A:		rs7534585	0.1923	0.1284	1418,354,631	0.3402,0.0851,0.0282,0.1002,0.1873	0.1673							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120496127	120496127	A	C	het	off-target;anno_omim	QUAL=7123;DP=638;AF=0.45;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon14/33:c.2365+39T>G:		rs7534586	0.1923	0.1283	1417,353,631	0.3403,0.0851,0.0282,0.1002,0.1873	0.1671							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120512104	120512104	T	C	hom	off-target;anno_omim	QUAL=18002;DP=571;AF=1.00;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon6/33:c.1108+30A>G:		rs2493409	0.9786	0.9929	54659,30854,4055	0.9254,0.9968,1.0000,0.9994,0.9996	0.9944							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120529750	120529750	A	C	het	off-target;anno_omim	QUAL=11326;DP=925;AF=0.48;MQM=60	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon4/33:c.752-45T>G:		rs2453040	0.1907	0.1274	1359,328,608	0.3348,0.0836,0.0290,0.0995,0.1870	0.1663							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120539331	120539331	C	T	het	low_MQM;anno_omim	QUAL=25003;DP=1918;AF=0.52;MQM=49	NOTCH2	missense,intron	NOTCH2:ENST00000602566:missense:MODERATE:exon6/6:c.673G>A:p.Gly225Arg,NOTCH2:ENST00000256646:intron:MODIFIER:exon4/33:c.751+289G>A:		rs2124109	0.0000	0.4412	0,0,0	0.2691,0.4330,0.4699,0.4592,0.4575	0.4380							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];			COSM248829	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120611496	120611496	C	A	het	low_MQM;anno_omim	QUAL=276;DP=41;AF=0.49;MQM=47	NOTCH2	intron	NOTCH2:ENST00000256646:intron:MODIFIER:exon1/33:c.73+452G>T:		rs2794164	0.0000	0.0662	12,1,1	0.0000,0.0000,0.0000,0.0384,0.0781	0.4984							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120611960	120611960	C	T	het	low_MQM;pred_pathogenic;anno_omim	QUAL=4582;DP=1978;AF=0.21;MQM=47	NOTCH2	missense	NOTCH2:ENST00000256646:missense:MODERATE:exon1/34:c.61G>A:p.Ala21Thr		rs2603926	0.0000	0.3634	0,0,0	0.4154,0.3628,0.2914,0.3648,0.3769	0.1205	0.4330	T	T	B,B	T	22.40	600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];			COSM1600651	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120611964	120611964	G	C	het	anno_omim	QUAL=16640;DP=1978;AF=0.38;MQM=59	NOTCH2	missense	NOTCH2:ENST00000256646:missense:MODERATE:exon1/34:c.57C>G:p.Cys19Trp		rs11810554	0.0000	0.4493	3,1,2	0.2837,0.4355,0.4715,0.4630,0.4590	0.4433	0.7660	.,T	T,T	.,B,B	.,T	17.56	600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];			COSM132738	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120612003	120612004	GG	-	het	low_MQM;anno_high_impact;anno_omim	QUAL=3950;DP=2047;AF=0.20;MQM=48	NOTCH2	frameshift	NOTCH2:ENST00000256646:frameshift:HIGH:exon1/34:c.17_18delCC:p.Pro6fs		rs864309621	0.0000	0.4057	0,0,0	0.4075,0.4190,0.3707,0.4018,0.4387	0.1800							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];	218795 [benign DISEASE=not_specified]; 		COSM132830	n/a (AF>5%)	n/a (AF>5%)				DX132253_01: wahrscheinlich durch Pseudogen	NOTCH2 (inh=AD pLI=1.00)
chr1	120612006	120612006	G	A	het	anno_omim	QUAL=18646;DP=2048;AF=0.39;MQM=58	NOTCH2	synonymous	NOTCH2:ENST00000256646:synonymous:LOW:exon1/34:c.15C>T:p.Arg5Arg		rs4021006	0.3940	0.4638	259,151,10	0.3433,0.4635,0.4781,0.4709,0.4721	0.4512	1.0740					8.96	600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];			COSM1320072	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr1	120612034	120612034	T	G	het	low_MQM;anno_omim	QUAL=3549;DP=2046;AF=0.20;MQM=47	NOTCH2	5'UTR	NOTCH2:ENST00000256646:5'UTR:MODIFIER:exon1/34:c.-14A>C:	(CGC)n	rs201668322	0.0000	0.2585	0,0,0	0.2511,0.2613,0.1456,0.3044,0.1824	0.0631							600275 [NOTCH2 (provisional) Alagille syndrome 2,610205|Hajdu-Cheney syndrome,102500];				n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD pLI=1.00)
chr2	17941423	17941423	T	G	hom	off-target	QUAL=1007;DP=33;AF=1.00;MQM=60	GEN1,SMC6	intron	GEN1:ENST00000317402:intron:MODIFIER:exon2/13:c.161+52T>G:,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-5-14205A>C:,GEN1:ENST00000381254:intron:MODIFIER:exon2/13:c.161+52T>G:		rs2555072	0.7089	0.6821	28034,12149,1142	0.4798,0.8343,0.9563,0.6196,0.8609	0.6819											n/a (AF>5%)	n/a (AF>5%)					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.50)
chr2	17942775	17942775	T	A	hom		QUAL=3038;DP=92;AF=1.00;MQM=60	GEN1,SMC6	missense,intron	GEN1:ENST00000317402:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr,GEN1:ENST00000381254:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-5-15557A>T:		rs1812152	0.8137	0.7138	31946,12878,3045	0.7665,0.8463,0.9842,0.6217,0.8746	0.7162	0.5670	T,T,T,T	T	B	T,T,T,T	3.42					n/a (AF>5%)	n/a (AF>5%)					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.50)
chr2	17954027	17954027	G	A	hom		QUAL=972;DP=30;AF=1.00;MQM=60	GEN1,SMC6	missense,intron	GEN1:ENST00000317402:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn,GEN1:ENST00000381254:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-6+15055C>T:		rs300175	0.9770	0.9932	59666,33260,4705	0.9521,0.9979,0.9998,0.9998,0.9830	0.9944	-2.1950	T,T,T	T	B	T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.50)
chr2	17954421	17954421	C	G	hom	off-target	QUAL=3002;DP=93;AF=1.00;MQM=60	GEN1,SMC6	intron	GEN1:ENST00000317402:intron:MODIFIER:exon9/13:c.990+22C>G:,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-6+14661G>C:,GEN1:ENST00000381254:intron:MODIFIER:exon9/13:c.990+22C>G:		rs300177	0.8115	0.7165	31145,12559,2772	0.7612,0.8470,0.9843,0.6257,0.8745	0.7152											n/a (AF>5%)	n/a (AF>5%)					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.50)
chr2	17962450	17962450	A	G	hom		QUAL=3083;DP=96;AF=1.00;MQM=60	GEN1,SMC6	synonymous,intron	GEN1:ENST00000317402:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu,GEN1:ENST00000381254:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-6+6632T>C:		rs300168	0.5739	0.5758	22044,8822,268	0.2226,0.7599,0.9234,0.5135,0.7708	0.5886											n/a (AF>5%)	n/a (AF>5%)					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.50)
chr2	17962518	17962518	C	T	hom		QUAL=3598;DP=112;AF=1.00;MQM=60	GEN1,SMC6	missense,intron	GEN1:ENST00000317402:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile,GEN1:ENST00000381254:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile,SMC6:ENST00000402989:intron:MODIFIER:exon4/29:c.-6+6564G>A:		rs300169	0.7580	0.6982	30600,12834,1870	0.6009,0.8358,0.9843,0.6210,0.8743	0.7038	0.1800	T,T,T	T	B	T,T	1.94					n/a (AF>5%)	n/a (AF>5%)					GEN1 (inh=n/a pLI=0.00), SMC6 (inh=n/a pLI=0.50)
chr2	47601106	47601106	T	C	het	anno_omim	QUAL=747;DP=42;AF=0.71;MQM=60	EPCAM	missense	EPCAM:ENST00000405271:missense:MODERATE:exon4/10:c.428T>C:p.Met143Thr,EPCAM:ENST00000263735:missense:MODERATE:exon3/9:c.344T>C:p.Met115Thr		rs1126497	0.6661	0.5198	17704,6502,3641	0.8345,0.4629,0.8267,0.4397,0.4887	0.6033	0.0400	T,T,T	T	B,B	T,T,T	0.24	185535 [EPCAM (confirmed) Diarrhea 5,with tufting enteropathy,congenital,613217|Colorectal cancer,hereditary nonpolyposis,type 8,613244];	183700 [benign/likely benign DISEASE=hereditary_nonpolyposis_colon_cancer,hereditary_cancer-predisposing_syndrome,lynch_syndrome,lynch_syndrome_i,not_specified]; 		COSM3927762	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR pLI=0.00)
chr2	47635523	47635523	-	T	het	off-target;low_QUAL;low_DP;anno_omim	QUAL=28;DP=19;AF=0.32;MQM=60	MSH2	splice_region&intron	MSH2:ENST00000233146:splice_region&intron:LOW:exon1/15:c.212-4dupT:,MSH2:ENST00000543555:splice_region&intron:LOW:exon2/16:c.14-4dupT:,MSH2:ENST00000406134:splice_region&intron:LOW:exon1/15:c.212-4dupT:		rs757515274	0.0000	0.1447	0,0,0	0.1269,0.1648,0.1565,0.1266,0.2328	0.1994							609309 [MSH2 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 1,120435|Muir-Torre syndrome,158320|Mismatch repair cancer syndrome,276300];				n/a (AF>5%)	n/a (AF>5%)					MSH2 (inh=AR+AD pLI=1.00)
chr2	48010488	48010488	G	A	het	low_DP;pred_pathogenic;pred_pathogenic_3;anno_omim	QUAL=143;DP=14;AF=0.50;MQM=60	MSH6	missense	MSH6:ENST00000234420:missense:MODERATE:exon1/10:c.116G>A:p.Gly39Glu,MSH6:ENST00000540021:missense:MODERATE:exon1/8:c.116G>A:p.Gly39Glu		rs1042821	0.2009	0.2141	1894,1004,189	0.2661,0.1126,0.2905,0.2189,0.2258	0.1903	1.7010	T,D,T	T	B,B,B	D,D	0.28	600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	36581 [benign DISEASE=hereditary_nonpolyposis_colon_cancer,hereditary_cancer-predisposing_syndrome,lynch_syndrome,lynch_syndrome_i,not_specified,not_provided]; 	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6]; 	COSM3749667	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD pLI=n/a)
chr2	48018030	48018030	A	G	het	off-target;anno_omim	QUAL=10785;DP=929;AF=0.46;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon1/9:c.261-36A>G:,MSH6:ENST00000540021:intron:MODIFIER:exon1/7:c.237+7421A>G:,MSH6:ENST00000538136:intron:MODIFIER:exon1/9:c.-642-36A>G:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.170-1451T>C:		rs1800931	0.0220	0.0373	107,87,0	0.0085,0.0316,0.0173,0.0508,0.0166	0.0389							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	89301 [benign DISEASE=lynch_syndrome]; 			11	522					MSH6 (inh=AR+AD pLI=n/a), FBXO11 (inh=AD pLI=1.00)
chr2	48022981	48022981	G	T	het	off-target;anno_omim	QUAL=281;DP=26;AF=0.46;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon2/9:c.458-52G>T:,MSH6:ENST00000540021:intron:MODIFIER:exon1/7:c.238-2769G>T:,MSH6:ENST00000538136:intron:MODIFIER:exon2/9:c.-445-52G>T:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.170-6402C>A:	FLAM_C	rs1800934	0.2244	0.0000	0,0,0	0,0,0,0,0	0.2087							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	89532 [benign DISEASE=lynch_syndrome]; 			n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD pLI=n/a), FBXO11 (inh=AD pLI=1.00)
chr2	48030692	48030692	T	A	het	low_DP;anno_omim	QUAL=247;DP=17;AF=0.65;MQM=60	MSH6,FBXO11	synonymous,intron	MSH6:ENST00000234420:synonymous:LOW:exon5/10:c.3306T>A:p.Thr1102Thr,MSH6:ENST00000540021:synonymous:LOW:exon3/8:c.2916T>A:p.Thr972Thr,MSH6:ENST00000538136:synonymous:LOW:exon5/10:c.2400T>A:p.Thr800Thr,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+4642A>T:		rs2020910	0.0493	0.0204	196,0,0	0.0087,0.0162,0.2103,0.0023,0.0087	0.0197							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	36589 [benign DISEASE=hereditary_nonpolyposis_colon_cancer,hereditary_cancer-predisposing_syndrome,lynch_syndrome,not_specified]; 			3	71	1	[1] Ilnaz Sepahi 29-03-2016 batch import			MSH6 (inh=AR+AD pLI=n/a), FBXO11 (inh=AD pLI=1.00)
chr2	48030838	48030838	A	T	het	off-target;anno_omim	QUAL=2490;DP=238;AF=0.49;MQM=60	MSH6,FBXO11	splice_region&intron,intron	MSH6:ENST00000234420:splice_region&intron:LOW:exon5/9:c.3438+14A>T:,MSH6:ENST00000540021:splice_region&intron:LOW:exon3/7:c.3048+14A>T:,MSH6:ENST00000538136:splice_region&intron:LOW:exon5/9:c.2532+14A>T:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+4496T>A:		rs2020911	0.4010	0.4043	10612,4778,173	0.1787,0.5252,0.6168,0.3780,0.4789	0.4111							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	42471 [benign DISEASE=hereditary_cancer-predisposing_syndrome,lynch_syndrome,hereditary_nonpolyposis_colorectal_cancer_type_5,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD pLI=n/a), FBXO11 (inh=AD pLI=1.00)
chr2	48032875	48032878	CTAT	-	het	off-target;anno_omim	QUAL=603;DP=44;AF=0.59;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon7/9:c.3646+35_3646+38delATCT:,MSH6:ENST00000540021:intron:MODIFIER:exon5/7:c.3256+35_3256+38delATCT:,MSH6:ENST00000538136:intron:MODIFIER:exon7/9:c.2740+35_2740+38delATCT:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+2456_169+2459delATAG:		rs2234731	0.7622	0.6925	29410,15213,3345	0.8045,0.5247,0.8683,0.6778,0.7289	0.7064							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	89429 [benign DISEASE=lynch_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD pLI=n/a), FBXO11 (inh=AD pLI=1.00)
chr2	48033551	48033551	C	G	hom	off-target;anno_omim	QUAL=1514;DP=48;AF=1.00;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon8/9:c.3802-40C>G:,MSH6:ENST00000540021:intron:MODIFIER:exon6/7:c.3412-40C>G:,MSH6:ENST00000538136:intron:MODIFIER:exon8/9:c.2896-40C>G:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+1783G>C:		rs3136367	0.8091	0.7427	33739,17563,4350	0.9197,0.6173,0.8813,0.7273,0.7431	0.7725							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	36594 [benign DISEASE=lynch_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD pLI=n/a), FBXO11 (inh=AD pLI=1.00)
chr2	48033891	48033891	T	-	het	off-target;anno_omim	QUAL=298;DP=38;AF=0.45;MQM=60	MSH6,FBXO11	splice_region&intron,intron	MSH6:ENST00000234420:splice_region&intron:LOW:exon9/9:c.4002-10delT:,MSH6:ENST00000540021:splice_region&intron:LOW:exon7/7:c.3612-10delT:,MSH6:ENST00000538136:splice_region&intron:LOW:exon9/9:c.3096-10delT:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+1443delA:	(T)n	rs267608137	0.0000	0.4245	82,55,7	0.3808,0.4144,0.4194,0.4281,0.4362	0.2881							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	89508 [likely benign DISEASE=lynch_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD pLI=n/a), FBXO11 (inh=AD pLI=1.00)
chr2	147596973	147596973	A	G	het		QUAL=10825;DP=818;AF=0.51;MQM=60	AC103881.1				rs4411641	0.5090	0.4661	11314,4775,1636	0.6525,0.6519,0.4518,0.4208,0.4239	0.4881											n/a (AF>5%)	n/a (AF>5%)					AC103881.1 (inh=n/a pLI=n/a)
chr2	190670539	190670539	-	A	het	off-target;anno_high_impact	QUAL=45;DP=44;AF=0.20;MQM=60	PMS1	frameshift,intron	PMS1:ENST00000409985:frameshift:HIGH:exon4/4:c.488dupA:p.Leu164fs,PMS1:ENST00000441310:intron:MODIFIER:exon4/12:c.418+70dupA:,PMS1:ENST00000418224:intron:MODIFIER:exon3/11:c.-111+9873dupA:,PMS1:ENST00000409823:intron:MODIFIER:exon4/11:c.418+70dupA:,PMS1:ENST00000374826:intron:MODIFIER:exon4/4:c.418+70dupA:,PMS1:ENST00000447232:intron:MODIFIER:exon4/11:c.418+70dupA:,PMS1:ENST00000432292:intron:MODIFIER:exon2/10:c.-110-12193dupA:		rs3214425;rs397844233;rs555414470	0.2153	0.2434	527,220,112	0.3260,0.2932,0.2704,0.2425,0.1604	0.2766											n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD pLI=0.00)
chr2	215595164	215595164	G	A	het	pred_pathogenic;pred_pathogenic_3;anno_omim	QUAL=261;DP=27;AF=0.44;MQM=60	BARD1	missense	BARD1:ENST00000260947:missense:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:ENST00000432456:missense:MODERATE:exon2/3:c.85C>T:p.Arg29Cys,BARD1:ENST00000449967:missense:MODERATE:exon9/10:c.1540C>T:p.Arg514Cys		rs3738888	0.0054	0.0079	4,2,0	0.0018,0.0117,0.0108,0.0081,0.0047	0.0084	5.1650	D,D,D,D	T	B,B	T,T,T,T	27.20	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	136500 [benign/likely benign DISEASE=neoplasm_of_the_breast,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,not_specified]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	0	63	2	[2] Ilnaz Sepahi 29-03-2016 batch import	n/a (1xTP, 0xFP)		BARD1 (inh=n/a pLI=0.00)
chr2	215610638	215610638	A	G	het	off-target;anno_omim	QUAL=3825;DP=272;AF=0.51;MQM=60	BARD1	intron	BARD1:ENST00000260947:intron:MODIFIER:exon7/10:c.1678-60T>C:,BARD1:ENST00000449967:intron:MODIFIER:exon6/9:c.1246-60T>C:		rs4986842	0.0030	0.0000	0,0,0	0,0,0,0,0	0.0060							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];				0	53					BARD1 (inh=n/a pLI=0.00)
chr2	215632155	215632155	T	C	het	off-target;anno_omim	QUAL=1539;DP=109;AF=0.57;MQM=60	BARD1	intron	BARD1:ENST00000260947:intron:MODIFIER:exon6/10:c.1568+51A>G:,BARD1:ENST00000449967:intron:MODIFIER:exon5/9:c.1136+51A>G:		rs5031009	0.3662	0.3737	8118,4428,670	0.3651,0.2796,0.3634,0.3751,0.4062	0.3854							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];				n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215632192	215632192	G	A	het	off-target;anno_omim	QUAL=1787;DP=114;AF=0.57;MQM=60	BARD1	splice_region&intron	BARD1:ENST00000260947:splice_region&intron:LOW:exon6/10:c.1568+14C>T:,BARD1:ENST00000449967:splice_region&intron:LOW:exon5/9:c.1136+14C>T:		rs5031011	0.3522	0.3614	8067,4322,639	0.3445,0.2795,0.3698,0.3587,0.3982	0.3655							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	256214 [benign/likely benign DISEASE=neoplasm_of_the_breast,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215632255	215632255	C	T	het	anno_omim	QUAL=3044;DP=110;AF=0.55;MQM=60	BARD1	missense	BARD1:ENST00000260947:missense:MODERATE:exon6/11:c.1519G>A:p.Val507Met,BARD1:ENST00000449967:missense:MODERATE:exon5/10:c.1087G>A:p.Val363Met		rs2070094	0.3662	0.3783	8892,4897,739	0.3714,0.2845,0.3685,0.3802,0.4078	0.3845	-5.2640	T,T	T	B,B	T,T	4.77	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	140757 [benign/likely benign DISEASE=neoplasm_of_the_breast,hereditary_cancer-predisposing_syndrome,not_specified]; 	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1]; 	COSM3757929, COSM3757930	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215632256	215632256	A	G	hom	anno_omim	QUAL=3044;DP=110;AF=0.55;MQM=60	BARD1	synonymous	BARD1:ENST00000260947:synonymous:LOW:exon6/11:c.1518T>C:p.His506His,BARD1:ENST00000449967:synonymous:LOW:exon5/10:c.1086T>C:p.His362His		rs2070093	0.7706	0.8134	40550,21983,1885	0.5989,0.8250,0.9539,0.8113,0.8412	0.8177							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	183704 [benign/likely benign DISEASE=neoplasm_of_the_breast,hereditary_cancer-predisposing_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215634055	215634055	C	T	het	off-target;anno_omim	QUAL=2564;DP=270;AF=0.47;MQM=60	BARD1	splice_region&intron	BARD1:ENST00000260947:splice_region&intron:LOW:exon4/10:c.1315-19G>A:,BARD1:ENST00000449967:splice_region&intron:LOW:exon3/9:c.883-19G>A:		rs6704780	0.3652	0.3818	8670,4748,730	0.3759,0.2865,0.3740,0.3842,0.4081	0.3855							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	256213 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215645464	215645464	C	G	het	anno_omim	QUAL=1090;DP=79;AF=0.53;MQM=60	BARD1	missense	BARD1:ENST00000260947:missense:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser,BARD1:ENST00000449967:missense:MODERATE:exon3/10:c.702G>C:p.Arg234Ser		rs2229571	0.4593	0.5487	19001,12920,845	0.3970,0.3984,0.3684,0.6215,0.4908	0.5520	-0.6010	T,T	T	B,B	T,T	8.65	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	142769 [benign/likely benign DISEASE=neoplasm_of_the_breast,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,not_specified]; 	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM3757932, COSM3757931	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215674090	215674090	T	G	hom	off-target;anno_omim	QUAL=3891;DP=122;AF=1.00;MQM=60	BARD1	intron	BARD1:ENST00000260947:intron:MODIFIER:exon1/10:c.158+46A>C:,BARD1:ENST00000449967:intron:MODIFIER:exon1/9:c.-126+46A>C:		rs35933323	0.7448	0.7387	28663,14756,2178	0.7693,0.8326,0.8215,0.7199,0.6702	0.7484							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];				n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215674224	215674224	G	A	het	pred_pathogenic;anno_omim	QUAL=8572;DP=821;AF=0.50;MQM=60	BARD1	missense,5'UTR	BARD1:ENST00000260947:missense:MODERATE:exon1/11:c.70C>T:p.Pro24Ser,BARD1:ENST00000449967:5'UTR:MODIFIER:exon1/10:c.-214C>T:		rs1048108	0.3313	0.4377	7357,4010,154	0.2830,0.4848,0.4161,0.4443,0.4407	0.3842	0.9680	T,D	T	B	T,D	11.97	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	183698 [benign/likely benign DISEASE=neoplasm_of_the_breast,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,not_specified]; 	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM442275, COSM1482743	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215674323	215674323	C	G	hom	off-target;anno_omim	QUAL=3254;DP=107;AF=1.00;MQM=60	BARD1	5'UTR	BARD1:ENST00000260947:5'UTR:MODIFIER:exon1/11:c.-30G>C:,BARD1:ENST00000449967:5'UTR:MODIFIER:exon1/10:c.-313G>C:		rs1129804	0.7446	0.7072	3938,1466,266	0.7778,0.8082,0.7932,0.7273,0.6715	0.7473							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	334199 [likely benign DISEASE=neoplasm_of_the_breast]; 			n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215674341	215674341	A	G	hom	off-target;anno_omim	QUAL=3159;DP=106;AF=1.00;MQM=60	BARD1	5'UTR	BARD1:ENST00000260947:5'UTR:MODIFIER:exon1/11:c.-48T>C:,BARD1:ENST00000449967:5'UTR:MODIFIER:exon1/10:c.-331T>C:		rs17489363	0.7450	0.6895	3139,1035,182	0.7690,0.7137,0.7895,0.7078,0.6669	0.7475							601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];	334200 [likely benign DISEASE=neoplasm_of_the_breast]; 			n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	220415596	220415597	GA	-	hom	off-target;anno_omim	QUAL=4914;DP=162;AF=0.99;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon20/20:c.5684-33_5684-32delTC:,OBSL1:ENST00000265318:intron:MODIFIER:exon19/19:c.*1078-33_*1078-32delTC:,OBSL1:ENST00000373876:intron:MODIFIER:exon19/19:c.5408-33_5408-32delTC:		rs869062633	0.3840	0.4172	8518,5164,579	0.3947,0.5176,0.3934,0.4394,0.2544	0.4483							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220416570	220416570	C	T	hom	off-target;low_DP;anno_omim	QUAL=341;DP=13;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon19/20:c.5414-50G>A:,OBSL1:ENST00000265318:intron:MODIFIER:exon18/19:c.*808-50G>A:,OBSL1:ENST00000373876:intron:MODIFIER:exon18/19:c.5138-50G>A:		rs4672931	0.9287	0.9787	44431,26796,1921	0.7763,0.9833,0.9999,0.9943,0.9995	0.9774							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220416803	220416803	A	T	hom	off-target;anno_omim	QUAL=37811;DP=1170;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon19/20:c.5413+31T>A:,OBSL1:ENST00000265318:intron:MODIFIER:exon18/19:c.*807+31T>A:,OBSL1:ENST00000373876:intron:MODIFIER:exon18/19:c.5137+31T>A:		rs4672933	0.9782	0.9943	30079,17103,2024	0.9348,0.9956,1.0000,0.9995,0.9998	0.9954							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220416942	220416942	G	C	hom	anno_omim	QUAL=1045;DP=34;AF=1.00;MQM=60	OBSL1	splice_region&intron	OBSL1:ENST00000404537:splice_region&intron:LOW:exon18/20:c.5309-4C>G:,OBSL1:ENST00000265318:splice_region&intron:LOW:exon17/19:c.*703-4C>G:,OBSL1:ENST00000373876:splice_region&intron:LOW:exon17/19:c.5033-4C>G:		rs34490902	0.3876	0.4668	7360,4539,456	0.4481,0.5826,0.4512,0.4963,0.2865	0.4581							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	194972 [benign DISEASE=three_m_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220417228	220417228	G	T	hom	off-target;anno_omim	QUAL=2363;DP=79;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon18/20:c.5308+30C>A:,OBSL1:ENST00000265318:intron:MODIFIER:exon17/19:c.*702+30C>A:,OBSL1:ENST00000373876:intron:MODIFIER:exon17/19:c.5032+30C>A:		rs60549465	0.3391	0.4657	7246,4585,138	0.2912,0.5660,0.4424,0.4984,0.3213	0.4210							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220417266	220417266	C	T	hom	pred_pathogenic;pred_pathogenic_3;anno_omim	QUAL=4420;DP=146;AF=1.00;MQM=60	OBSL1	missense,3'UTR	OBSL1:ENST00000404537:missense:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln,OBSL1:ENST00000373876:missense:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln,OBSL1:ENST00000265318:3'UTR:MODIFIER:exon17/20:c.*694G>A:		rs59332477	0.3766	0.4683	9523,5689,497	0.4328,0.5761,0.4484,0.4920,0.2937	0.4426	3.5850	D,T	T	D	T,T	35.00	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	288014 [benign DISEASE=three_m_syndrome,not_specified]; 		COSM3757971	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220419236	220419236	T	C	hom	anno_omim	QUAL=14236;DP=471;AF=1.00;MQM=60	OBSL1	synonymous,3'UTR	OBSL1:ENST00000404537:synonymous:LOW:exon15/21:c.4836A>G:p.Thr1612Thr,OBSL1:ENST00000373876:synonymous:LOW:exon14/20:c.4560A>G:p.Thr1520Thr,OBSL1:ENST00000265318:3'UTR:MODIFIER:exon14/20:c.*230A>G:		rs10932813	0.9852	0.9961	59432,32960,4475	0.9595,0.9963,1.0000,0.9996,0.9998	0.9967							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	334466 [benign DISEASE=three_m_syndrome]; 			n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220419339	220419339	T	C	hom	anno_omim	QUAL=21638;DP=704;AF=1.00;MQM=60	OBSL1	missense,3'UTR	OBSL1:ENST00000404537:missense:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg,OBSL1:ENST00000373876:missense:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg,OBSL1:ENST00000265318:3'UTR:MODIFIER:exon14/20:c.*127A>G:		rs10932814	0.9611	0.9859	57479,32224,3674	0.8814,0.9887,1.0000,0.9946,0.9995	0.9872	0.1950	T,T	T	B	T,T	7.19	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	334469 [benign DISEASE=three_m_syndrome]; 			n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220420956	220420956	A	G	hom	pred_pathogenic;anno_omim	QUAL=1398;DP=55;AF=1.00;MQM=60	OBSL1	missense,synonymous	OBSL1:ENST00000265318:missense:MODERATE:exon13/20:c.3995T>C:p.Met1332Thr,OBSL1:ENST00000404537:synonymous:LOW:exon14/21:c.4395T>C:p.Asp1465Asp,OBSL1:ENST00000373876:synonymous:LOW:exon13/20:c.4119T>C:p.Asp1373Asp,OBSL1:ENST00000265317:synonymous:LOW:exon5/5:c.1092T>C:p.Asp364Asp,OBSL1:ENST00000603926:synonymous:LOW:exon14/14:c.4395T>C:p.Asp1465Asp		rs10932816	0.9637	0.9901	56732,32015,3610	0.8883,0.9927,0.9999,0.9995,0.9996	0.9917	-3.7700	D,.	T		T	0.26	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	334475 [benign DISEASE=three_m_syndrome]; 		COSM4133493	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220421417	220421417	C	G	hom	pred_pathogenic;anno_omim	QUAL=23446;DP=736;AF=1.00;MQM=60	OBSL1	missense	OBSL1:ENST00000404537:missense:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp,OBSL1:ENST00000265318:missense:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp,OBSL1:ENST00000373876:missense:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp,OBSL1:ENST00000265317:missense:MODERATE:exon4/5:c.792G>C:p.Glu264Asp,OBSL1:ENST00000603926:missense:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp		rs1983210	0.7246	0.7461	32983,18089,1813	0.6154,0.6814,0.7179,0.7457,0.8970	0.7385	0.9020	T,T,T,T,.	T,T	B,P,B,.	T,T,T,T,.	24.50	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	334483 [benign DISEASE=three_m_syndrome]; 		COSM442368	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220421456	220421456	C	A	hom	off-target;anno_omim	QUAL=22661;DP=688;AF=1.00;MQM=60	OBSL1	splice_region&intron	OBSL1:ENST00000404537:splice_region&intron:LOW:exon12/20:c.4067-11G>T:,OBSL1:ENST00000265318:splice_region&intron:LOW:exon11/19:c.3791-11G>T:,OBSL1:ENST00000373876:splice_region&intron:LOW:exon11/19:c.3791-11G>T:,OBSL1:ENST00000265317:splice_region&intron:LOW:exon3/4:c.764-11G>T:,OBSL1:ENST00000603926:splice_region&intron:LOW:exon12/13:c.4067-11G>T:		rs1983211	0.1170	0.1859	1511,912,3	0.0356,0.2466,0.1450,0.1964,0.1973	0.1689							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	334484 [benign DISEASE=three_m_syndrome]; 			n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220422029	220422029	G	A	hom	off-target;anno_omim	QUAL=4770;DP=167;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon12/20:c.4066+36C>T:,OBSL1:ENST00000265318:intron:MODIFIER:exon11/19:c.3790+36C>T:,OBSL1:ENST00000373876:intron:MODIFIER:exon11/19:c.3790+516C>T:,OBSL1:ENST00000265317:intron:MODIFIER:exon3/4:c.763+516C>T:,OBSL1:ENST00000603926:intron:MODIFIER:exon12/13:c.4066+36C>T:		rs55873563	0.1188	0.1828	158,124,3	0.0357,0.2869,0.1797,0.2146,0.1496	0.1582							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220422400	220422400	C	G	hom	off-target;anno_omim	QUAL=10361;DP=382;AF=1.00;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon11/20:c.3791-60G>C:,OBSL1:ENST00000265318:intron:MODIFIER:exon10/19:c.3515-60G>C:,OBSL1:ENST00000373876:intron:MODIFIER:exon11/19:c.3790+145G>C:,OBSL1:ENST00000265317:intron:MODIFIER:exon3/4:c.763+145G>C:,OBSL1:ENST00000603926:intron:MODIFIER:exon11/13:c.3791-60G>C:		rs2278200	0.4087	0.0000	0,0,0	0,0,0,0,0	0.4663							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220422686	220422686	C	T	het	pred_pathogenic;anno_omim	QUAL=543;DP=63;AF=0.44;MQM=60	OBSL1	missense	OBSL1:ENST00000404537:missense:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys,OBSL1:ENST00000265318:missense:MODERATE:exon10/20:c.3373G>A:p.Glu1125Lys,OBSL1:ENST00000373876:missense:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys,OBSL1:ENST00000265317:missense:MODERATE:exon3/5:c.622G>A:p.Glu208Lys,OBSL1:ENST00000603926:missense:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys		rs72957510	0.0070	0.0061	1,1,0	0.0197,0.0018,0.0000,0.0075,0.0026	0.0079	0.5010	T,D,T,T	T	P,B,P,B	T,T,T,T	16.43	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	193901 [conflicting interpretations of pathogenicity DISEASE=three_m_syndrome,not_specified,not_provided]; 			2	86					OBSL1 (inh=AR pLI=0.00)
chr2	220422774	220422774	A	G	hom	anno_omim	QUAL=24045;DP=760;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:ENST00000404537:synonymous:LOW:exon11/21:c.3561T>C:p.Pro1187Pro,OBSL1:ENST00000265318:synonymous:LOW:exon10/20:c.3285T>C:p.Pro1095Pro,OBSL1:ENST00000373876:synonymous:LOW:exon11/20:c.3561T>C:p.Pro1187Pro,OBSL1:ENST00000265317:synonymous:LOW:exon3/5:c.534T>C:p.Pro178Pro,OBSL1:ENST00000603926:synonymous:LOW:exon11/14:c.3561T>C:p.Pro1187Pro		rs2278201	0.4191	0.4303	11375,6202,1290	0.5217,0.5442,0.4095,0.4364,0.2616	0.4746	-4.6180		T			0.01	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	334496 [benign DISEASE=three_m_syndrome]; 		COSM3757974	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220428381	220428381	A	T	het	off-target;anno_omim	QUAL=3406;DP=282;AF=0.45;MQM=60	OBSL1	intron	OBSL1:ENST00000404537:intron:MODIFIER:exon6/20:c.2408-32T>A:,OBSL1:ENST00000265318:intron:MODIFIER:exon6/19:c.2408-32T>A:,OBSL1:ENST00000373876:intron:MODIFIER:exon6/19:c.2408-32T>A:,OBSL1:ENST00000603926:intron:MODIFIER:exon6/13:c.2408-32T>A:,OBSL1:ENST00000373873:intron:MODIFIER:exon6/8:c.2408-32T>A:,OBSL1:ENST00000289656:intron:MODIFIER:exon6/8:c.1169-32T>A:		rs2303543	0.5567	0.6463	25389,15212,464	0.3032,0.5306,0.6880,0.6811,0.7565	0.6445							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220430203	220430203	C	T	hom	anno_omim	QUAL=23697;DP=741;AF=1.00;MQM=60	OBSL1	missense	OBSL1:ENST00000404537:missense:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000265318:missense:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000373876:missense:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000603926:missense:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000373873:missense:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys,OBSL1:ENST00000289656:missense:MODERATE:exon6/9:c.929G>A:p.Arg310Lys		rs1039898	0.7927	0.8655	45551,27067,1985	0.6345,0.8285,0.9110,0.9012,0.8372	0.8672	-0.1200	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	6.75	610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	334508 [benign DISEASE=three_m_syndrome]; 		COSM4133496, COSM4133495	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220432709	220432709	A	T	het	off-target;anno_omim	QUAL=9152;DP=726;AF=0.48;MQM=60	OBSL1	splice_region&intron	OBSL1:ENST00000404537:splice_region&intron:LOW:exon2/20:c.1283-18T>A:,OBSL1:ENST00000265318:splice_region&intron:LOW:exon2/19:c.1283-18T>A:,OBSL1:ENST00000373876:splice_region&intron:LOW:exon2/19:c.1283-18T>A:,OBSL1:ENST00000603926:splice_region&intron:LOW:exon2/13:c.1283-18T>A:,OBSL1:ENST00000373873:splice_region&intron:LOW:exon2/8:c.1283-18T>A:,OBSL1:ENST00000289656:splice_region&intron:LOW:exon2/8:c.44-18T>A:		rs2292360	0.3678	0.4234	11346,6780,170	0.1831,0.3628,0.4955,0.4488,0.4452	0.4228							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];				n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00)
chr2	220435034	220435034	A	G	hom	anno_omim	QUAL=20345;DP=649;AF=1.00;MQM=60	OBSL1,INHA	synonymous,intron	OBSL1:ENST00000404537:synonymous:LOW:exon1/21:c.921T>C:p.Leu307Leu,OBSL1:ENST00000265318:synonymous:LOW:exon1/20:c.921T>C:p.Leu307Leu,OBSL1:ENST00000373876:synonymous:LOW:exon1/20:c.921T>C:p.Leu307Leu,OBSL1:ENST00000603926:synonymous:LOW:exon1/14:c.921T>C:p.Leu307Leu,OBSL1:ENST00000373873:synonymous:LOW:exon1/9:c.921T>C:p.Leu307Leu,OBSL1:ENST00000289656:intron:MODIFIER:exon1/8:c.-228+1082T>C:		rs10180675	0.7833	0.8644	44374,26362,1758	0.6169,0.8284,0.9105,0.9013,0.8356	0.8651							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	193382 [benign DISEASE=three_m_syndrome,not_specified]; 		COSM4133504, COSM4133503	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00), INHA (inh=n/a pLI=0.17)
chr2	220435375	220435375	G	A	het	low_DP;anno_omim	QUAL=376;DP=19;AF=0.84;MQM=60	OBSL1,INHA	synonymous,intron	OBSL1:ENST00000404537:synonymous:LOW:exon1/21:c.580C>T:p.Leu194Leu,OBSL1:ENST00000265318:synonymous:LOW:exon1/20:c.580C>T:p.Leu194Leu,OBSL1:ENST00000373876:synonymous:LOW:exon1/20:c.580C>T:p.Leu194Leu,OBSL1:ENST00000603926:synonymous:LOW:exon1/14:c.580C>T:p.Leu194Leu,OBSL1:ENST00000373873:synonymous:LOW:exon1/9:c.580C>T:p.Leu194Leu,OBSL1:ENST00000289656:intron:MODIFIER:exon1/8:c.-228+741C>T:		rs1061399	0.3588	0.4448	1102,271,4	0.2097,0.0000,0.0000,0.4310,0.4564	0.4282							610991 [OBSL1 (confirmed) 3-M syndrome 2,612921];	290129 [benign DISEASE=three_m_syndrome,not_specified]; 		COSM4133505, COSM442371	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR pLI=0.00), INHA (inh=n/a pLI=0.17)
chr3	10076843	10076844	TT	-	het	off-target;anno_omim	QUAL=1941;DP=168;AF=0.45;MQM=60	FANCD2	splice_region&intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon5/42:c.378-6_378-5delTT:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon5/42:c.378-6_378-5delTT:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon5/43:c.378-6_378-5delTT:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon5/43:c.378-6_378-5delTT:,FANCD2:ENST00000431693:splice_region&intron:LOW:exon4/7:c.378-6_378-5delTT:		rs55973240	0.2115	0.2080	2296,839,957	0.4585,0.1937,0.0809,0.1890,0.2181	0.2354							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	342255 [benign/likely benign DISEASE=fanconi_anemia,not_provided]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10076975	10076975	A	C	het	off-target;anno_omim	QUAL=1279;DP=99;AF=0.48;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon6/42:c.438+58A>C:,FANCD2:ENST00000383806:intron:MODIFIER:exon6/42:c.438+58A>C:,FANCD2:ENST00000383807:intron:MODIFIER:exon6/43:c.438+58A>C:,FANCD2:ENST00000419585:intron:MODIFIER:exon6/43:c.438+58A>C:,FANCD2:ENST00000431693:intron:MODIFIER:exon5/7:c.438+58A>C:		rs17032276	0.1811	0.0000	0,0,0	0,0,0,0,0	0.1962							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10077955	10077955	A	G	het	off-target;anno_omim	QUAL=553;DP=46;AF=0.63;MQM=60	FANCD2	splice_region&intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon6/42:c.439-16A>G:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon6/42:c.439-16A>G:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon6/43:c.439-16A>G:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon6/43:c.439-16A>G:,FANCD2:ENST00000431693:splice_region&intron:LOW:exon5/7:c.439-16A>G:		rs17032278	0.1821	0.1662	1918,849,580	0.3365,0.1523,0.0658,0.1574,0.1757	0.1945							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257083 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10081545	10081545	G	C	het	off-target;anno_omim	QUAL=5185;DP=484;AF=0.47;MQM=60	FANCD2	splice_region&intron,synonymous	FANCD2:ENST00000287647:splice_region&intron:LOW:exon9/42:c.695+16G>C:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon9/42:c.695+16G>C:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon9/43:c.695+16G>C:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon9/43:c.695+16G>C:,FANCD2:ENST00000431693:synonymous:LOW:exon8/8:c.711G>C:p.Leu237Leu		rs17032283	0.1821	0.1659	1907,843,573	0.3340,0.1529,0.0656,0.1571,0.1757	0.1966							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257086 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10084224	10084224	C	T	het	off-target;anno_omim	QUAL=14505;DP=1027;AF=0.54;MQM=60	FANCD2	splice_region&intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon10/42:c.784-19C>T:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon10/42:c.784-19C>T:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon10/43:c.784-19C>T:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon10/43:c.784-19C>T:		rs9879080	0.2107	0.1743	2300,854,954	0.4296,0.1552,0.0654,0.1575,0.1740	0.2261							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257087 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10085130	10085130	C	G	het	off-target;low_DP;anno_omim	QUAL=62;DP=10;AF=0.40;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon12/42:c.990-38C>G:,FANCD2:ENST00000383806:intron:MODIFIER:exon12/42:c.990-38C>G:,FANCD2:ENST00000383807:intron:MODIFIER:exon12/43:c.990-38C>G:,FANCD2:ENST00000419585:intron:MODIFIER:exon12/43:c.990-38C>G:		rs9809061	0.2117	0.1758	2122,785,871	0.4323,0.1561,0.0676,0.1596,0.1769	0.2263							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257088 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10085536	10085536	A	G	het	anno_omim	QUAL=2144;DP=294;AF=0.43;MQM=60	FANCD2	synonymous	FANCD2:ENST00000287647:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:ENST00000383806:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:ENST00000383807:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val,FANCD2:ENST00000419585:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0.0000	0.1239	37,0,37	0.3091,0.0956,0.0391,0.1116,0.1379	0.1939							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257065 [benign DISEASE=fanconi_anemia,not_specified]; 		COSM3759562, COSM3759563	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10089773	10089773	A	C	het	off-target;anno_omim	QUAL=1155;DP=94;AF=0.52;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon16/42:c.1413+38A>C:,FANCD2:ENST00000383806:intron:MODIFIER:exon16/42:c.1413+38A>C:,FANCD2:ENST00000383807:intron:MODIFIER:exon16/43:c.1413+38A>C:,FANCD2:ENST00000419585:intron:MODIFIER:exon16/43:c.1413+38A>C:		rs7615646	0.1791	0.1404	234,75,40	0.2477,0.1375,0.0628,0.1338,0.1584	0.2214							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257067 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10094206	10094206	-	T	het	off-target;anno_omim	QUAL=110;DP=25;AF=0.36;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon18/42:c.1656+38dupT:,FANCD2:ENST00000383806:intron:MODIFIER:exon18/42:c.1656+38dupT:,FANCD2:ENST00000383807:intron:MODIFIER:exon18/43:c.1656+38dupT:,FANCD2:ENST00000419585:intron:MODIFIER:exon18/43:c.1656+38dupT:		rs544799101	0.0000	0.1695	52,15,29	0.3370,0.1878,0.0470,0.1628,0.1526	0.2108							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10106532	10106532	C	T	het	anno_omim	QUAL=1275;DP=75;AF=0.64;MQM=60	FANCD2	missense	FANCD2:ENST00000287647:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000383806:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000383807:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu,FANCD2:ENST00000419585:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0.0000	0.1545	988,525,211	0.2804,0.1427,0.0588,0.1502,0.1680	0.1871	-0.1810	T,T,T,T	T	B,B	T,T,T,T	1.75	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	134315 [benign DISEASE=fanconi_anemia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10107520	10107520	G	T	het	off-target;anno_omim	QUAL=12200;DP=1013;AF=0.48;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon24/42:c.2270-28G>T:,FANCD2:ENST00000383806:intron:MODIFIER:exon24/42:c.2270-28G>T:,FANCD2:ENST00000383807:intron:MODIFIER:exon24/43:c.2270-28G>T:,FANCD2:ENST00000419585:intron:MODIFIER:exon24/43:c.2270-28G>T:		rs34608006	0.1753	0.1729	1736,780,494	0.3281,0.1621,0.0698,0.1659,0.1821	0.1932							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257074 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10119917	10119917	T	C	het	off-target;anno_omim	QUAL=741;DP=72;AF=0.46;MQM=60	FANCD2	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon30/42:c.2976+36T>C:,FANCD2:ENST00000383806:intron:MODIFIER:exon30/42:c.2976+36T>C:,FANCD2:ENST00000383807:intron:MODIFIER:exon30/43:c.2976+36T>C:,FANCD2:ENST00000419585:intron:MODIFIER:exon30/43:c.2976+36T>C:		rs6805869	0.2115	0.1750	2309,845,954	0.4300,0.1560,0.0659,0.1573,0.1793	0.2259							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257077 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00)
chr3	10128965	10128965	-	T	het	off-target;anno_omim	QUAL=47;DP=38;AF=0.18;MQM=60	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon34/42:c.3466+36dupT:,FANCD2:ENST00000383806:intron:MODIFIER:exon34/42:c.3466+36dupT:,FANCD2:ENST00000383807:intron:MODIFIER:exon34/43:c.3466+36dupT:,FANCD2:ENST00000419585:intron:MODIFIER:exon34/43:c.3466+36dupT:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*44-5751dupA:		rs371321981;rs71052293	0.0000	0.0390	55,13,16	0.0591,0.0193,0.0119,0.0284,0.0822	0.0522							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10132127	10132127	A	T	het	off-target;low_QUAL;anno_omim	QUAL=14;DP=28;AF=0.21;MQM=57	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon37/42:c.3777+58A>T:,FANCD2:ENST00000383806:intron:MODIFIER:exon36/42:c.3683+1493A>T:,FANCD2:ENST00000383807:intron:MODIFIER:exon37/43:c.3777+58A>T:,FANCD2:ENST00000419585:intron:MODIFIER:exon37/43:c.3777+58A>T:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*44-8912T>A:			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];				5	22					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10133949	10133949	A	G	het	off-target;anno_omim	QUAL=2575;DP=178;AF=0.55;MQM=60	FANCD2,FANCD2OS	splice_region&intron,intron	FANCD2:ENST00000287647:splice_region&intron:LOW:exon38/42:c.3849+13A>G:,FANCD2:ENST00000383806:splice_region&intron:LOW:exon37/42:c.*5+13A>G:,FANCD2:ENST00000383807:splice_region&intron:LOW:exon38/43:c.3849+13A>G:,FANCD2:ENST00000419585:splice_region&intron:LOW:exon38/43:c.3849+13A>G:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*44-10734T>C:		rs9811771	0.2542	0.1918	2872,852,1283	0.4983,0.1826,0.0865,0.1583,0.2252	0.2462							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257079 [benign DISEASE=fanconi_anemia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10138069	10138069	T	G	het	anno_omim	QUAL=9089;DP=785;AF=0.47;MQM=60	FANCD2,FANCD2OS	synonymous,3'UTR,intron	FANCD2:ENST00000287647:synonymous:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000383807:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000419585:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2:ENST00000383806:3'UTR:MODIFIER:exon41/43:c.*254T>G:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.1868	2695,850,1177	0.4741,0.1820,0.0864,0.1576,0.2072	0.2404							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257081 [benign DISEASE=fanconi_anemia,not_specified]; 	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10138189	10138189	T	C	het	off-target;anno_omim	QUAL=2797;DP=207;AF=0.53;MQM=60	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647:intron:MODIFIER:exon42/42:c.4185+33T>C:,FANCD2:ENST00000383806:intron:MODIFIER:exon41/42:c.*341+33T>C:,FANCD2:ENST00000383807:intron:MODIFIER:exon42/43:c.4185+33T>C:,FANCD2:ENST00000419585:intron:MODIFIER:exon42/43:c.4185+33T>C:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+7693A>G:		rs2272124	0.2418	0.1869	2676,845,1171	0.4740,0.1822,0.0865,0.1578,0.2069	0.2406							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	257082 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	10140671	10140671	G	A	het	off-target;anno_omim	QUAL=10294;DP=680;AF=0.54;MQM=60	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647:3'UTR:MODIFIER:exon43/43:c.*37G>A:,FANCD2:ENST00000383806:intron:MODIFIER:exon42/42:c.*437+172G>A:,FANCD2:ENST00000383807:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2:ENST00000419585:intron:MODIFIER:exon43/43:c.4281+172G>A:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+5211C>T:		rs7626117	0.3452	0.2285	4893,1088,2964	0.7552,0.2055,0.0866,0.1772,0.2296	0.3366							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	342381 [benign DISEASE=fanconi_anemia]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	37067097	37067097	A	T	het	off-target;anno_omim	QUAL=1093;DP=250;AF=0.24;MQM=60	MLH1	intron	MLH1:ENST00000231790:intron:MODIFIER:exon11/18:c.1039-31A>T:,MLH1:ENST00000458205:intron:MODIFIER:exon12/19:c.316-31A>T:,MLH1:ENST00000539477:intron:MODIFIER:exon10/17:c.316-31A>T:,MLH1:ENST00000455445:intron:MODIFIER:exon11/18:c.316-31A>T:,MLH1:ENST00000435176:intron:MODIFIER:exon11/18:c.745-31A>T:,MLH1:ENST00000536378:intron:MODIFIER:exon11/18:c.316-31A>T:	(TA)n	rs59684491	0.0000	0.0613	2,0,0	0.0000,0.0000,0.0000,0.0819,0.0474	0.2230							120436 [MLH1 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 2,609310|Mismatch repair cancer syndrome,276300|Muir-Torre syndrome,158320];				n/a (AF>5%)	n/a (AF>5%)					MLH1 (inh=AR+AD pLI=0.97)
chr3	37067099	37067099	A	T	het	off-target;anno_omim	QUAL=1093;DP=250;AF=0.24;MQM=60	MLH1	intron	MLH1:ENST00000231790:intron:MODIFIER:exon11/18:c.1039-29A>T:,MLH1:ENST00000458205:intron:MODIFIER:exon12/19:c.316-29A>T:,MLH1:ENST00000539477:intron:MODIFIER:exon10/17:c.316-29A>T:,MLH1:ENST00000455445:intron:MODIFIER:exon11/18:c.316-29A>T:,MLH1:ENST00000435176:intron:MODIFIER:exon11/18:c.745-29A>T:,MLH1:ENST00000536378:intron:MODIFIER:exon11/18:c.316-29A>T:	(TA)n	rs6771325	0.0000	0.0185	14,4,0	0.0000,0.0000,0.0000,0.0197,0.0157	0.0362							120436 [MLH1 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 2,609310|Mismatch repair cancer syndrome,276300|Muir-Torre syndrome,158320];				273	1253	2	[2] auto-classification 24.10.2017  			MLH1 (inh=AR+AD pLI=0.97)
chr3	142168331	142168331	C	T	hom	anno_omim	QUAL=1594;DP=49;AF=1.00;MQM=60	ATR	synonymous	ATR:ENST00000350721:synonymous:LOW:exon47/47:c.7875G>A:p.Gln2625Gln,ATR:ENST00000383101:synonymous:LOW:exon46/46:c.7683G>A:p.Gln2561Gln		rs1802904	0.9163	0.8646	45665,23944,4913	0.9721,0.7549,0.9302,0.8463,0.9348	0.8880							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	93669 [benign/likely benign DISEASE=seckel_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142178144	142178144	C	T	het	anno_omim	QUAL=1052;DP=77;AF=0.55;MQM=60	ATR	missense	ATR:ENST00000350721:missense:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln,ATR:ENST00000383101:missense:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln		rs2229032	0.1022	0.1328	1212,874,28	0.0808,0.0969,0.1019,0.1571,0.0939	0.1332	0.0440	T,T	T	B	T,T	11.30	601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	136470 [benign/likely benign DISEASE=seckel_syndrome,not_specified]; 		COSM149485	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142188337	142188337	A	C	het	pred_pathogenic;anno_omim	QUAL=9942;DP=682;AF=0.56;MQM=60	ATR,RP11-383G6.3	missense	ATR:ENST00000350721:missense:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp,ATR:ENST00000383101:missense:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp		rs28910273	0.0020	0.0033	2,1,0	0.0019,0.0017,0.0000,0.0049,0.0014	0.0032	2.3460	T,D	T	B	T,T	6.31	601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	158000 [conflicting interpretations of pathogenicity DISEASE=not_specified,not_provided]; 			0	49	2	[2] Ilnaz Sepahi 29-03-2016 batch import			ATR (inh=AR+AD pLI=1.00), RP11-383G6.3 (inh=n/a pLI=n/a)
chr3	142215171	142215171	T	C	het	off-target;low_DP;anno_omim	QUAL=124;DP=8;AF=0.75;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon34/46:c.5898+32A>G:,ATR:ENST00000383101:intron:MODIFIER:exon33/45:c.5706+32A>G:	(TA)n	rs11719960	0.0000	0.0594	291,230,2	0.0050,0.0384,0.0536,0.0973,0.0410	0.0286							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	157998 [likely benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142215178	142215178	A	C	het	off-target;low_DP;anno_omim	QUAL=124;DP=8;AF=0.75;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon34/46:c.5898+25T>G:,ATR:ENST00000383101:intron:MODIFIER:exon33/45:c.5706+25T>G:	(TA)n	rs7620648	0.0000	0.0000	0,0,0	0,0,0,0,0	0.6677							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	157997 [likely benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142217537	142217537	A	G	het	anno_omim	QUAL=3564;DP=350;AF=0.51;MQM=60	ATR	synonymous	ATR:ENST00000350721:synonymous:LOW:exon32/47:c.5460T>C:p.Tyr1820Tyr,ATR:ENST00000383101:synonymous:LOW:exon31/46:c.5268T>C:p.Tyr1756Tyr		rs2227932	0.0669	0.0942	705,391,2	0.0165,0.0372,0.0016,0.1085,0.1608	0.0927							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	136471 [benign/likely benign DISEASE=seckel_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142255090	142255090	T	C	het	off-target;anno_omim	QUAL=1306;DP=111;AF=0.46;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon19/46:c.3726-47A>G:,ATR:ENST00000383101:intron:MODIFIER:exon18/45:c.3534-47A>G:		rs73240314	0.1172	0.1374	1200,832,62	0.1207,0.0995,0.1022,0.1588,0.0942	0.1424							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	157979 [likely benign DISEASE=not_specified]; 		COSN167032	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142259707	142259707	A	-	het	off-target;anno_omim	QUAL=9283;DP=908;AF=0.43;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon18/46:c.3581+39delT:,ATR:ENST00000383101:intron:MODIFIER:exon17/45:c.3389+39delT:		rs201551475	0.0000	0.4574	74,42,18	0.4484,0.4522,0.4507,0.4622,0.4530	0.4586							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];				n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142277427	142277427	A	G	het	off-target;anno_omim	QUAL=6988;DP=587;AF=0.48;MQM=60	ATR	intron	ATR:ENST00000350721:intron:MODIFIER:exon8/46:c.1885+39T>C:,ATR:ENST00000383101:intron:MODIFIER:exon7/45:c.1693+39T>C:	(TAGA)n	rs73240318	0.1122	0.0745	414,288,4	0.0191,0.0326,0.0638,0.0910,0.0673	0.1045							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	157967 [likely benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142277575	142277575	A	T	het	anno_omim	QUAL=3151;DP=274;AF=0.47;MQM=60	ATR	synonymous	ATR:ENST00000350721:synonymous:LOW:exon8/47:c.1776T>A:p.Gly592Gly,ATR:ENST00000383101:synonymous:LOW:exon7/46:c.1584T>A:p.Gly528Gly		rs2227930	0.5980	0.5529	19239,11031,3356	0.8024,0.4389,0.4642,0.5741,0.4362	0.6300							601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	157965 [benign/likely benign DISEASE=seckel_syndrome,not_specified]; 		COSM149486	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	142281612	142281612	A	G	het	anno_omim	QUAL=6583;DP=530;AF=0.49;MQM=60	ATR	missense	ATR:ENST00000350721:missense:MODERATE:exon4/47:c.632T>C:p.Met211Thr,ATR:ENST00000383101:missense:MODERATE:exon4/46:c.632T>C:p.Met211Thr		rs2227928	0.5974	0.5540	19098,10972,3300	0.8000,0.4404,0.4658,0.5752,0.4390	0.6291	1.2730	T,T	T	B	T,T	1.62	601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];	93668 [benign/likely benign DISEASE=seckel_syndrome,not_specified]; 		COSM149487	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD pLI=1.00)
chr3	156421525	156421525	G	T	het	off-target	QUAL=5995;DP=480;AF=0.51;MQM=60	TIPARP	intron	TIPARP:ENST00000295924:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:ENST00000486483:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:ENST00000461166:intron:MODIFIER:exon5/5:c.1526+34G>T:,TIPARP:ENST00000542783:intron:MODIFIER:exon5/5:c.1526+34G>T:	AluYm1	rs34277251	0.3832	0.4306	10742,5291,26	0.0873,0.5825,0.7162,0.4223,0.3940	0.4396											n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a pLI=1.00)
chr3	178917005	178917005	A	G	het	off-target;anno_omim	QUAL=850;DP=54;AF=0.63;MQM=60	PIK3CA	intron	PIK3CA:ENST00000263967:intron:MODIFIER:exon2/20:c.352+40A>G:		rs3729674	0.2734	0.2156	2868,1297,889	0.4305,0.2088,0.1025,0.2006,0.2480	0.2451							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];				n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD pLI=1.00)
chr3	178922274	178922274	C	A	hom	off-target;anno_omim	QUAL=13692;DP=480;AF=1.00;MQM=60	PIK3CA	splice_region&intron	PIK3CA:ENST00000263967:splice_region&intron:LOW:exon5/20:c.1060-17C>A:		rs2699896	0.5847	0.5614	20164,11339,3659	0.8624,0.4762,0.2535,0.5811,0.5597	0.6189							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];	259957 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD pLI=1.00)
chr3	178922430	178922430	A	G	hom	off-target;anno_omim	QUAL=1931;DP=64;AF=1.00;MQM=60	PIK3CA	intron	PIK3CA:ENST00000263967:intron:MODIFIER:exon6/20:c.1145+54A>G:		rs3729679	0.5180	0.0000	0,0,0	0,0,0,0,0	0.5566							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];			COSN167081	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD pLI=1.00)
chr3	178938747	178938747	A	T	het	off-target;anno_omim	QUAL=4435;DP=376;AF=0.47;MQM=55	PIK3CA	intron	PIK3CA:ENST00000263967:intron:MODIFIER:exon13/20:c.2016-27A>T:		rs6443625	0.2730	0.2911	1131,461,300	0.4520,0.3226,0.1841,0.2741,0.2819	0.2446							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];				n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD pLI=1.00)
chr3	178942431	178942431	C	G	hom	off-target;low_DP;anno_omim	QUAL=183;DP=7;AF=1.00;MQM=60	PIK3CA	intron	PIK3CA:ENST00000263967:intron:MODIFIER:exon15/20:c.2295-57C>G:		rs2699889	0.6294	0.0000	0,0,0	0,0,0,0,0	0.6499							171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];				n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AR+AD pLI=1.00)
chr4	185999587	185999587	T	A	het	off-target	QUAL=686;DP=71;AF=0.46;MQM=60	RP11-386B13.3				rs6818170	0.6675	0.6436	23810,13741,2802	0.8290,0.5382,0.4129,0.6704,0.6561	0.6815											n/a (AF>5%)	n/a (AF>5%)					RP11-386B13.3 (inh=n/a pLI=n/a)
chr5	57617403	57617403	G	C	het		QUAL=11921;DP=940;AF=0.50;MQM=60	PGAM1P1,PLK2	intergenic_region	PLK2:ENSG00000248271-ENSG00000145632:intergenic_region:MODIFIER::n.57617403G>C:	MLT1E1A	rs37535	0.5719	0.0000	0,0,0	0,0,0,0,0	0.5792											n/a (AF>5%)	n/a (AF>5%)					PGAM1P1 (inh=n/a pLI=n/a), PLK2 (inh=n/a pLI=1.00)
chr5	79950508	79950508	C	T	hom	off-target;anno_omim	QUAL=2919;DP=109;AF=1.00;MQM=60	MSH3,DHFR	5'UTR_premature_start_codon_gain,5'UTR	MSH3:ENST00000265081:5'UTR_premature_start_codon_gain:LOW:exon1/24:c.-39C>T:,DHFR:ENST00000439211:5'UTR:MODIFIER:exon1/6:c.-200G>A:,MSH3:ENST00000265081:5'UTR:MODIFIER:exon1/24:c.-39C>T:		rs1105525	0.1230	0.1997	1596,914,9	0.0705,0.1125,0.0975,0.2138,0.2621	0.1573							126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency,613839]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR pLI=0.00), DHFR (inh=AR pLI=0.24)
chr5	79950512	79950512	A	G	hom	off-target;anno_omim	QUAL=2919;DP=109;AF=1.00;MQM=60	DHFR,MSH3	5'UTR	DHFR:ENST00000439211:5'UTR:MODIFIER:exon1/6:c.-204T>C:,MSH3:ENST00000265081:5'UTR:MODIFIER:exon1/24:c.-35A>G:		rs1105524	0.7043	0.6744	22308,11896,3085	0.9259,0.5136,0.4212,0.6758,0.7680	0.7128							126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency,613839]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR pLI=0.24), MSH3 (inh=AR pLI=0.00)
chr5	79950781	79950781	A	G	het	pred_pathogenic;anno_omim	QUAL=420;DP=38;AF=0.47;MQM=60	MSH3,DHFR	missense&splice_region,5'UTR	MSH3:ENST00000265081:missense&splice_region:MODERATE:exon1/24:c.235A>G:p.Ile79Val,DHFR:ENST00000439211:5'UTR:MODIFIER:exon1/6:c.-473T>C:		rs1650697	0.7686	0.9029	4978,2224,393	0.9612,0.9345,0.0000,0.9441,0.8551	0.8573	-0.4930	T,T	T	B	D	0.01	126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency,613839]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];	402591 [benign DISEASE=not_specified]; 		COSM4160035	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR pLI=0.00), DHFR (inh=AR pLI=0.24)
chr5	79966178	79966178	G	A	het	off-target;anno_omim	QUAL=5439;DP=416;AF=0.50;MQM=60	MSH3	intron	MSH3:ENST00000265081:intron:MODIFIER:exon4/23:c.792+50G>A:		rs6151630	0.0232	0.0419	129,87,1	0.0113,0.0143,0.0001,0.0551,0.0361	0.0408							600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				12	567					MSH3 (inh=AR pLI=0.00)
chr5	80149981	80149981	A	G	hom	pred_pathogenic;anno_omim	QUAL=28046;DP=904;AF=1.00;MQM=60	MSH3	missense	MSH3:ENST00000265081:missense:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg		rs184967	0.9022	0.8731	46317,23581,4199	0.8984,0.9204,0.9993,0.8417,0.8844	0.8733	0.4010	T,T	T	B	D	4.93	600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];			COSM4160036	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR pLI=0.00)
chr5	80160597	80160600	AATG	-	het	off-target;low_DP;anno_omim	QUAL=58;DP=16;AF=0.38;MQM=60	MSH3	intron	MSH3:ENST00000265081:intron:MODIFIER:exon21/23:c.3001-33_3001-30delTGAA:		rs34486413	0.4030	0.5059	13685,8991,244	0.2691,0.3426,0.4183,0.5607,0.5420	0.4859							600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR pLI=0.00)
chr5	80168937	80168937	G	A	hom	pred_pathogenic;anno_omim	QUAL=3771;DP=114;AF=1.00;MQM=60	MSH3	missense&splice_region	MSH3:ENST00000265081:missense&splice_region:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr		rs26279	0.7202	0.7305	32457,17163,2349	0.6733,0.7601,0.7438,0.7176,0.7953	0.7300	1.0140	T,T	T	B	D	7.28	600887 [MSH3 (provisional) Endometrial carcinoma,somatic,608089|Familial adenomatous polyposis 4,617100];				n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR pLI=0.00)
chr5	112162854	112162854	T	C	het	anno_omim	QUAL=1678;DP=184;AF=0.42;MQM=60	APC	synonymous	APC:ENST00000257430:synonymous:LOW:exon12/16:c.1458T>C:p.Tyr486Tyr,APC:ENST00000457016:synonymous:LOW:exon12/16:c.1458T>C:p.Tyr486Tyr,APC:ENST00000508376:synonymous:LOW:exon13/17:c.1458T>C:p.Tyr486Tyr		rs2229992	0.5100	0.5780	21255,11677,216	0.2053,0.7160,0.6791,0.5906,0.6413	0.5854							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	42238 [benign, other DISEASE=hereditary_cancer-predisposing_syndrome,familial_adenomatous_polyposis_1,familial_colorectal_cancer,not_specified,apc-associated_polyposis_disorders]; 		COSM1432175	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD pLI=1.00)
chr5	112164561	112164561	G	A	het	anno_omim	QUAL=2531;DP=179;AF=0.51;MQM=60	APC,CTC-554D6.1	synonymous	APC:ENST00000257430:synonymous:LOW:exon14/16:c.1635G>A:p.Ala545Ala,APC:ENST00000457016:synonymous:LOW:exon14/16:c.1635G>A:p.Ala545Ala,APC:ENST00000508376:synonymous:LOW:exon15/17:c.1635G>A:p.Ala545Ala		rs351771	0.6661	0.6481	25918,12755,1477	0.5365,0.7478,0.8230,0.6170,0.7196	0.6493							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	42239 [benign, other DISEASE=hereditary_cancer-predisposing_syndrome,familial_adenomatous_polyposis_1,familial_colorectal_cancer,not_specified,apc-associated_polyposis_disorders]; 		COSM3760868	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112175770	112175770	G	A	het	anno_omim	QUAL=5170;DP=423;AF=0.49;MQM=60	APC,CTC-554D6.1	synonymous	APC:ENST00000257430:synonymous:LOW:exon16/16:c.4479G>A:p.Thr1493Thr,APC:ENST00000457016:synonymous:LOW:exon16/16:c.4479G>A:p.Thr1493Thr,APC:ENST00000508376:synonymous:LOW:exon17/17:c.4479G>A:p.Thr1493Thr		rs41115	0.6655	0.6486	25933,12779,1447	0.5370,0.7486,0.8227,0.6172,0.7186	0.6496							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	42242 [benign, other DISEASE=hereditary_cancer-predisposing_syndrome,familial_adenomatous_polyposis_1,familial_colorectal_cancer,not_specified,apc-associated_polyposis_disorders]; 		COSM3760869	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112176325	112176325	G	A	het	anno_omim	QUAL=233;DP=26;AF=0.50;MQM=60	APC,CTC-554D6.1	synonymous	APC:ENST00000257430:synonymous:LOW:exon16/16:c.5034G>A:p.Gly1678Gly,APC:ENST00000457016:synonymous:LOW:exon16/16:c.5034G>A:p.Gly1678Gly,APC:ENST00000508376:synonymous:LOW:exon17/17:c.5034G>A:p.Gly1678Gly		rs42427	0.6667	0.6514	26051,12877,1489	0.5418,0.7501,0.8236,0.6214,0.7185	0.6524							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	42243 [benign, other DISEASE=hereditary_cancer-predisposing_syndrome,familial_adenomatous_polyposis_1,familial_colorectal_cancer,not_specified,apc-associated_polyposis_disorders]; 		COSM3760870	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112176559	112176559	T	G	het	anno_omim	QUAL=3246;DP=262;AF=0.49;MQM=60	APC,CTC-554D6.1	synonymous	APC:ENST00000257430:synonymous:LOW:exon16/16:c.5268T>G:p.Ser1756Ser,APC:ENST00000457016:synonymous:LOW:exon16/16:c.5268T>G:p.Ser1756Ser,APC:ENST00000508376:synonymous:LOW:exon17/17:c.5268T>G:p.Ser1756Ser		rs866006	0.6669	0.6508	26034,12847,1478	0.5388,0.7491,0.8223,0.6207,0.7194	0.6513							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	42245 [benign, other DISEASE=hereditary_cancer-predisposing_syndrome,familial_adenomatous_polyposis_1,familial_colorectal_cancer,not_specified,apc-associated_polyposis_disorders]; 			n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112176756	112176756	T	A	het	pred_pathogenic;anno_omim	QUAL=4289;DP=382;AF=0.45;MQM=60	APC,CTC-554D6.1	missense	APC:ENST00000257430:missense:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp,APC:ENST00000457016:missense:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp,APC:ENST00000508376:missense:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp		rs459552	0.8654	0.7981	38872,19648,4738	0.9566,0.8304,0.9018,0.7685,0.7869	0.8113	3.6530	T,T,T	T	B,B	D,D,D	13.24	611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	21030 [benign, other DISEASE=hereditary_cancer-predisposing_syndrome,familial_adenomatous_polyposis_1,familial_colorectal_cancer,not_specified,apc-associated_polyposis_disorders,not_provided]; 		COSM3760871	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	112177171	112177171	G	A	het	anno_omim	QUAL=9897;DP=815;AF=0.48;MQM=60	APC,CTC-554D6.1	synonymous	APC:ENST00000257430:synonymous:LOW:exon16/16:c.5880G>A:p.Pro1960Pro,APC:ENST00000457016:synonymous:LOW:exon16/16:c.5880G>A:p.Pro1960Pro,APC:ENST00000508376:synonymous:LOW:exon17/17:c.5880G>A:p.Pro1960Pro		rs465899	0.6665	0.6488	25923,12754,1497	0.5414,0.7483,0.8224,0.6175,0.7179	0.6497							611731 [APC (confirmed) Adenomatous polyposis coli,175100|Gastric cancer,somatic,613659|Adenoma,periampullary,somatic|Hepatoblastoma,somatic,114550|Desmoid disease,hereditary,135290|Colorectal cancer,somatic,114500|Brain tumor-polyposis syndrome 2,175100|Gardner syndrome,175100];	42247 [benign, other DISEASE=hereditary_cancer-predisposing_syndrome,familial_adenomatous_polyposis_1,familial_colorectal_cancer,not_specified,apc-associated_polyposis_disorders]; 		COSM3760872	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD pLI=1.00), CTC-554D6.1 (inh=n/a pLI=n/a)
chr5	131892979	131892979	G	A	hom	off-target;anno_omim	QUAL=1592;DP=66;AF=0.98;MQM=60	RAD50	5'UTR	RAD50:ENST00000265335:5'UTR:MODIFIER:exon1/25:c.-38G>A:,RAD50:ENST00000378823:5'UTR:MODIFIER:exon1/25:c.-455G>A:		rs4526098	0.9249	0.9752	57988,33161,2994	0.7598,0.9862,1.0000,0.9969,0.9922	0.9797							604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder,613078];				n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR pLI=0.00)
chr5	131915213	131915213	G	A	het	off-target;anno_omim	QUAL=1499;DP=145;AF=0.46;MQM=60	RAD50	splice_region&intron	RAD50:ENST00000265335:splice_region&intron:LOW:exon4/24:c.551+19G>A:,RAD50:ENST00000378823:splice_region&intron:LOW:exon4/24:c.134+19G>A:		rs17166050	0.1677	0.1988	2524,1547,69	0.1170,0.1439,0.1701,0.2129,0.2240	0.1988							604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder,613078];	259870 [benign DISEASE=not_specified]; 	CS139954 [CLASS=DFP MUT=ALT PHEN="Acute lymphoblastic leukaemia decreased risk" GENE=RAD50]; 		n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR pLI=0.00)
chr5	131925483	131925483	G	C	het	pred_pathogenic;anno_omim	QUAL=814;DP=67;AF=0.49;MQM=60	RAD50	missense	RAD50:ENST00000265335:missense:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala,RAD50:ENST00000378823:missense:MODERATE:exon9/25:c.989G>C:p.Gly330Ala		rs55653181	0.0002	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0000	6.3310	T,T,T	T	B	T,T,T	18.91	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder,613078];	216618 [uncertain significance DISEASE=hereditary_cancer-predisposing_syndrome]; 			0	4					RAD50 (inh=AR pLI=0.00)
chr5	176334195	176334195	C	T	het	off-target	QUAL=11593;DP=625;AF=0.69;MQM=60	UIMC1	splice_region&intron	UIMC1:ENST00000377219:splice_region&intron:LOW:exon12/14:c.1852-17G>A:,UIMC1:ENST00000377227:splice_region&intron:LOW:exon12/14:c.1849-17G>A:,UIMC1:ENST00000506128:splice_region&intron:LOW:exon12/14:c.1351-17G>A:,UIMC1:ENST00000511320:splice_region&intron:LOW:exon12/14:c.1849-17G>A:		rs2292255	0.5905	0.5247	15293,7868,3362	0.8274,0.3588,0.4985,0.5222,0.4732	0.5923											n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a pLI=0.02)
chr5	176338288	176338288	C	T	het	off-target	QUAL=3679;DP=323;AF=0.48;MQM=60	UIMC1	intron	UIMC1:ENST00000377219:intron:MODIFIER:exon11/14:c.1679+24G>A:,UIMC1:ENST00000377227:intron:MODIFIER:exon11/14:c.1676+24G>A:,UIMC1:ENST00000506128:intron:MODIFIER:exon11/14:c.1178+24G>A:,UIMC1:ENST00000511320:intron:MODIFIER:exon11/14:c.1676+24G>A:		rs17078630	0.0092	0.0238	52,45,0	0.0052,0.0149,0.0001,0.0349,0.0050	0.0247											13	329					UIMC1 (inh=n/a pLI=0.02)
chr6	35420628	35420628	A	C	het	off-target;low_DP;anno_omim	QUAL=67;DP=8;AF=0.50;MQM=60	FANCE	intron	FANCE:ENST00000229769:intron:MODIFIER:exon1/9:c.248+58A>C:		rs9470029	0.6172	0.0000	0,0,0	0,0,0,0,0	0.6322							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];				n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR pLI=0.01)
chr6	35423489	35423489	A	G	het	off-target;anno_omim	QUAL=7904;DP=636;AF=0.49;MQM=60	FANCE	intron	FANCE:ENST00000229769:intron:MODIFIER:exon1/9:c.249-35A>G:		rs7757405	0.7766	0.7201	31745,15391,3873	0.8635,0.8243,0.6837,0.6803,0.7461	0.7428							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];	261434 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR pLI=0.01)
chr6	35423662	35423662	A	C	het	anno_omim	QUAL=884;DP=100;AF=0.41;MQM=60	FANCE	synonymous	FANCE:ENST00000229769:synonymous:LOW:exon2/10:c.387A>C:p.Pro129Pro		rs4713867	0.7780	0.7211	31791,15371,3918	0.8694,0.8254,0.6838,0.6807,0.7478	0.7434							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];	261435 [benign DISEASE=fanconi_anemia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR pLI=0.01)
chr6	35424188	35424188	A	G	het	off-target;anno_omim	QUAL=1441;DP=106;AF=0.53;MQM=60	FANCE	intron	FANCE:ENST00000229769:intron:MODIFIER:exon2/9:c.855+58A>G:		rs3800377	0.7191	0.0000	0,0,0	0,0,0,0,0	0.7157							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];				n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR pLI=0.01)
chr6	35425416	35425416	A	G	het	off-target;anno_omim	QUAL=10912;DP=832;AF=0.50;MQM=60	FANCE	intron	FANCE:ENST00000229769:intron:MODIFIER:exon3/9:c.900+39A>G:		rs13214239	0.3596	0.4966	15583,9793,110	0.1347,0.6463,0.3644,0.5487,0.4341	0.5042							613976 [FANCE (provisional) Fanconi anemia,complementation group E,600901];	261436 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR pLI=0.01)
chr6	131148863	131148863	A	T	het		QUAL=4396;DP=373;AF=0.52;MQM=60	SMLR1	intron	SMLR1:ENST00000541421:intron:MODIFIER:exon1/1:c.238+72A>T:		rs9388856	0.4794	0.0000	0,0,0	0,0,0,0,0	0.3798											n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a pLI=n/a)
chr6	131148891	131148891	-	AT	het	off-target	QUAL=6756;DP=703;AF=0.41;MQM=60	SMLR1	intron	SMLR1:ENST00000541421:intron:MODIFIER:exon1/1:c.238+113_238+114dupAT:		rs113795427;rs753973009	0.4884	0.0000	0,0,0	0,0,0,0,0	0.3974											n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a pLI=n/a)
chr7	6026775	6026775	T	C	hom	pred_pathogenic;anno_omim	QUAL=527;DP=22;AF=1.00;MQM=60	PMS2	missense,intron	PMS2:ENST00000265849:missense:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu,PMS2:ENST00000441476:missense:MODERATE:exon8/12:c.1303A>G:p.Lys435Glu,PMS2:ENST00000406569:missense:MODERATE:exon11/12:c.1621A>G:p.Lys541Glu,PMS2:ENST00000382321:intron:MODIFIER:exon7/10:c.804-4153A>G:		rs2228006	0.8832	0.8514	44055,24216,4305	0.9229,0.6563,0.9238,0.8550,0.8961	0.8722	1.4430	T,T,T,T	T	B,B,B	T,T,D	0.14	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	135065 [benign DISEASE=hereditary_nonpolyposis_colorectal_cancer_type_4,not_specified]; 		COSM4162329	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD pLI=0.00)
chr7	6036980	6036980	G	C	hom	anno_omim	QUAL=763;DP=26;AF=1.00;MQM=60	PMS2	synonymous	PMS2:ENST00000265849:synonymous:LOW:exon7/15:c.780C>G:p.Ser260Ser,PMS2:ENST00000441476:synonymous:LOW:exon4/12:c.462C>G:p.Ser154Ser,PMS2:ENST00000382321:synonymous:LOW:exon7/11:c.780C>G:p.Ser260Ser,PMS2:ENST00000406569:synonymous:LOW:exon7/12:c.780C>G:p.Ser260Ser		rs1805319	0.8313	0.8109	39906,22309,3695	0.8459,0.6438,0.9219,0.8199,0.8172	0.8205							600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	36693 [benign DISEASE=hereditary_nonpolyposis_colon_cancer,hereditary_cancer-predisposing_syndrome,lynch_syndrome,not_specified]; 		COSM4162330	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD pLI=0.00)
chr7	6037057	6037057	-	A	het	anno_omim	QUAL=220;DP=28;AF=0.50;MQM=60	PMS2	splice_region&intron	PMS2:ENST00000265849:splice_region&intron:LOW:exon6/14:c.706-4dupT:,PMS2:ENST00000441476:splice_region&intron:LOW:exon3/11:c.388-4dupT:,PMS2:ENST00000382321:splice_region&intron:LOW:exon6/10:c.706-4dupT:,PMS2:ENST00000406569:splice_region&intron:LOW:exon6/11:c.706-4dupT:		rs570998668;rs774538869	0.0264	0.0393	0,0,0	0.0490,0.0373,0.0111,0.0421,0.0429	0.0961							600259 [PMS2 (confirmed) Mismatch repair cancer syndrome,276300|Colorectal cancer,hereditary nonpolyposis,type 4,614337];	198429 [conflicting interpretations of pathogenicity DISEASE=hereditary_nonpolyposis_colon_cancer,lynch_syndrome,hereditary_nonpolyposis_colorectal_cancer_type_4,not_specified]; 		COSM1735804	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD pLI=0.00)
chr7	128843169	128843169	C	T	hom	off-target;low_DP;anno_omim	QUAL=315;DP=12;AF=1.00;MQM=60	SMO	intron	SMO:ENST00000249373:intron:MODIFIER:exon1/11:c.332-56C>T:		rs2566871	0.4615	0.0000	0,0,0	0,0,0,0,0	0.4969							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];				n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a pLI=0.15)
chr7	128845018	128845018	C	T	hom	off-target;anno_omim	QUAL=6716;DP=206;AF=1.00;MQM=60	SMO	intron	SMO:ENST00000249373:intron:MODIFIER:exon2/11:c.538-26C>T:		rs2703091	0.7524	0.7960	38561,23420,2469	0.6883,0.7113,0.7579,0.8385,0.7664	0.7967							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];				n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a pLI=0.15)
chr7	128845277	128845277	G	C	hom	off-target;anno_omim	QUAL=1590;DP=55;AF=1.00;MQM=60	SMO	intron	SMO:ENST00000249373:intron:MODIFIER:exon3/11:c.747+24G>C:		rs2075777	0.7520	0.8013	30520,18440,1802	0.7005,0.7218,0.7656,0.8410,0.7678	0.7964							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];				n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a pLI=0.15)
chr7	128846328	128846328	G	C	hom	anno_omim	QUAL=28451;DP=909;AF=1.00;MQM=60	SMO	synonymous	SMO:ENST00000249373:synonymous:LOW:exon6/12:c.1164G>C:p.Gly388Gly		rs2228617	0.7562	0.7975	38862,23503,2520	0.6930,0.7136,0.7695,0.8386,0.7667	0.7982							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];	403462 [benign DISEASE=not_specified]; 		COSM4004294	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a pLI=0.15)
chr7	128846469	128846469	A	G	hom	off-target;anno_omim	QUAL=27652;DP=857;AF=1.00;MQM=60	SMO	intron	SMO:ENST00000249373:intron:MODIFIER:exon6/11:c.1264+41A>G:		rs2735842	0.7532	0.7971	38446,23377,2515	0.6936,0.7139,0.7598,0.8386,0.7682	0.7970							601500 [SMO (provisional) Basal cell carcinoma,somatic,605462|Curry-Jones syndrome,somatic mosaic,601707];				n/a (AF>5%)	n/a (AF>5%)					SMO (inh=n/a pLI=0.15)
chr7	142460261	142460261	T	A	hom	off-target;anno_omim	QUAL=2051;DP=69;AF=1.00;MQM=60	PRSS1	intron	PRSS1:ENST00000486171:intron:MODIFIER:exon4/5:c.497-21T>A:,PRSS1:ENST00000311737:intron:MODIFIER:exon3/4:c.455-21T>A:		rs201825825	0.9980	0.5815	9485,5327,520	0.5519,0.5953,0.6567,0.5834,0.5413	0.7902							276000 [PRSS1 (confirmed) Pancreatitis,hereditary,167800|Trypsinogen deficiency,614044];				n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AR+AD pLI=0.00)
chr7	142460313	142460313	T	C	hom	anno_omim	QUAL=4965;DP=165;AF=1.00;MQM=60	PRSS1	synonymous	PRSS1:ENST00000486171:synonymous:LOW:exon5/6:c.528T>C:p.Asp176Asp,PRSS1:ENST00000311737:synonymous:LOW:exon4/5:c.486T>C:p.Asp162Asp		rs6666	0.3966	0.3693	0,0,0	0.3447,0.3997,0.2022,0.4117,0.2580	0.4118							276000 [PRSS1 (confirmed) Pancreatitis,hereditary,167800|Trypsinogen deficiency,614044];	239391 [benign DISEASE=hereditary_pancreatitis,not_specified]; 		COSM4161889	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AR+AD pLI=0.00)
chr7	142460865	142460865	T	C	hom	anno_omim	QUAL=10142;DP=357;AF=1.00;MQM=60	PRSS1	synonymous	PRSS1:ENST00000486171:synonymous:LOW:exon6/6:c.780T>C:p.Asn260Asn,PRSS1:ENST00000311737:synonymous:LOW:exon5/5:c.738T>C:p.Asn246Asn		rs6667	0.3938	0.5041	16344,11218,985	0.4361,0.5517,0.2309,0.5803,0.3087	0.5213							276000 [PRSS1 (confirmed) Pancreatitis,hereditary,167800|Trypsinogen deficiency,614044];	258803 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AR+AD pLI=0.00)
chr8	90955624	90955624	T	A	het	off-target;anno_omim	QUAL=411;DP=31;AF=0.55;MQM=60	NBN	intron	NBN:ENST00000265433:intron:MODIFIER:exon13/15:c.2071-30A>T:,NBN:ENST00000409330:intron:MODIFIER:exon13/15:c.1825-30A>T:		rs3736639	0.3792	0.3535	7667,3557,535	0.3156,0.3480,0.4457,0.3289,0.4302	0.3540							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	258769 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	90958422	90958422	T	C	het	anno_omim	QUAL=584;DP=47;AF=0.55;MQM=60	NBN	synonymous	NBN:ENST00000265433:synonymous:LOW:exon13/16:c.2016A>G:p.Pro672Pro,NBN:ENST00000409330:synonymous:LOW:exon13/16:c.1770A>G:p.Pro590Pro		rs1061302	0.3528	0.3451	7411,3552,277	0.2278,0.3452,0.4444,0.3280,0.4301	0.3470							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	183696 [benign DISEASE=hereditary_cancer-predisposing_syndrome,microcephaly,_normal_intelligence_and_immunodeficiency,not_specified]; 		COSM3763441	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	90958530	90958530	T	C	het	anno_omim	QUAL=377;DP=36;AF=0.44;MQM=60	NBN	splice_region&intron	NBN:ENST00000265433:splice_region&intron:LOW:exon12/15:c.1915-7A>G:,NBN:ENST00000409330:splice_region&intron:LOW:exon12/15:c.1669-7A>G:		rs2308962	0.3790	0.3529	7684,3567,522	0.3151,0.3481,0.4442,0.3284,0.4290	0.3535							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	258768 [benign DISEASE=microcephaly,_normal_intelligence_and_immunodeficiency,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	90967711	90967711	A	G	het	anno_omim	QUAL=349;DP=37;AF=0.43;MQM=60	NBN	synonymous	NBN:ENST00000265433:synonymous:LOW:exon10/16:c.1197T>C:p.Asp399Asp,NBN:ENST00000409330:synonymous:LOW:exon10/16:c.951T>C:p.Asp317Asp		rs709816	0.6086	0.4676	14308,4457,3067	0.7691,0.5891,0.6466,0.3671,0.5164	0.5139							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	183701 [benign DISEASE=hereditary_cancer-predisposing_syndrome,microcephaly,_normal_intelligence_and_immunodeficiency,not_specified]; 		COSM3763442	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	90970935	90970935	G	A	het	off-target;anno_omim	QUAL=463;DP=48;AF=0.42;MQM=60	NBN	splice_region&intron	NBN:ENST00000265433:splice_region&intron:LOW:exon9/15:c.1124+18C>T:,NBN:ENST00000409330:splice_region&intron:LOW:exon9/15:c.878+18C>T:		rs2234744	0.3530	0.3446	7405,3556,278	0.2271,0.3447,0.4439,0.3277,0.4294	0.3468							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	199080 [benign DISEASE=hereditary_cancer-predisposing_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	90990479	90990479	C	G	het	pred_pathogenic;anno_omim	QUAL=10738;DP=828;AF=0.50;MQM=60	NBN	missense	NBN:ENST00000265433:missense:MODERATE:exon5/16:c.553G>C:p.Glu185Gln,NBN:ENST00000409330:missense:MODERATE:exon5/16:c.307G>C:p.Glu103Gln		rs1805794	0.3570	0.3453	7417,3546,292	0.2357,0.3451,0.4438,0.3275,0.4294	0.3472	2.1330	T,T,T,T	T	B	T,T,T	6.33	602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	134876 [benign DISEASE=hereditary_cancer-predisposing_syndrome,microcephaly,_normal_intelligence_and_immunodeficiency,not_specified]; 	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN]; 	COSM3763443	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	90995019	90995019	C	T	het	low_DP;anno_omim	QUAL=99;DP=19;AF=0.37;MQM=60	NBN	synonymous,5'UTR	NBN:ENST00000265433:synonymous:LOW:exon2/16:c.102G>A:p.Leu34Leu,NBN:ENST00000409330:5'UTR:MODIFIER:exon2/16:c.-145G>A:		rs1063045	0.3792	0.3527	7704,3573,531	0.3136,0.3477,0.4446,0.3283,0.4297	0.3536							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	183697 [benign DISEASE=hereditary_cancer-predisposing_syndrome,microcephaly,_normal_intelligence_and_immunodeficiency,not_specified]; 		COSM3763444	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	107236280	107236280	G	T	hom		QUAL=20602;DP=650;AF=1.00;MQM=60	SLC16A14P1,RP11,778D12.2	intergenic_region	778D12.2:ENSG00000213708-ENSG00000254021:intergenic_region:MODIFIER::n.107236280G>T:	LTR33	rs1393978	0.6096	0.0000	0,0,0	0,0,0,0,0	0.5551											n/a (AF>5%)	n/a (AF>5%)					SLC16A14P1 (inh=n/a pLI=n/a), PRPF31 (inh=AD pLI=0.95), 778D12.2 (inh=n/a pLI=n/a)
chr9	5921881	5921881	G	A	het	pred_pathogenic	QUAL=15214;DP=1060;AF=0.54;MQM=60	KIAA2026	missense	KIAA2026:ENST00000399933:missense:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile,KIAA2026:ENST00000381461:missense:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile		rs72697396	0.0002	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0001	0.0001	1.9050	D,D	T	B		10.38					0	6					KIAA2026 (inh=n/a pLI=n/a)
chr9	17235643	17235643	T	-	het	off-target	QUAL=521;DP=40;AF=0.60;MQM=60	CNTLN	splice_region&intron	CNTLN:ENST00000380647:splice_region&intron:LOW:exon3/25:c.535-7delT:,CNTLN:ENST00000262360:splice_region&intron:LOW:exon3/25:c.535-7delT:,CNTLN:ENST00000425824:splice_region&intron:LOW:exon3/25:c.535-7delT:,CNTLN:ENST00000380641:splice_region&intron:LOW:exon3/6:c.535-7delT:		rs397708736	0.9133	0.8147	40766,18442,4471	0.9553,0.9162,0.9998,0.7433,0.9308	0.7966											n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17273878	17273878	A	G	het		QUAL=1145;DP=64;AF=0.72;MQM=60	CNTLN	splice_region&intron	CNTLN:ENST00000380647:splice_region&intron:LOW:exon6/25:c.983+14A>G:,CNTLN:ENST00000262360:splice_region&intron:LOW:exon6/25:c.987+10A>G:,CNTLN:ENST00000425824:splice_region&intron:LOW:exon6/25:c.987+10A>G:,CNTLN:ENST00000380641:splice_region&intron:LOW:exon6/6:c.983+14A>G:		rs12376938	0.2258	0.2540	4272,2504,149	0.1768,0.1999,0.0799,0.2722,0.3636	0.2504											n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17273926	17273926	C	G	het	off-target;low_DP	QUAL=173;DP=16;AF=0.50;MQM=60	CNTLN	intron	CNTLN:ENST00000380647:intron:MODIFIER:exon6/25:c.983+62C>G:,CNTLN:ENST00000262360:intron:MODIFIER:exon6/25:c.987+58C>G:,CNTLN:ENST00000425824:intron:MODIFIER:exon6/25:c.987+58C>G:,CNTLN:ENST00000380641:intron:MODIFIER:exon6/6:c.983+62C>G:		rs12379655	0.3343	0.0000	0,0,0	0,0,0,0,0	0.2866											n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17342383	17342383	C	T	hom		QUAL=983;DP=30;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:ENST00000380647:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp,CNTLN:ENST00000262360:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp,CNTLN:ENST00000425824:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp		rs1442527	0.9495	0.9865	58803,33327,3518	0.8475,0.9913,1.0000,0.9996,0.9998	0.9887											n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17394536	17394536	C	T	hom		QUAL=1783;DP=56;AF=1.00;MQM=60	CNTLN	missense	CNTLN:ENST00000380647:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile,CNTLN:ENST00000262360:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile,CNTLN:ENST00000425824:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile		rs7035276	0.7806	0.8284	39183,24109,2187	0.6960,0.7505,0.8115,0.8720,0.7574	0.8298	0.3250	T,T,T	T	B,B,B	T,T,T	7.83					n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17394996	17394996	T	C	hom		QUAL=3142;DP=98;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:ENST00000380647:synonymous:LOW:exon15/26:c.2544T>C:p.His848His,CNTLN:ENST00000262360:synonymous:LOW:exon15/26:c.2544T>C:p.His848His,CNTLN:ENST00000425824:synonymous:LOW:exon15/26:c.2544T>C:p.His848His		rs3739489	0.8411	0.8799	46938,28083,2939	0.7749,0.7791,0.8155,0.9175,0.8721	0.8779											n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17395108	17395108	C	T	hom	off-target	QUAL=6825;DP=215;AF=1.00;MQM=60	CNTLN	intron	CNTLN:ENST00000380647:intron:MODIFIER:exon15/25:c.2615+41C>T:,CNTLN:ENST00000262360:intron:MODIFIER:exon15/25:c.2615+41C>T:,CNTLN:ENST00000425824:intron:MODIFIER:exon15/25:c.2615+41C>T:		rs3739488	0.7819	0.8306	38889,24447,2325	0.6977,0.7547,0.8128,0.8725,0.7514	0.8304											n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17409366	17409366	G	A	hom		QUAL=12154;DP=384;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:ENST00000380647:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr,CNTLN:ENST00000262360:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr,CNTLN:ENST00000425824:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr		rs2780211	0.8389	0.8748	46375,27819,2946	0.7781,0.7800,0.8149,0.9131,0.8525	0.8734										COSM3982792	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17457513	17457513	A	-	hom	low_DP;anno_high_impact	QUAL=104;DP=4;AF=1.00;MQM=60	CNTLN	splice_acceptor	CNTLN:ENST00000380647:splice_acceptor:HIGH:exon18/25:c.3115-2delA:,CNTLN:ENST00000262360:splice_acceptor:HIGH:exon18/25:c.3115-2delA:,CNTLN:ENST00000425824:splice_acceptor:HIGH:exon18/25:c.3115-2delA:	(TATATT)n	rs35399020;rs397766990	0.7342	0.8450	40782,25898,1543	0.6173,0.7465,0.7078,0.9139,0.7928	0.8546											n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	17494875	17494877	TTT	-	het	off-target	QUAL=311;DP=53;AF=0.28;MQM=60	CNTLN	splice_region&intron,intron	CNTLN:ENST00000262360:splice_region&intron:LOW:exon25/25:c.4120-11_4120-9delTTT:,CNTLN:ENST00000380647:intron:MODIFIER:exon25/25:c.4120-7655_4120-7653delTTT:,CNTLN:ENST00000425824:intron:MODIFIER:exon25/25:c.4120-7655_4120-7653delTTT:	Tigger3b:AluSx	rs776507555	0.0000	0.0003	0,0,0	0.0000,0.0000,0.0000,0.0000,0.0000	0.0467											174	19	2	[2] auto-classification 15.09.2017  			CNTLN (inh=n/a pLI=0.00)
chr9	17494875	17494875	T	-	het	off-target	QUAL=311;DP=53;AF=0.19;MQM=60	CNTLN	splice_region&intron,intron	CNTLN:ENST00000262360:splice_region&intron:LOW:exon25/25:c.4120-9delT:,CNTLN:ENST00000380647:intron:MODIFIER:exon25/25:c.4120-7653delT:,CNTLN:ENST00000425824:intron:MODIFIER:exon25/25:c.4120-7653delT:	Tigger3b:AluSx	rs35224903	0.0000	0.0003	0,0,0	0.0000,0.0000,0.0000,0.0010,0.0000	0.4820											n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a pLI=0.00)
chr9	35074917	35074917	T	C	hom	anno_omim	QUAL=3127;DP=99;AF=1.00;MQM=60	FANCG	splice_region&intron	FANCG:ENST00000378643:splice_region&intron:LOW:exon12/13:c.1636+7A>G:		rs587118	0.2202	0.3957	11389,8269,33	0.0810,0.5121,0.0039,0.4965,0.2672	0.4029							602956 [FANCG (confirmed) Fanconi anemia,complementation group G,614082];	259477 [benign DISEASE=fanconi_anemia,not_specified,amyotrophic_lateral_sclerosis,_dominant,inclusion_body_myopathy,_dominant]; 			n/a (AF>5%)	n/a (AF>5%)					FANCG (inh=n/a pLI=0.00)
chr9	35077441	35077441	T	C	hom	off-target;anno_omim	QUAL=6891;DP=209;AF=1.00;MQM=60	FANCG	intron	FANCG:ENST00000378643:intron:MODIFIER:exon4/13:c.511-45A>G:		rs554098	0.7015	0.7459	34313,20097,2882	0.7440,0.8530,0.4653,0.7761,0.7100	0.7489							602956 [FANCG (confirmed) Fanconi anemia,complementation group G,614082];	259478 [benign DISEASE=not_specified]; 		COSN168536	n/a (AF>5%)	n/a (AF>5%)					FANCG (inh=n/a pLI=0.00)
chr9	90062823	90062823	A	G	hom		QUAL=14896;DP=528;AF=1.00;MQM=60	RP11,497K15.1,DAPK1	intergenic_region	DAPK1:ENSG00000228373-ENSG00000196730:intergenic_region:MODIFIER::n.90062823A>G:		rs12682834	0.6368	0.6466	23839,12412,915	0.4769,0.7028,0.6831,0.6351,0.7421	0.6502											n/a (AF>5%)	n/a (AF>5%)					PRPF31 (inh=AD pLI=0.95), 497K15.1 (inh=n/a pLI=n/a), DAPK1 (inh=n/a pLI=1.00)
chr9	98209594	98209594	G	A	het	pred_pathogenic;pred_pathogenic_3;anno_omim	QUAL=1180;DP=71;AF=0.66;MQM=60	PTCH1	missense	PTCH1:ENST00000331920:missense:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu,PTCH1:ENST00000418258:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:ENST00000421141:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:ENST00000437951:missense:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu,PTCH1:ENST00000430669:missense:MODERATE:exon23/23:c.3746C>T:p.Pro1249Leu,PTCH1:ENST00000429896:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:ENST00000375274:missense:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu		rs357564	0.3968	0.3855	9126,3704,255	0.2385,0.5013,0.5667,0.3410,0.4485	0.3889	9.4050	D,D,D,D,D,D,D,D	T	P,P,B	D,D,D,D,D,D,D	28.80	601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];	41663 [benign DISEASE=holoprosencephaly,gorlin_syndrome,hereditary_cancer-predisposing_syndrome,not_specified,not_provided]; 		COSM1638395, COSM1638394, COSM1638396, COSM1638397	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD pLI=1.00)
chr9	98232224	98232224	A	-	het	anno_omim	QUAL=263;DP=59;AF=0.54;MQM=60	PTCH1	splice_region&intron	PTCH1:ENST00000331920:splice_region&intron:LOW:exon12/23:c.1729-11delT:,PTCH1:ENST00000418258:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:ENST00000421141:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:ENST00000437951:splice_region&intron:LOW:exon12/23:c.1531-11delT:,PTCH1:ENST00000430669:splice_region&intron:LOW:exon12/22:c.1531-11delT:,PTCH1:ENST00000429896:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:ENST00000375274:splice_region&intron:LOW:exon12/23:c.1726-11delT:		rs779000277	0.0000	0.0014	2,2,0	0.0000,0.0005,0.0000,0.0024,0.0000	0.0011							601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];				0	19					PTCH1 (inh=AD pLI=1.00)
chr9	98239190	98239190	G	C	hom	off-target;anno_omim	QUAL=1285;DP=42;AF=1.00;MQM=60	PTCH1	intron	PTCH1:ENST00000331920:intron:MODIFIER:exon10/23:c.1504-51C>G:,PTCH1:ENST00000418258:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:ENST00000421141:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:ENST00000437951:intron:MODIFIER:exon10/23:c.1306-51C>G:,PTCH1:ENST00000430669:intron:MODIFIER:exon10/22:c.1306-51C>G:,PTCH1:ENST00000429896:intron:MODIFIER:exon10/23:c.1051-51C>G:,PTCH1:ENST00000375274:intron:MODIFIER:exon10/23:c.1501-51C>G:		rs574688	0.1627	0.2302	2455,1639,15	0.0540,0.2112,0.0665,0.2690,0.2765	0.2283							601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];				n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD pLI=1.00)
chr10	43595968	43595968	A	G	hom	anno_omim	QUAL=16324;DP=535;AF=1.00;MQM=60	RET	synonymous	RET:ENST00000355710:synonymous:LOW:exon2/20:c.135A>G:p.Ala45Ala,RET:ENST00000340058:synonymous:LOW:exon2/19:c.135A>G:p.Ala45Ala		rs1800858	0.7536	0.7365	33200,17899,4676	0.9516,0.7545,0.5491,0.7351,0.7313	0.7726							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623|Hirschsprung disease,protection against,142623];	167589 [benign DISEASE=not_specified]; 		COSM4144677, COSM4144678	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD pLI=1.00)
chr10	43612226	43612226	C	T	het	off-target;anno_omim	QUAL=2409;DP=326;AF=0.45;MQM=60	RET	intron	RET:ENST00000355710:intron:MODIFIER:exon12/19:c.2284+47C>T:,RET:ENST00000340058:intron:MODIFIER:exon12/18:c.2284+47C>T:		rs760466	0.1206	0.2145	3184,2585,13	0.0543,0.1945,0.0636,0.2803,0.1428	0.2076							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623|Hirschsprung disease,protection against,142623];	261396 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD pLI=1.00)
chr10	43613843	43613843	G	T	hom	anno_omim	QUAL=37745;DP=1158;AF=1.00;MQM=60	RET	synonymous	RET:ENST00000355710:synonymous:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:ENST00000340058:synonymous:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.7419	33769,19608,4074	0.8852,0.7684,0.4999,0.7685,0.6419	0.7799							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623|Hirschsprung disease,protection against,142623];	167590 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD pLI=1.00)
chr10	43615505	43615505	G	A	het	off-target;anno_omim	QUAL=9231;DP=736;AF=0.51;MQM=60	RET	intron	RET:ENST00000355710:intron:MODIFIER:exon14/19:c.2608-24G>A:,RET:ENST00000340058:intron:MODIFIER:exon14/18:c.2608-24G>A:		rs2472737	0.1731	0.2127	2529,1606,104	0.1584,0.1548,0.2358,0.2302,0.1680	0.2082							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623|Hirschsprung disease,protection against,142623];	24956 [benign DISEASE=no_men2_disease,not_specified]; 	CS116395 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD pLI=1.00)
chr10	43622217	43622217	T	C	hom	off-target;anno_omim	QUAL=1163;DP=42;AF=1.00;MQM=60	RET	3'UTR,intron	RET:ENST00000340058:3'UTR:MODIFIER:exon19/19:c.*15T>C:,RET:ENST00000355710:intron:MODIFIER:exon19/19:c.3187+47T>C:		rs2075912	0.7550	0.8031	33460,19436,3910	0.9186,0.8035,0.5352,0.8291,0.7458	0.8233							164761 [RET (confirmed) Multiple endocrine neoplasia IIA,171400|Medullary thyroid carcinoma,155240|Multiple endocrine neoplasia IIB,162300|Central hypoventilation syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung disease,susceptibility to,1,142623|Hirschsprung disease,protection against,142623];	165056 [benign DISEASE=not_specified]; 	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET]; 		n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD pLI=1.00)
chr10	88635779	88635779	C	A	het	pred_pathogenic;anno_omim	QUAL=850;DP=71;AF=0.56;MQM=52	BMPR1A	missense	BMPR1A:ENST00000372037:missense:MODERATE:exon3/13:c.4C>A:p.Pro2Thr		rs11528010	0.4998	0.3558	9160,2415,2340	0.6641,0.3955,0.7194,0.2675,0.2993	0.4141	3.7680	T,T	T	B	D	8.67	601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal,174900|Polyposis syndrome,hereditary mixed,2,610069|Juvenile polyposis syndrome,infantile form,174900];	41782 [benign DISEASE=hereditary_cancer-predisposing_syndrome,juvenile_polyposis_syndrome,not_specified,juvenile_polyposis,not_provided]; 		COSM3752019, COSM3752020	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD pLI=0.64)
chr10	88649763	88649763	C	T	het	off-target;anno_omim	QUAL=672;DP=53;AF=0.49;MQM=60	BMPR1A	intron	BMPR1A:ENST00000372037:intron:MODIFIER:exon3/12:c.68-56C>T:		rs7087358	0.5312	0.0000	0,0,0	0,0,0,0,0	0.4605							601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal,174900|Polyposis syndrome,hereditary mixed,2,610069|Juvenile polyposis syndrome,infantile form,174900];				n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD pLI=0.64)
chr10	88683122	88683122	T	C	het	off-target;anno_omim	QUAL=5568;DP=620;AF=0.45;MQM=60	BMPR1A	splice_region&intron	BMPR1A:ENST00000372037:splice_region&intron:LOW:exon11/12:c.1343-11T>C:		rs7074064	0.4966	0.3538	9075,2400,2368	0.6675,0.3717,0.7199,0.2665,0.3028	0.4136							601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal,174900|Polyposis syndrome,hereditary mixed,2,610069|Juvenile polyposis syndrome,infantile form,174900];	259286 [benign DISEASE=not_specified,juvenile_polyposis]; 			n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD pLI=0.64)
chr10	89720907	89720907	T	G	het	off-target;anno_omim	QUAL=251;DP=29;AF=0.52;MQM=60	PTEN	intron	PTEN:ENST00000371953:intron:MODIFIER:exon8/8:c.1026+32T>G:		rs555895	0.4325	0.3699	8381,3687,1202	0.5007,0.4550,0.4829,0.3381,0.3119	0.3864							601728 [PTEN (confirmed) Cowden syndrome 1,158350|Lhermitte-Duclos syndrome,158350|Bannayan-Riley-Ruvalcaba syndrome,153480|Meningioma,607174|Glioma susceptibility 2,613028|Macrocephaly/autism syndrome,605309|PTEN hamartoma tumor syndrome|VATER association with macrocephaly and ventriculomegaly,276950|Prostate cancer,somatic,176807|Malignant melanoma,somatic,155600|Endometrial carcinoma,somatic,608089|Squamous cell carcinoma,head and neck,somatic,275355];	92810 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AR+AD pLI=0.99)
chr10	104264107	104264107	C	T	hom	anno_omim	QUAL=9942;DP=414;AF=1.00;MQM=60	SUFU	splice_region&intron	SUFU:ENST00000369902:splice_region&intron:LOW:exon1/11:c.182+16C>T:,SUFU:ENST00000369899:splice_region&intron:LOW:exon1/10:c.182+16C>T:,SUFU:ENST00000423559:splice_region&intron:LOW:exon1/9:c.182+16C>T:		rs2274351	0.3962	0.4857	14438,9985,516	0.3362,0.2931,0.3184,0.5573,0.4941	0.4761							607035 [SUFU (confirmed) Medulloblastoma,desmoplastic,155255|Meningioma,familial,susceptibility to,607174|Basal cell nevus syndrome,109400|Joubert syndrome 32,617757];	260689 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD pLI=1.00)
chr10	104356822	104356822	A	G	hom	off-target;anno_omim	QUAL=2286;DP=74;AF=1.00;MQM=60	SUFU	intron	SUFU:ENST00000369902:intron:MODIFIER:exon6/11:c.757-75A>G:,SUFU:ENST00000369899:intron:MODIFIER:exon6/10:c.757-75A>G:,SUFU:ENST00000423559:intron:MODIFIER:exon6/9:c.757-75A>G:		rs10786690	0.9902	0.0000	0,0,0	0,0,0,0,0	0.9931							607035 [SUFU (confirmed) Medulloblastoma,desmoplastic,155255|Meningioma,familial,susceptibility to,607174|Basal cell nevus syndrome,109400|Joubert syndrome 32,617757];				n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD pLI=1.00)
chr10	104387019	104387019	T	C	het	anno_omim	QUAL=14824;DP=1200;AF=0.49;MQM=60	SUFU	splice_region&intron	SUFU:ENST00000369902:splice_region&intron:LOW:exon11/11:c.1365+19T>C:		rs12414407	0.7196	0.6628	26892,13897,2970	0.7546,0.5756,0.7466,0.6442,0.7180	0.6862							607035 [SUFU (confirmed) Medulloblastoma,desmoplastic,155255|Meningioma,familial,susceptibility to,607174|Basal cell nevus syndrome,109400|Joubert syndrome 32,617757];	260688 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD pLI=1.00)
chr10	104389932	104389932	T	G	hom	anno_omim	QUAL=59615;DP=1897;AF=1.00;MQM=60	SUFU	3'UTR	SUFU:ENST00000369902:3'UTR:MODIFIER:exon12/12:c.*20T>G:		rs4917980	0.9974	0.9994	60625,33359,5139	0.9939,0.9996,1.0000,0.9999,1.0000	0.9995							607035 [SUFU (confirmed) Medulloblastoma,desmoplastic,155255|Meningioma,familial,susceptibility to,607174|Basal cell nevus syndrome,109400|Joubert syndrome 32,617757];				n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD pLI=1.00)
chr11	13102890	13102890	C	A	het	off-target	QUAL=22536;DP=1762;AF=0.50;MQM=60	CTC-497E21.5				rs2727397	0.5050	0.0000	0,0,0	0,0,0,0,0	0.5678											n/a (AF>5%)	n/a (AF>5%)					CTC-497E21.5 (inh=n/a pLI=n/a)
chr11	13102924	13102924	G	A	het		QUAL=293;DP=26;AF=0.54;MQM=60	CTC-497E21.5				rs2583136	0.5052	0.0000	0,0,0	0,0,0,0,0	0.5680											n/a (AF>5%)	n/a (AF>5%)					CTC-497E21.5 (inh=n/a pLI=n/a)
chr11	64572018	64572018	T	C	hom	pred_pathogenic;anno_omim	QUAL=8209;DP=259;AF=1.00;MQM=60	MEN1	missense	MEN1:ENST00000337652:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:ENST00000377316:missense:MODERATE:exon8/8:c.1456A>G:p.Thr486Ala,MEN1:ENST00000377321:missense:MODERATE:exon10/10:c.1516A>G:p.Thr506Ala,MEN1:ENST00000377326:missense:MODERATE:exon9/9:c.1621A>G:p.Thr541Ala,MEN1:ENST00000312049:missense:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala,MEN1:ENST00000315422:missense:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala,MEN1:ENST00000443283:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:ENST00000394374:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:ENST00000394376:missense:MODERATE:exon11/11:c.1636A>G:p.Thr546Ala,MEN1:ENST00000377313:missense:MODERATE:exon9/9:c.1636A>G:p.Thr546Ala		rs2959656	0.8345	0.9378	54048,33008,2619	0.7079,0.8797,0.7002,0.9952,0.9958	0.9391	0.1310	T,T,T,T,T,T,T,T,T,T	T	B,B,B	D,D,D,D,D,D,D,D,D,D	0.03	613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1,131100|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	134640 [benign DISEASE=not_specified]; 		COSM255213	n/a (AF>5%)	n/a (AF>5%)					MEN1 (inh=AD pLI=1.00)
chr11	64572557	64572557	A	G	hom	anno_omim	QUAL=6555;DP=204;AF=1.00;MQM=60	MEN1	synonymous,intron	MEN1:ENST00000337652:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:ENST00000377321:synonymous:LOW:exon9/10:c.1194T>C:p.His398His,MEN1:ENST00000377326:synonymous:LOW:exon8/9:c.1299T>C:p.His433His,MEN1:ENST00000312049:synonymous:LOW:exon9/10:c.1299T>C:p.His433His,MEN1:ENST00000315422:synonymous:LOW:exon9/10:c.1299T>C:p.His433His,MEN1:ENST00000443283:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:ENST00000394374:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:ENST00000394376:synonymous:LOW:exon10/11:c.1314T>C:p.His438His,MEN1:ENST00000377313:synonymous:LOW:exon8/9:c.1314T>C:p.His438His,MEN1:ENST00000377316:intron:MODIFIER:exon7/7:c.1186-269T>C:		rs540012	0.9760	0.9928	59759,33299,4389	0.9202,0.9962,1.0000,0.9999,0.9999	0.9944							613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1,131100|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	167288 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MEN1 (inh=AD pLI=1.00)
chr11	64577620	64577620	G	C	het	off-target;anno_omim	QUAL=269;DP=43;AF=0.49;MQM=60	MEN1	splice_region&intron,5'UTR	MEN1:ENST00000337652:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000377321:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000312049:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000315422:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000443283:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000394374:splice_region&intron:LOW:exon1/9:c.-23-16C>G:,MEN1:ENST00000394376:splice_region&intron:LOW:exon2/10:c.-23-16C>G:,MEN1:ENST00000377316:5'UTR:MODIFIER:exon1/8:c.-39C>G:,MEN1:ENST00000377326:5'UTR:MODIFIER:exon1/9:c.-39C>G:		rs509606	0.1749	0.3084	333,73,6	0.2095,0.5779,0.4982,0.2776,0.2720	0.1813							613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1,131100|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	439889 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MEN1 (inh=AD pLI=1.00)
chr11	108100105	108100105	-	TT	het	off-target;anno_omim	QUAL=406;DP=50;AF=0.20;MQM=60	ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon4/62:c.331+68_331+69dupTT:,ATM:ENST00000452508:intron:MODIFIER:exon5/63:c.331+68_331+69dupTT:		rs11390378	0.0000	0.1206	5,4,0	0.0403,0.0874,0.0408,0.0994,0.1949	0.1501							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00)
chr11	108100105	108100105	-	T	het	off-target;anno_omim	QUAL=406;DP=50;AF=0.44;MQM=60	ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon4/62:c.331+69dupT:,ATM:ENST00000452508:intron:MODIFIER:exon5/63:c.331+69dupT:		rs11390378;rs397713128	0.4848	0.4396	391,165,25	0.3647,0.4600,0.3948,0.4235,0.4745	0.4739							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00)
chr11	108119616	108119616	A	-	het	off-target;low_QUAL;anno_omim	QUAL=11;DP=36;AF=0.14;MQM=60	ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon8/62:c.1066-31delA:,ATM:ENST00000452508:intron:MODIFIER:exon9/63:c.1066-31delA:	AluSp	rs35813860	0.0000	0.3608	0,0,0	0.3275,0.3473,0.3650,0.3638,0.3720	0.3534							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00)
chr11	108129657	108129657	A	G	het	off-target;low_DP;anno_omim	QUAL=38;DP=16;AF=0.25;MQM=60	ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon15/62:c.2377-56A>G:,ATM:ENST00000452508:intron:MODIFIER:exon16/63:c.2377-56A>G:		rs672655	0.4764	0.0000	0,0,0	0,0,0,0,0	0.4867							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00)
chr11	108141956	108141956	T	-	het	off-target;anno_omim	QUAL=411;DP=192;AF=0.22;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region&intron:LOW:exon19/62:c.2922-8delT:,ATM:ENST00000452508:splice_region&intron:LOW:exon20/63:c.2922-8delT:		rs373881770	0.0000	0.4363	1,0,0	0.3998,0.3315,0.4452,0.4475,0.4617	0.4320							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00)
chr11	108150208	108150208	T	-	het	anno_omim	QUAL=889;DP=98;AF=0.39;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region&intron:LOW:exon22/62:c.3285-9delT:,ATM:ENST00000452508:splice_region&intron:LOW:exon23/63:c.3285-9delT:	(TTTG)n	rs1799757	0.0675	0.1845	730,488,5	0.0413,0.1616,0.0155,0.2381,0.1006	0.1139							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	181857 [benign/likely benign DISEASE=ataxia-telangiectasia_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00)
chr11	108151707	108151707	-	A	het	off-target;anno_omim	QUAL=1048;DP=77;AF=0.53;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region&intron:LOW:exon23/62:c.3403-13dupA:,ATM:ENST00000452508:splice_region&intron:LOW:exon24/63:c.3403-13dupA:		rs3218681	0.5421	0.5675	18905,10528,1022	0.4650,0.6185,0.3845,0.5758,0.6280	0.5618							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	181858 [benign/likely benign DISEASE=ataxia-telangiectasia_syndrome,hereditary_cancer-predisposing_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00)
chr11	108175394	108175394	T	C	het	low_DP;anno_omim	QUAL=161;DP=14;AF=0.57;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region&intron:LOW:exon36/62:c.5497-8T>C:,ATM:ENST00000452508:splice_region&intron:LOW:exon37/63:c.5497-8T>C:		rs3092829	0.0132	0.0230	38,34,0	0.0076,0.0164,0.0007,0.0332,0.0064	0.0226							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	132706 [benign DISEASE=ataxia-telangiectasia_syndrome,hereditary_cancer-predisposing_syndrome,not_specified]; 			10	548	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATM (inh=AR+AD pLI=0.00)
chr11	108175462	108175462	G	A	het	pred_pathogenic;anno_omim	QUAL=388;DP=30;AF=0.53;MQM=60	ATM	missense	ATM:ENST00000278616:missense:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn,ATM:ENST00000452508:missense:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn		rs1801516	0.0669	0.1101	953,666,5	0.0249,0.0524,0.0066,0.1433,0.0740	0.1146	6.3420	T,T	T	B	T,T	23.20	607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	128458 [benign/likely benign DISEASE=ataxia-telangiectasia_syndrome,hereditary_cancer-predisposing_syndrome,not_specified]; 	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM]; 	COSM41596, COSM3736031	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00)
chr11	108183167	108183167	A	G	hom	anno_omim	QUAL=14178;DP=445;AF=1.00;MQM=60	ATM,C11orf65	missense,intron	ATM:ENST00000278616:missense:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser,ATM:ENST00000452508:missense:MODERATE:exon41/64:c.5948A>G:p.Asn1983Ser,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.641-3369T>C:		rs659243	1.0000	1.0000	60654,33353,5170	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000	-1.0580	T,T	T	B,B	T,T	0.01	607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];	133627 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00), C11orf65 (inh=n/a pLI=0.00)
chr11	108225483	108225483	C	T	het	off-target;anno_omim	QUAL=1990;DP=159;AF=0.48;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron:MODIFIER:exon60/62:c.8787-55C>T:,ATM:ENST00000452508:intron:MODIFIER:exon61/63:c.8787-55C>T:,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.640+31164G>A:		rs664982	0.5351	0.0000	0,0,0	0,0,0,0,0	0.5278							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD pLI=0.00), C11orf65 (inh=n/a pLI=0.00)
chr11	108225661	108225661	A	G	het	off-target;anno_omim	QUAL=4410;DP=275;AF=0.58;MQM=60	C11orf65,ATM	intron	ATM:ENST00000278616:intron:MODIFIER:exon61/62:c.8850+60A>G:,ATM:ENST00000452508:intron:MODIFIER:exon62/63:c.8850+60A>G:,C11orf65:ENST00000525729:intron:MODIFIER:exon6/6:c.640+30986T>C:		rs664143	0.6282	0.0000	0,0,0	0,0,0,0,0	0.6048							607585 [ATM (confirmed) Ataxia-telangiectasia,208900|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to,114480|Lymphoma,mantle cell,somatic|T-cell prolymphocytic leukemia,somatic];				n/a (AF>5%)	n/a (AF>5%)					C11orf65 (inh=n/a pLI=0.00), ATM (inh=AR+AD pLI=0.00)
chr11	125497466	125497466	G	T	het	off-target	QUAL=1071;DP=108;AF=0.49;MQM=60	CHEK1	intron	CHEK1:ENST00000427383:intron:MODIFIER:exon2/11:c.337+738G>T:,CHEK1:ENST00000438015:intron:MODIFIER:exon2/12:c.66-36G>T:,CHEK1:ENST00000428830:intron:MODIFIER:exon2/13:c.66-36G>T:,CHEK1:ENST00000544373:intron:MODIFIER:exon2/11:c.66-36G>T:,CHEK1:ENST00000534070:intron:MODIFIER:exon2/12:c.66-36G>T:,CHEK1:ENST00000524737:intron:MODIFIER:exon1/12:c.66-36G>T:,CHEK1:ENST00000278916:intron:MODIFIER:exon1/10:c.66-36G>T:		rs491528	0.3530	0.3481	4414,2078,588	0.4026,0.2360,0.4664,0.3372,0.3769	0.3153											n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a pLI=0.00)
chr11	125514573	125514573	G	A	het	off-target	QUAL=843;DP=107;AF=0.42;MQM=60	CHEK1	intron	CHEK1:ENST00000427383:intron:MODIFIER:exon10/11:c.1281+35G>A:,CHEK1:ENST00000438015:intron:MODIFIER:exon11/12:c.1233+35G>A:,CHEK1:ENST00000428830:intron:MODIFIER:exon11/13:c.1233+35G>A:,CHEK1:ENST00000544373:intron:MODIFIER:exon11/11:c.1233+35G>A:,CHEK1:ENST00000534070:intron:MODIFIER:exon11/12:c.1233+35G>A:,CHEK1:ENST00000524737:intron:MODIFIER:exon10/12:c.1233+35G>A:,CHEK1:ENST00000278916:intron:MODIFIER:exon9/10:c.1101+410G>A:		rs521102	0.4361	0.5059	15784,8765,412	0.2796,0.6334,0.3903,0.5161,0.5813	0.5122											n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a pLI=0.00)
chr11	125525195	125525195	A	G	hom		QUAL=1962;DP=59;AF=1.00;MQM=60	CHEK1	missense	CHEK1:ENST00000427383:missense:MODERATE:exon12/12:c.1459A>G:p.Ile487Val,CHEK1:ENST00000438015:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:ENST00000428830:missense:MODERATE:exon13/14:c.1411A>G:p.Ile471Val,CHEK1:ENST00000544373:missense:MODERATE:exon12/12:c.1309A>G:p.Ile437Val,CHEK1:ENST00000534070:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:ENST00000524737:missense:MODERATE:exon12/13:c.1411A>G:p.Ile471Val,CHEK1:ENST00000278916:missense:MODERATE:exon11/11:c.1279A>G:p.Ile427Val		rs506504	0.9858	0.9726	57363,30871,5146	0.9951,0.9849,0.9997,0.9623,0.9812	0.9774	1.1780	T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T,T	0.83					n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a pLI=0.00)
chr12	58144665	58144665	C	T	het	off-target;anno_omim	QUAL=1951;DP=162;AF=0.49;MQM=60	CDK4	intron	CDK4:ENST00000257904:intron:MODIFIER:exon4/7:c.522+41G>A:,CDK4:ENST00000312990:intron:MODIFIER:exon3/6:c.265-211G>A:,CDK4:ENST00000549606:intron:MODIFIER:exon1/3:c.-158+1293G>A:,CDK4:ENST00000540325:intron:MODIFIER:exon3/6:c.162+41G>A:		rs2069502	0.3367	0.3541	8775,3639,30	0.0775,0.3607,0.6407,0.3232,0.4990	0.3552							123829 [CDK4 (confirmed) Melanoma,cutaneous malignant,3,609048];				n/a (AF>5%)	n/a (AF>5%)					CDK4 (inh=n/a pLI=0.98)
chr12	58145156	58145156	C	T	het	off-target;anno_omim	QUAL=5464;DP=416;AF=0.58;MQM=60	CDK4	intron	CDK4:ENST00000257904:intron:MODIFIER:exon2/7:c.219-31G>A:,CDK4:ENST00000312990:intron:MODIFIER:exon2/6:c.219-31G>A:,CDK4:ENST00000549606:intron:MODIFIER:exon1/3:c.-158+802G>A:,CDK4:ENST00000540325:intron:MODIFIER:exon2/6:c.-7+127G>A:		rs2270777	0.2480	0.3392	7925,6306,137	0.1670,0.2130,0.1568,0.4344,0.2362	0.3417							123829 [CDK4 (confirmed) Melanoma,cutaneous malignant,3,609048];				n/a (AF>5%)	n/a (AF>5%)					CDK4 (inh=n/a pLI=0.98)
chr13	32890572	32890572	G	A	het	off-target;anno_omim	QUAL=1359;DP=118;AF=0.45;MQM=60	BRCA2	5'UTR	BRCA2:ENST00000380152:5'UTR:MODIFIER:exon2/27:c.-26G>A:,BRCA2:ENST00000544455:5'UTR:MODIFIER:exon2/28:c.-26G>A:		rs1799943	0.2093	0.2465	3755,2063,51	0.1005,0.1895,0.3805,0.2581,0.2829	0.2455							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	125965 [benign DISEASE=fanconi_anemia,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_2,not_specified]; 	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2]; 		n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32903685	32903685	C	T	het	off-target;anno_omim	QUAL=606;DP=44;AF=0.55;MQM=60	BRCA2	intron	BRCA2:ENST00000380152:intron:MODIFIER:exon8/26:c.681+56C>T:,BRCA2:ENST00000544455:intron:MODIFIER:exon8/27:c.681+56C>T:		rs2126042	0.1859	0.0000	0,0,0	0,0,0,0,0	0.2161							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	126192 [benign DISEASE=breast-ovarian_cancer,_familial_2,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32905219	32905219	-	T	het	off-target;anno_omim	QUAL=103;DP=107;AF=0.17;MQM=60	BRCA2	intron	BRCA2:ENST00000380152:intron:MODIFIER:exon9/26:c.793+64dupT:,BRCA2:ENST00000544455:intron:MODIFIER:exon9/27:c.793+64dupT:		rs760080447	0.0000	0.0825	0,0,0	0.0767,0.0589,0.0482,0.0550,0.1776	0.1155							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];				n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32911888	32911888	A	G	het	anno_omim	QUAL=826;DP=75;AF=0.49;MQM=60	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.3396A>G:p.Lys1132Lys,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.3396A>G:p.Lys1132Lys		rs1801406	0.2668	0.2945	5391,3115,273	0.2292,0.2087,0.3848,0.3064,0.2924	0.2984							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	126010 [benign DISEASE=fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_2,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32913055	32913055	A	G	hom	anno_omim	QUAL=32057;DP=994;AF=1.00;MQM=60	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.4563A>G:p.Leu1521Leu,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.4563A>G:p.Leu1521Leu		rs206075	0.9740	0.9931	59672,33182,4417	0.9264,0.9967,0.9999,0.9995,0.9999	0.9945							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	132779 [benign DISEASE=fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_2,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32915005	32915005	G	C	hom	anno_omim	QUAL=857;DP=26;AF=1.00;MQM=60	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon11/27:c.6513G>C:p.Val2171Val,BRCA2:ENST00000544455:synonymous:LOW:exon11/28:c.6513G>C:p.Val2171Val		rs206076	0.9736	0.9930	59677,33272,4398	0.9253,0.9967,0.9999,0.9995,0.9998	0.9943							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	132780 [benign DISEASE=fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_2,not_specified]; 		COSM4147690, COSM4147689	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929232	32929232	A	G	het	anno_omim	QUAL=437;DP=38;AF=0.50;MQM=60	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous:LOW:exon14/27:c.7242A>G:p.Ser2414Ser,BRCA2:ENST00000544455:synonymous:LOW:exon14/28:c.7242A>G:p.Ser2414Ser		rs1799955	0.2326	0.2244	3228,1556,231	0.2116,0.1796,0.3847,0.2143,0.2161	0.2299							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	126133 [benign DISEASE=fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_2,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32929387	32929387	T	C	hom	pred_pathogenic;anno_omim	QUAL=19363;DP=598;AF=1.00;MQM=60	BRCA2	missense	BRCA2:ENST00000380152:missense:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala,BRCA2:ENST00000544455:missense:MODERATE:exon14/28:c.7397T>C:p.Val2466Ala		rs169547	0.9758	0.9937	59912,33304,4522	0.9330,0.9970,0.9999,0.9996,0.9998	0.9950	2.3530	T,T	T		T,T	0.37	600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	133738 [conflicting interpretations of pathogenicity DISEASE=ductal_breast_carcinoma,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	32936646	32936646	T	C	hom	off-target;anno_omim	QUAL=2098;DP=63;AF=1.00;MQM=60	BRCA2	splice_region&intron	BRCA2:ENST00000380152:splice_region&intron:LOW:exon16/26:c.7806-14T>C:,BRCA2:ENST00000544455:splice_region&intron:LOW:exon16/27:c.7806-14T>C:		rs9534262	0.5316	0.5208	16490,8840,1661	0.5729,0.5100,0.5544,0.5137,0.4878	0.5470							600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555|Fanconi anemia,complementation group D1,605724|Prostate cancer,176807|Breast cancer,male,susceptibility to,114480|Wilms tumor,194070|Medulloblastoma,155255|Glioblastoma 3,613029|Pancreatic cancer 2,613347];	126158 [benign DISEASE=fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_2,not_specified]; 	CS147979 [CLASS=FP MUT=ALT PHEN="Alternative splicing" GENE=BRCA2]; 		n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD pLI=0.00)
chr13	79766188	79766188	A	G	het		QUAL=10953;DP=825;AF=0.52;MQM=60	BCAS2P3,RBM26	intergenic_region	RBM26:ENSG00000226670-ENSG00000139746:intergenic_region:MODIFIER::n.79766188A>G:		rs2988039	0.5066	0.3571	7871,1863,1908	0.6999,0.4414,0.7111,0.2617,0.3608	0.4099											n/a (AF>5%)	n/a (AF>5%)					BCAS2P3 (inh=n/a pLI=n/a), RBM26 (inh=n/a pLI=1.00)
chr14	45606387	45606387	A	G	het	pred_pathogenic;pred_pathogenic_3	QUAL=593;DP=53;AF=0.47;MQM=60	FANCM	missense	FANCM:ENST00000267430:missense:MODERATE:exon2/23:c.624A>G:p.Ile208Met,FANCM:ENST00000556036:missense:MODERATE:exon2/11:c.624A>G:p.Ile208Met,FANCM:ENST00000542564:missense:MODERATE:exon2/22:c.624A>G:p.Ile208Met		rs45547534	0.0054	0.0107	9,6,0	0.0030,0.0057,0.0000,0.0149,0.0100	0.0102	0.1250	D,D,D	T	D,D,P	T,T,T	24.00		241326 [benign DISEASE=fanconi_anemia,not_specified]; 		COSM3753963	3	153	2	[2] Ilnaz Sepahi 12-10-2016 batch import			FANCM (inh=AR pLI=0.00)
chr14	68290372	68290372	T	G	het	off-target	QUAL=6800;DP=523;AF=0.50;MQM=60	RAD51B	intron	RAD51B:ENST00000487861:intron:MODIFIER:exon2/10:c.84+28T>G:,RAD51B:ENST00000471583:intron:MODIFIER:exon2/10:c.84+28T>G:,RAD51B:ENST00000487270:intron:MODIFIER:exon2/10:c.84+28T>G:,RAD51B:ENST00000488612:intron:MODIFIER:exon2/11:c.84+28T>G:,RAD51B:ENST00000390683:intron:MODIFIER:exon1/9:c.84+28T>G:		rs17783124	0.2504	0.3030	5813,4121,633	0.3526,0.1929,0.0786,0.3613,0.2367	0.3193											n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a pLI=0.00)
chr14	68301767	68301767	-	A	het	off-target	QUAL=2995;DP=252;AF=0.49;MQM=60	RAD51B	intron	RAD51B:ENST00000487861:intron:MODIFIER:exon3/10:c.199-22dupA:,RAD51B:ENST00000471583:intron:MODIFIER:exon3/10:c.199-22dupA:,RAD51B:ENST00000487270:intron:MODIFIER:exon3/10:c.199-22dupA:,RAD51B:ENST00000488612:intron:MODIFIER:exon3/11:c.199-22dupA:,RAD51B:ENST00000390683:intron:MODIFIER:exon2/9:c.199-22dupA:		rs397897257;rs531055380	0.3195	0.3203	6502,4087,1269	0.5000,0.2065,0.1464,0.3582,0.2371	0.3701											n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a pLI=0.00)
chr14	68331675	68331675	A	T	hom	off-target	QUAL=13305;DP=531;AF=0.93;MQM=60	RAD51B	intron	RAD51B:ENST00000487861:intron:MODIFIER:exon4/10:c.316-45A>T:,RAD51B:ENST00000471583:intron:MODIFIER:exon4/10:c.316-45A>T:,RAD51B:ENST00000487270:intron:MODIFIER:exon4/10:c.316-45A>T:,RAD51B:ENST00000488612:intron:MODIFIER:exon4/11:c.316-45A>T:,RAD51B:ENST00000390683:intron:MODIFIER:exon3/9:c.316-45A>T:		rs1474939	0.0000	0.9998	9038,3595,1015	0.9990,1.0000,1.0000,0.9997,1.0000	0.9758											n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a pLI=0.00)
chr14	68944344	68944344	T	-	het	off-target	QUAL=901;DP=396;AF=0.20;MQM=60	RAD51B	splice_region&intron,intron	RAD51B:ENST00000471583:splice_region&intron:LOW:exon10/10:c.1037-8delT:,RAD51B:ENST00000487861:intron:MODIFIER:exon10/10:c.1036+9390delT:,RAD51B:ENST00000487270:intron:MODIFIER:exon10/10:c.1036+9390delT:,RAD51B:ENST00000488612:intron:MODIFIER:exon10/11:c.1036+9390delT:,RAD51B:ENST00000390683:intron:MODIFIER:exon9/9:c.1036+9390delT:	(T)n	rs567396898;rs768547850	0.2957	0.3406	2,0,2	0.3429,0.3331,0.3066,0.3415,0.3575	0.3354											n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a pLI=0.00)
chr14	104165753	104165753	G	A	het	anno_omim	QUAL=12804;DP=967;AF=0.51;MQM=60	XRCC3,KLC1	missense,intron	XRCC3:ENST00000352127:missense:MODERATE:exon7/9:c.722C>T:p.Thr241Met,XRCC3:ENST00000554913:missense:MODERATE:exon8/10:c.722C>T:p.Thr241Met,XRCC3:ENST00000553264:missense:MODERATE:exon6/8:c.722C>T:p.Thr241Met,XRCC3:ENST00000555055:missense:MODERATE:exon8/10:c.722C>T:p.Thr241Met,XRCC3:ENST00000445556:missense:MODERATE:exon7/9:c.722C>T:p.Thr241Met,XRCC3:ENST00000554974:missense:MODERATE:exon2/4:c.107C>T:p.Thr36Met,KLC1:ENST00000334553:intron:MODIFIER:exon15/16:c.1849-1239G>A:,KLC1:ENST00000348520:intron:MODIFIER:exon13/14:c.1651-1239G>A:,KLC1:ENST00000555836:intron:MODIFIER:exon15/16:c.1822-1239G>A:,KLC1:ENST00000557450:intron:MODIFIER:exon13/14:c.1624-1239G>A:,KLC1:ENST00000452929:intron:MODIFIER:exon14/15:c.1782-1239G>A:,KLC1:ENST00000554280:intron:MODIFIER:exon14/15:c.1755-1239G>A:		rs861539	0.2169	0.3075	5751,4513,219	0.2232,0.1645,0.0586,0.3903,0.2474	0.2910	0.6420	T,T,T,T,T,T	T	B	T,T,T,T,T,T	10.54	600675 [XRCC3 (provisional) Melanoma,cutaneous malignant,6,613972|Breast cancer,susceptibility to,114480];	8944 [risk factor DISEASE=cutaneous_malignant_melanoma_6]; 	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3]; 	COSM1128325	n/a (AF>5%)	n/a (AF>5%)					XRCC3 (inh=n/a pLI=0.00), KLC1 (inh=n/a pLI=0.74)
chr14	105242966	105242966	T	C	het	off-target;anno_omim	QUAL=1980;DP=134;AF=0.61;MQM=60	AKT1	intron	AKT1:ENST00000349310:intron:MODIFIER:exon5/14:c.287+30A>G:,AKT1:ENST00000554581:intron:MODIFIER:exon3/12:c.287+30A>G:,AKT1:ENST00000407796:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:ENST00000402615:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:ENST00000555528:intron:MODIFIER:exon4/13:c.287+30A>G:,AKT1:ENST00000544168:intron:MODIFIER:exon2/11:c.101+30A>G:,AKT1:ENST00000554848:intron:MODIFIER:exon4/13:c.287+30A>G:		rs2494735	0.5964	0.4649	13485,4174,2524	0.7049,0.6037,0.6490,0.3628,0.5490	0.4871							164730 [AKT1 (confirmed) Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Ovarian cancer,somatic,167000|Schizophrenia,susceptibility to,181500|Proteus syndrome,somatic,176920|Cowden syndrome 6,615109];				n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD pLI=0.97)
chr14	105258892	105258892	C	T	hom	off-target;anno_omim	QUAL=3612;DP=111;AF=1.00;MQM=60	AKT1	intron	AKT1:ENST00000349310:intron:MODIFIER:exon3/14:c.46+43G>A:,AKT1:ENST00000554581:intron:MODIFIER:exon1/12:c.46+43G>A:,AKT1:ENST00000407796:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:ENST00000402615:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:ENST00000555528:intron:MODIFIER:exon2/13:c.46+43G>A:,AKT1:ENST00000554848:intron:MODIFIER:exon2/13:c.46+43G>A:		rs2494748	0.3562	0.5107	16940,12430,349	0.2561,0.4494,0.1960,0.6158,0.4175	0.5148							164730 [AKT1 (confirmed) Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Ovarian cancer,somatic,167000|Schizophrenia,susceptibility to,181500|Proteus syndrome,somatic,176920|Cowden syndrome 6,615109];				n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD pLI=0.97)
chr14	105258893	105258893	A	G	hom	off-target;anno_omim	QUAL=3612;DP=111;AF=1.00;MQM=60	AKT1	intron	AKT1:ENST00000349310:intron:MODIFIER:exon3/14:c.46+42T>C:,AKT1:ENST00000554581:intron:MODIFIER:exon1/12:c.46+42T>C:,AKT1:ENST00000407796:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:ENST00000402615:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:ENST00000555528:intron:MODIFIER:exon2/13:c.46+42T>C:,AKT1:ENST00000554848:intron:MODIFIER:exon2/13:c.46+42T>C:		rs2494749	0.7093	0.8237	42310,27943,4018	0.8854,0.6892,0.3421,0.9238,0.6875	0.8742							164730 [AKT1 (confirmed) Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Ovarian cancer,somatic,167000|Schizophrenia,susceptibility to,181500|Proteus syndrome,somatic,176920|Cowden syndrome 6,615109];				n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD pLI=0.97)
chr15	40998342	40998342	T	G	het	off-target;anno_omim	QUAL=1309;DP=99;AF=0.56;MQM=60	RAD51	intron	RAD51:ENST00000382643:intron:MODIFIER:exon4/9:c.347-2881T>G:,RAD51:ENST00000423169:intron:MODIFIER:exon3/8:c.226-33T>G:,RAD51:ENST00000267868:intron:MODIFIER:exon3/9:c.226-33T>G:,RAD51:ENST00000557850:intron:MODIFIER:exon3/7:c.225+4943T>G:,RAD51:ENST00000532743:intron:MODIFIER:exon4/9:c.347-2881T>G:		rs45457497	0.3542	0.2652	6006,1024,329	0.2513,0.5441,0.6767,0.1719,0.2807	0.2708							179617 [RAD51 (confirmed) Breast cancer,susceptibility to,114480|Mirror movements 2,614508|Fanconi anemia,complementation group R,617244];				n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD pLI=0.99)
chr15	43701947	43701947	A	-	het		QUAL=368;DP=58;AF=0.43;MQM=60	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044:splice_region&intron:LOW:exon24/27:c.5306-8delT:,TP53BP1:ENST00000263801:splice_region&intron:LOW:exon24/27:c.5291-8delT:,TP53BP1:ENST00000382039:splice_region&intron:LOW:exon23/26:c.5156-8delT:,TP53BP1:ENST00000450115:splice_region&intron:LOW:exon24/27:c.5300-8delT:		rs397711844;rs56813954	0.2502	0.3694	2441,1310,43	0.2062,0.3860,0.4383,0.3781,0.3986	0.3494										COSM1608394	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43707808	43707808	A	T	het		QUAL=1611;DP=136;AF=0.46;MQM=60	TP53BP1	synonymous	TP53BP1:ENST00000382044:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:ENST00000263801:synonymous:LOW:exon23/28:c.5058T>A:p.Ser1686Ser,TP53BP1:ENST00000382039:synonymous:LOW:exon22/27:c.4923T>A:p.Ser1641Ser,TP53BP1:ENST00000450115:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser		rs2230451	0.1286	0.1634	1830,1156,143	0.1732,0.0941,0.0017,0.1873,0.2096	0.1601										COSM3754329	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43720156	43720156	A	-	het	off-target	QUAL=1080;DP=385;AF=0.18;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon18/27:c.3828+58delT:,TP53BP1:ENST00000263801:intron:MODIFIER:exon18/27:c.3813+58delT:,TP53BP1:ENST00000382039:intron:MODIFIER:exon18/26:c.3828+58delT:,TP53BP1:ENST00000450115:intron:MODIFIER:exon18/27:c.3828+58delT:	AluJb	rs879219800	0.0000	0.0000	0,0,0	0,0,0,0,0	0.0163											25	1841					TP53BP1 (inh=n/a pLI=1.00)
chr15	43720197	43720197	C	T	het	off-target	QUAL=4142;DP=350;AF=0.55;MQM=60	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044:splice_region&intron:LOW:exon18/27:c.3828+17G>A:,TP53BP1:ENST00000263801:splice_region&intron:LOW:exon18/27:c.3813+17G>A:,TP53BP1:ENST00000382039:splice_region&intron:LOW:exon18/26:c.3828+17G>A:,TP53BP1:ENST00000450115:splice_region&intron:LOW:exon18/27:c.3828+17G>A:		rs550239	0.3804	0.2075	4173,527,2160	0.6457,0.2175,0.4141,0.1172,0.2349	0.2747											n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43724646	43724646	T	G	hom	pred_pathogenic	QUAL=20028;DP=634;AF=1.00;MQM=60	TP53BP1	missense	TP53BP1:ENST00000382044:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:ENST00000263801:missense:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln,TP53BP1:ENST00000382039:missense:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln,TP53BP1:ENST00000450115:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln		rs2602141	0.5264	0.3750	10244,3163,3807	0.8518,0.3133,0.4170,0.3043,0.4526	0.4422	3.2610	T,T,T,T	T	B,B,B,B	T,T,T,T	12.43			CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3754330	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43730486	43730486	A	G	het	off-target	QUAL=11449;DP=895;AF=0.49;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon16/27:c.3191+36T>C:,TP53BP1:ENST00000263801:intron:MODIFIER:exon16/27:c.3176+36T>C:,TP53BP1:ENST00000382039:intron:MODIFIER:exon16/26:c.3191+36T>C:,TP53BP1:ENST00000450115:intron:MODIFIER:exon16/27:c.3191+36T>C:		rs16957730	0.1368	0.1666	1818,1126,187	0.2003,0.0954,0.0018,0.1880,0.2138	0.1656											n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43739686	43739686	-	A	het	low_QUAL	QUAL=7;DP=21;AF=0.24;MQM=60	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044:splice_region&intron:LOW:exon12/27:c.2717-4dupT:,TP53BP1:ENST00000263801:splice_region&intron:LOW:exon12/27:c.2702-4dupT:,TP53BP1:ENST00000382039:splice_region&intron:LOW:exon12/26:c.2717-4dupT:,TP53BP1:ENST00000450115:splice_region&intron:LOW:exon12/27:c.2717-4dupT:		rs753702168	0.0000	0.1141	1,0,0	0.0887,0.1920,0.1193,0.0952,0.1761	0.0749										COSM1735775	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43748304	43748304	A	G	hom		QUAL=30186;DP=958;AF=1.00;MQM=60	TP53BP1	synonymous	TP53BP1:ENST00000382044:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:ENST00000263801:synonymous:LOW:exon12/28:c.2487T>C:p.Asp829Asp,TP53BP1:ENST00000382039:synonymous:LOW:exon12/27:c.2502T>C:p.Asp834Asp,TP53BP1:ENST00000450115:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp		rs690367	0.5262	0.3739	10243,3157,3934	0.8659,0.3131,0.4163,0.3042,0.4373	0.4464										COSM3754331	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43762196	43762196	C	T	het	pred_pathogenic	QUAL=3267;DP=207;AF=0.57;MQM=60	TP53BP1	missense	TP53BP1:ENST00000382044:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:ENST00000263801:missense:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser,TP53BP1:ENST00000382039:missense:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser,TP53BP1:ENST00000450115:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser		rs689647	0.3824	0.2064	4213,530,2154	0.6456,0.2173,0.4150,0.1169,0.2284	0.2743	1.1390	D,D,D,D,T	T	B,B,B,B	T,T,T,T,T	15.65			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1]; 	COSM3754332	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43767774	43767774	G	C	hom		QUAL=3605;DP=116;AF=1.00;MQM=60	TP53BP1	missense	TP53BP1:ENST00000382044:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:ENST00000263801:missense:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu,TP53BP1:ENST00000382039:missense:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu,TP53BP1:ENST00000450115:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu		rs560191	0.5258	0.3737	10224,3146,3930	0.8657,0.3122,0.4173,0.3038,0.4376	0.4463	0.2260	T,T,T,T,T	T	B,B,B,B	T,T,T,T,T	10.81			CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3744615	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43773036	43773036	A	C	het	off-target	QUAL=10479;DP=864;AF=0.48;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon5/27:c.499+57T>G:,TP53BP1:ENST00000263801:intron:MODIFIER:exon5/27:c.484+57T>G:,TP53BP1:ENST00000382039:intron:MODIFIER:exon5/26:c.499+57T>G:,TP53BP1:ENST00000450115:intron:MODIFIER:exon5/27:c.499+57T>G:		rs7173383	0.1368	0.0000	0,0,0	0,0,0,0,0	0.1652											n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43784000	43784000	C	T	hom	off-target	QUAL=26780;DP=852;AF=1.00;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon3/27:c.287-49G>A:,TP53BP1:ENST00000263801:intron:MODIFIER:exon3/27:c.272-49G>A:,TP53BP1:ENST00000382039:intron:MODIFIER:exon3/26:c.287-49G>A:,TP53BP1:ENST00000450115:intron:MODIFIER:exon3/27:c.287-49G>A:		rs555252	0.9515	0.9843	58805,33322,3976	0.8783,0.9940,0.9991,0.9996,0.9670	0.9872											n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	75643615	75643615	-	T	hom	off-target	QUAL=337;DP=115;AF=0.21;MQM=60	NEIL1	intron	NEIL1:ENST00000355059:intron:MODIFIER:exon2/9:c.435-818dupT:,NEIL1:ENST00000564784:intron:MODIFIER:exon3/10:c.435-818dupT:,NEIL1:ENST00000569035:intron:MODIFIER:exon2/9:c.435-818dupT:		rs11422837;rs397739988;rs768966115	0.0000	0.0644	13,2,0	0.0000,0.0000,0.0000,0.0585,0.0635	0.3703											n/a (AF>5%)	n/a (AF>5%)					NEIL1 (inh=n/a pLI=0.00)
chr16	3639139	3639139	A	G	het	anno_omim	QUAL=1344;DP=102;AF=0.52;MQM=60	SLX4	synonymous	SLX4:ENST00000294008:synonymous:LOW:exon12/15:c.4500T>C:p.Asn1500Asn		rs3810812	0.7396	0.6116	23691,8817,3963	0.8755,0.6829,0.7233,0.5155,0.7649	0.6327							613278 [SLX4 (provisional) Fanconi anemia,complementation group P,613951];	262053 [benign DISEASE=fanconi_anemia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					SLX4 (inh=AR pLI=0.00)
chr16	3639230	3639230	G	A	het	pred_pathogenic;anno_omim;anno_pathogenic_hgmd	QUAL=1417;DP=112;AF=0.49;MQM=60	SLX4	missense	SLX4:ENST00000294008:missense:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0002,0.0000	0.0001	0.3390	T	T	B	T	20.60	613278 [SLX4 (provisional) Fanconi anemia,complementation group P,613951];		CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		0	6					SLX4 (inh=AR pLI=0.00)
chr16	23625463	23625463	A	T	hom	off-target;anno_omim	QUAL=1216;DP=38;AF=1.00;MQM=60	PALB2,CTD-2196E14.3	intron	PALB2:ENST00000261584:intron:MODIFIER:exon10/12:c.3114-51T>A:		rs249936	0.9968	0.9975	37488,19526,3750	1.0000,0.9995,1.0000,1.0000,0.9848	1.0000							610355 [PALB2 (provisional) Fanconi anemia,complementation group N,610832|Breast cancer,susceptibility to,114480|Pancreatic cancer,susceptibility to,3,613348];	126714 [likely benign DISEASE=familial_cancer_of_breast]; 			n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD pLI=0.00), CTD-2196E14.3 (inh=n/a pLI=n/a)
chr16	23640467	23640467	G	A	het	off-target;anno_omim	QUAL=249;DP=23;AF=0.48;MQM=60	PALB2	intron	PALB2:ENST00000261584:intron:MODIFIER:exon6/12:c.2586+58C>T:		rs249954	0.3500	0.0000	0,0,0	0,0,0,0,0	0.3119							610355 [PALB2 (provisional) Fanconi anemia,complementation group N,610832|Breast cancer,susceptibility to,114480|Pancreatic cancer,susceptibility to,3,613348];	126663 [benign DISEASE=familial_cancer_of_breast]; 			n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD pLI=0.00)
chr16	68771341	68771343	TCT	-	het	anno_omim	QUAL=532;DP=137;AF=0.32;MQM=60	CDH1	disruptive_inframe_deletion	CDH1:ENST00000261769:disruptive_inframe_deletion:MODERATE:exon1/16:c.23_25delTCT:p.Leu8_Ser9delinsPro,CDH1:ENST00000422392:disruptive_inframe_deletion:MODERATE:exon1/15:c.23_25delTCT:p.Leu8_Ser9delinsPro			0.0000	0.0000	0,0,0	0,0,0,0,0	0.0000							192090 [CDH1 (confirmed) Endometrial carcinoma,somatic,608089|Ovarian carcinoma,somatic,167000|Breast cancer,lobular,114480|Gastric cancer,familial diffuse,with or without cleft lip and/or palate,137215|Prostate cancer,susceptibility to,176807|Blepharocheilodontic syndrome 1,119580];				0	0					CDH1 (inh=AD pLI=0.20)
chr16	68771372	68771372	C	T	hom	anno_omim	QUAL=4020;DP=129;AF=0.99;MQM=60	CDH1	splice_region&intron	CDH1:ENST00000261769:splice_region&intron:LOW:exon1/15:c.48+6C>T:,CDH1:ENST00000422392:splice_region&intron:LOW:exon1/14:c.48+6C>T:		rs3743674	0.7634	0.8111	5304,2436,102	0.6490,0.7026,0.7274,0.8769,0.7861	0.8150							192090 [CDH1 (confirmed) Endometrial carcinoma,somatic,608089|Ovarian carcinoma,somatic,167000|Breast cancer,lobular,114480|Gastric cancer,familial diffuse,with or without cleft lip and/or palate,137215|Prostate cancer,susceptibility to,176807|Blepharocheilodontic syndrome 1,119580];	136692 [benign DISEASE=hereditary_cancer-predisposing_syndrome,hereditary_diffuse_gastric_cancer,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD pLI=0.20)
chr16	68771418	68771418	-	GCCCCAGCCCCGT	hom	off-target;anno_omim	QUAL=2561;DP=102;AF=0.99;MQM=60	CDH1	intron	CDH1:ENST00000261769:intron:MODIFIER:exon1/15:c.48+62_48+63insCGTGCCCCAGCCC:,CDH1:ENST00000422392:intron:MODIFIER:exon1/14:c.48+62_48+63insCGTGCCCCAGCCC:		rs147838237;rs74406246	0.6887	0.8100	3615,1177,49	0.6620,0.0000,0.0000,0.8923,0.7852	0.8100							192090 [CDH1 (confirmed) Endometrial carcinoma,somatic,608089|Ovarian carcinoma,somatic,167000|Breast cancer,lobular,114480|Gastric cancer,familial diffuse,with or without cleft lip and/or palate,137215|Prostate cancer,susceptibility to,176807|Blepharocheilodontic syndrome 1,119580];				n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD pLI=0.20)
chr16	68857441	68857441	T	C	het	anno_omim	QUAL=14801;DP=1164;AF=0.52;MQM=60	CDH1	synonymous	CDH1:ENST00000261769:synonymous:LOW:exon13/16:c.2076T>C:p.Ala692Ala,CDH1:ENST00000422392:synonymous:LOW:exon12/15:c.1893T>C:p.Ala631Ala		rs1801552	0.7187	0.6548	26404,13014,4084	0.8860,0.6704,0.6399,0.6241,0.6614	0.6962							192090 [CDH1 (confirmed) Endometrial carcinoma,somatic,608089|Ovarian carcinoma,somatic,167000|Breast cancer,lobular,114480|Gastric cancer,familial diffuse,with or without cleft lip and/or palate,137215|Prostate cancer,susceptibility to,176807|Blepharocheilodontic syndrome 1,119580];	142770 [benign DISEASE=hereditary_cancer-predisposing_syndrome,hereditary_diffuse_gastric_cancer,not_specified]; 	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1]; 	COSM3755010	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD pLI=0.20)
chr16	81816733	81816733	C	T	het	anno_omim	QUAL=4992;DP=430;AF=0.51;MQM=60	PLCG2	intron	PLCG2:ENST00000359376:intron:MODIFIER:exon1/32:c.-47-2815C>T:		rs8045964	0.4241	0.5194	6242,2864,337	0.4590,0.4982,0.3754,0.5004,0.6446	0.4297							600220 [PLCG2 (provisional) Familial cold autoinflammatory syndrome 3,614468|Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878];				n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD pLI=1.00)
chr16	81816787	81816787	T	A	hom	off-target;anno_omim	QUAL=24041;DP=746;AF=1.00;MQM=60	PLCG2	intron	PLCG2:ENST00000359376:intron:MODIFIER:exon1/32:c.-47-2761T>A:		rs4476171	0.9980	0.0000	0,0,0	0,0,0,0,0	0.9994							600220 [PLCG2 (provisional) Familial cold autoinflammatory syndrome 3,614468|Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878];				n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD pLI=1.00)
chr16	89805261	89805261	A	G	hom	off-target;anno_omim	QUAL=18058;DP=580;AF=1.00;MQM=60	FANCA,ZNF276	3'UTR,intron	ZNF276:ENST00000289816:3'UTR:MODIFIER:exon11/11:c.*607A>G:,FANCA:ENST00000389301:intron:MODIFIER:exon42/42:c.4260+29T>C:,FANCA:ENST00000568369:intron:MODIFIER:exon42/42:c.4264+29T>C:		rs1800359	0.8508	0.7044	31320,11656,4512	0.9316,0.8066,0.9872,0.5917,0.8030	0.7261							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255266 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00), ZNF276 (inh=n/a pLI=0.00)
chr16	89805977	89805977	G	A	het	off-target;anno_omim	QUAL=2205;DP=181;AF=0.48;MQM=60	FANCA,ZNF276	splice_region&intron,3'UTR	FANCA:ENST00000389301:splice_region&intron:LOW:exon39/42:c.3935-16C>T:,FANCA:ENST00000568369:splice_region&intron:LOW:exon39/42:c.3935-16C>T:,ZNF276:ENST00000289816:3'UTR:MODIFIER:exon11/11:c.*1323G>A:		rs1061646	0.5381	0.4098	1784,308,375	0.5413,0.5638,0.7009,0.2888,0.4579	0.4248							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255264 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00), ZNF276 (inh=n/a pLI=0.00)
chr16	89806347	89806347	A	T	het	off-target;anno_omim	QUAL=873;DP=48;AF=0.71;MQM=60	ZNF276,FANCA	3'UTR,intron	ZNF276:ENST00000289816:3'UTR:MODIFIER:exon11/11:c.*1693A>T:,FANCA:ENST00000389301:intron:MODIFIER:exon39/42:c.3934+55T>A:,FANCA:ENST00000568369:intron:MODIFIER:exon39/42:c.3934+55T>A:		rs7195906	0.7065	0.5227	18679,4716,3149	0.7749,0.6948,0.9832,0.3763,0.6083	0.5477	-0.5840		T	B		1.77	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	135541 [not provided DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=n/a pLI=0.00), FANCA (inh=AR pLI=0.00)
chr16	89815217	89815217	C	T	het	off-target;anno_omim	QUAL=1919;DP=159;AF=0.51;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon32/42:c.3240-42G>A:,FANCA:ENST00000568369:intron:MODIFIER:exon32/42:c.3240-42G>A:		rs1800345	0.5449	0.4311	8845,2051,1234	0.5608,0.6781,0.7715,0.3107,0.4854	0.4272							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255254 [benign DISEASE=not_specified]; 	CS137887 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89818491	89818491	T	C	het	off-target;anno_omim	QUAL=9378;DP=751;AF=0.49;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon31/42:c.3066+55A>G:,FANCA:ENST00000568369:intron:MODIFIER:exon31/42:c.3066+55A>G:		rs3743860	0.5865	0.0000	0,0,0	0,0,0,0,0	0.4734							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];				n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89831510	89831510	C	A	het	off-target;anno_omim	QUAL=11990;DP=972;AF=0.48;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon27/42:c.2602-36G>T:,FANCA:ENST00000568369:intron:MODIFIER:exon27/42:c.2602-36G>T:		rs2159116	0.0933	0.1518	1622,1173,10	0.0354,0.0998,0.0038,0.1913,0.1858	0.1465							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255248 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89836323	89836323	C	T	het	pred_pathogenic;anno_omim	QUAL=835;DP=96;AF=0.41;MQM=60	FANCA	missense	FANCA:ENST00000389301:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:ENST00000568369:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp		rs7195066	0.6667	0.4690	16070,3144,2387	0.6766,0.6797,0.9854,0.3064,0.5907	0.4758	0.3050	T	T	B,B	D	3.27	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	134254 [benign DISEASE=fanconi_anemia,not_specified]; 	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA]; 	COSM435949	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89838078	89838078	A	G	het	anno_omim	QUAL=12861;DP=1060;AF=0.48;MQM=60	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:ENST00000568369:splice_region&intron:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.4315	12977,3039,1411	0.5199,0.6644,0.7516,0.3015,0.5747	0.4371							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255245 [benign DISEASE=fanconi_anemia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89845194	89845194	A	G	het	off-target;anno_omim	QUAL=6225;DP=616;AF=0.53;MQM=60	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon20/42:c.1826+15T>C:,FANCA:ENST00000568369:splice_region&intron:LOW:exon20/42:c.1826+15T>C:		rs1800337	0.6825	0.5115	18057,4737,2484	0.6900,0.6876,0.9845,0.3744,0.5947	0.5225							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255241 [benign DISEASE=fanconi_anemia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89849480	89849480	C	T	hom	pred_pathogenic;anno_omim	QUAL=6739;DP=202;AF=1.00;MQM=60	FANCA	missense	FANCA:ENST00000389301:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:ENST00000568369:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.6240	0.4995	16447,5298,2452	0.6852,0.6374,0.8551,0.3970,0.4906	0.5222	-0.0380	T	T	B,B	D	0.07	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	134244 [benign DISEASE=fanconi_anemia,not_specified]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89857964	89857964	T	C	het	off-target;anno_omim	QUAL=14528;DP=1042;AF=0.53;MQM=60	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon13/42:c.1226-20A>G:,FANCA:ENST00000568369:splice_region&intron:LOW:exon13/42:c.1226-20A>G:		rs1800330	0.5719	0.4370	13077,2988,1621	0.5588,0.6678,0.7611,0.3036,0.5731	0.4402							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255232 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89858505	89858505	T	C	het	off-target;anno_omim	QUAL=4325;DP=304;AF=0.51;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon12/42:c.1084-29A>G:,FANCA:ENST00000568369:intron:MODIFIER:exon12/42:c.1084-29A>G:		rs6500452	0.5317	0.4118	11866,2863,1375	0.5140,0.6594,0.7576,0.2917,0.4810	0.4178							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255229 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89858525	89858525	C	G	het	off-target;anno_omim	QUAL=4352;DP=307;AF=0.51;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon12/42:c.1084-49G>C:,FANCA:ENST00000568369:intron:MODIFIER:exon12/42:c.1084-49G>C:		rs1800287	0.7027	0.5175	18504,4730,2990	0.7575,0.6914,0.9845,0.3752,0.5916	0.5441							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255230 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89859008	89859008	G	A	het	off-target;anno_omim	QUAL=930;DP=105;AF=0.40;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon11/42:c.1007-53C>T:,FANCA:ENST00000568369:intron:MODIFIER:exon11/42:c.1007-53C>T:		rs3856	0.5302	0.0000	0,0,0	0,0,0,0,0	0.4014							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];				n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89859016	89859016	T	-	het	off-target;anno_omim	QUAL=875;DP=105;AF=0.40;MQM=60	FANCA	intron	FANCA:ENST00000389301:intron:MODIFIER:exon11/42:c.1007-61delA:,FANCA:ENST00000568369:intron:MODIFIER:exon11/42:c.1007-61delA:		rs869077718	0.6430	0.0000	0,0,0	0,0,0,0,0	0.4866							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];				n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89866043	89866043	T	C	het	anno_omim	QUAL=9337;DP=734;AF=0.49;MQM=60	FANCA	missense	FANCA:ENST00000389301:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:ENST00000568369:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:ENST00000389302:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala,FANCA:ENST00000563673:missense:MODERATE:exon9/10:c.796A>G:p.Thr266Ala,FANCA:ENST00000534992:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala,FANCA:ENST00000543736:missense:MODERATE:exon8/10:c.700A>G:p.Thr234Ala		rs7190823	0.6905	0.5166	18422,4824,2761	0.7267,0.6937,0.9847,0.3778,0.5923	0.5344	0.4020	T,T,T,T	T	B,B,B,B,B,B	T,T,T,T	0.01	607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	134294 [benign DISEASE=fanconi_anemia,not_specified]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 		n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr16	89869761	89869761	T	C	hom	off-target;anno_omim	QUAL=3854;DP=115;AF=1.00;MQM=60	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon7/42:c.710-12A>G:,FANCA:ENST00000568369:splice_region&intron:LOW:exon7/42:c.710-12A>G:,FANCA:ENST00000389302:splice_region&intron:LOW:exon7/10:c.710-12A>G:,FANCA:ENST00000563673:splice_region&intron:LOW:exon7/9:c.710-12A>G:,FANCA:ENST00000534992:splice_region&intron:LOW:exon7/10:c.710-12A>G:,FANCA:ENST00000543736:splice_region&intron:LOW:exon6/9:c.614-12A>G:		rs1800286	0.8429	0.7013	31090,11644,4387	0.9199,0.8051,0.9896,0.5904,0.7987	0.7226							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255269 [benign DISEASE=fanconi_anemia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr17	7572980	7572980	T	G	het	pred_pathogenic;anno_omim	QUAL=46;DP=221;AF=0.35;MQM=60	TP53	missense,3'UTR,intron	TP53:ENST00000269305:missense:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro,TP53:ENST00000445888:missense:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro,TP53:ENST00000420246:3'UTR:MODIFIER:exon12/12:c.*236A>C:,TP53:ENST00000455263:3'UTR:MODIFIER:exon12/12:c.*148A>C:,TP53:ENST00000413465:intron:MODIFIER:exon6/6:c.782+4519A>C:,TP53:ENST00000359597:intron:MODIFIER:exon8/8:c.994-3418A>C:		rs774269719	0.0000	0.0006	0,0,0	0.0005,0.0000,0.0004,0.0003,0.0001	0.0003	0.4640	T,T,T,.	D	B	D,D	14.48	191170 [TP53 (confirmed) Colorectal cancer,114500|Li-Fraumeni syndrome,151623|Hepatocellular carcinoma,114550|Osteosarcoma,259500|Choroid plexus papilloma,260500|Nasopharyngeal carcinoma,607107|Pancreatic cancer,260350|Adrenal cortical carcinoma,202300|Breast cancer,114480|Basal cell carcinoma 7,614740|Glioma susceptibility 1,137800];			COSM1658764, COSM1658763	0	36					TP53 (inh=AR+AD pLI=0.97)
chr17	7579472	7579472	G	C	het	pred_pathogenic;anno_omim	QUAL=7662;DP=573;AF=0.54;MQM=60	TP53	missense	TP53:ENST00000269305:missense:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:ENST00000413465:missense:MODERATE:exon3/7:c.215C>G:p.Pro72Arg,TP53:ENST00000359597:missense:MODERATE:exon3/9:c.215C>G:p.Pro72Arg,TP53:ENST00000420246:missense:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:ENST00000455263:missense:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:ENST00000445888:missense:MODERATE:exon4/11:c.215C>G:p.Pro72Arg		rs1042522	0.5429	0.6600	27306,18000,773	0.3843,0.7115,0.5892,0.7345,0.4988	0.6686	1.0150	T,T,T,T,T,T,T,T,T	T	B,B,B,B,B	D,D,D,D,D,D,D,D	0.36	191170 [TP53 (confirmed) Colorectal cancer,114500|Li-Fraumeni syndrome,151623|Hepatocellular carcinoma,114550|Osteosarcoma,259500|Choroid plexus papilloma,260500|Nasopharyngeal carcinoma,607107|Pancreatic cancer,260350|Adrenal cortical carcinoma,202300|Breast cancer,114480|Basal cell carcinoma 7,614740|Glioma susceptibility 1,137800];	12351 [drug response DISEASE=codon_72_polymorphism,_(rs1042522),hereditary_cancer-predisposing_syndrome,li-fraumeni_syndrome,li-fraumeni_syndrome_1,not_specified,antineoplastic_agents_response_-_efficacy,_toxicity/adr,cisplatin_response_-_efficacy,_toxicity/adr,cyclophosphamide_response_-_efficacy,_toxicity/adr,fluorouracil_response_-_efficacy,_toxicity/adr,paclitaxel_response_-_efficacy,_toxicity/adr,not_provided]; 		COSM250061, COSM3766192, COSM3766191, COSM3766190, COSM3766193	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AR+AD pLI=0.97)
chr17	7579644	7579659	CCCCAGCCCTCCAGGT	-	het	off-target;anno_omim	QUAL=124;DP=26;AF=0.58;MQM=60	TP53	intron	TP53:ENST00000269305:intron:MODIFIER:exon3/10:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000413465:intron:MODIFIER:exon2/6:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000359597:intron:MODIFIER:exon2/8:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000420246:intron:MODIFIER:exon3/11:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000455263:intron:MODIFIER:exon3/11:c.96+41_97-54delACCTGGAGGGCTGGGG:,TP53:ENST00000445888:intron:MODIFIER:exon3/10:c.96+41_97-54delACCTGGAGGGCTGGGG:		rs59758982	0.5865	0.0000	0,0,0	0,0,0,0,0	0.8232							191170 [TP53 (confirmed) Colorectal cancer,114500|Li-Fraumeni syndrome,151623|Hepatocellular carcinoma,114550|Osteosarcoma,259500|Choroid plexus papilloma,260500|Nasopharyngeal carcinoma,607107|Pancreatic cancer,260350|Adrenal cortical carcinoma,202300|Breast cancer,114480|Basal cell carcinoma 7,614740|Glioma susceptibility 1,137800];	440349 [benign DISEASE=hereditary_cancer-predisposing_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AR+AD pLI=0.97)
chr17	29553485	29553485	G	A	hom	anno_omim	QUAL=2535;DP=86;AF=1.00;MQM=60	NF1	synonymous	NF1:ENST00000358273:synonymous:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:ENST00000356175:synonymous:LOW:exon18/57:c.2034G>A:p.Pro678Pro		rs2285892	0.4968	0.3827	9925,3078,2462	0.6840,0.5117,0.5333,0.3012,0.3710	0.4369							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	183826 [benign/likely benign DISEASE=hereditary_cancer-predisposing_syndrome,neurofibromatosis,_type_1,cafe-au-lait_macules_with_pulmonary_stenosis,neurofibromatosis,_familial_spinal,neurofibromatosis-noonan_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD pLI=1.00)
chr17	29559061	29559061	-	T	het	off-target;anno_omim	QUAL=414;DP=149;AF=0.26;MQM=60	NF1	splice_region&intron	NF1:ENST00000358273:splice_region&intron:LOW:exon24/57:c.3198-4dupT:,NF1:ENST00000356175:splice_region&intron:LOW:exon24/56:c.3198-4dupT:		rs371047262	0.0000	0.0052	21,6,0	0.0012,0.0000,0.0094,0.0043,0.0071	0.1966							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD pLI=1.00)
chr17	29559932	29559932	C	A	hom	off-target;anno_omim	QUAL=1030;DP=35;AF=1.00;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon26/57:c.3496+33C>A:,NF1:ENST00000356175:intron:MODIFIER:exon26/56:c.3496+33C>A:		rs2066736	0.4581	0.3676	8780,2982,1958	0.6170,0.5013,0.4416,0.2994,0.3663	0.4125							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	257285 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD pLI=1.00)
chr17	29563073	29563073	-	TG	hom	off-target;anno_omim	QUAL=9318;DP=408;AF=0.91;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon29/57:c.3974+36_3974+37dupGT:,NF1:ENST00000356175:intron:MODIFIER:exon29/56:c.3974+36_3974+37dupGT:	(T)n	rs371036783;rs59745739	0.0016	0.0010	0,0,0	0.0025,0.0021,0.0008,0.0007,0.0009	0.0012							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				3	108					NF1 (inh=AD pLI=1.00)
chr17	29563085	29563085	T	G	hom	off-target;anno_omim	QUAL=10302;DP=390;AF=0.99;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon29/57:c.3974+46T>G:,NF1:ENST00000356175:intron:MODIFIER:exon29/56:c.3974+46T>G:	(T)n	rs72813695	0.0988	0.0054	2,0,0	0.0071,0.0051,0.0056,0.0056,0.0061	0.0116							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD pLI=1.00)
chr17	29663625	29663625	-	A	hom	off-target;anno_omim	QUAL=840;DP=41;AF=0.78;MQM=60	NF1	splice_region&intron	NF1:ENST00000358273:splice_region&intron:LOW:exon41/57:c.6148-17dupA:,NF1:ENST00000356175:splice_region&intron:LOW:exon40/56:c.6085-17dupA:		rs33925668;rs553817239	0.3437	0.2735	758,301,165	0.4019,0.4025,0.3588,0.2526,0.2144	0.3401							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD pLI=1.00)
chr17	29670190	29670190	C	G	hom	off-target;anno_omim	QUAL=5223;DP=163;AF=1.00;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon48/57:c.7189+37C>G:,NF1:ENST00000356175:intron:MODIFIER:exon47/56:c.7126+37C>G:,NF1:ENST00000417592:intron:MODIFIER:exon3/10:c.328+37C>G:,NF1:ENST00000444181:intron:MODIFIER:exon5/16:c.568+37C>G:		rs7405740	0.8738	0.9069	47463,26412,3102	0.8047,0.8816,0.8881,0.9155,0.9464	0.9082							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];	257300 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD pLI=1.00)
chr17	33433487	33433487	C	T	hom	anno_omim;anno_pathogenic_hgmd	QUAL=2531;DP=85;AF=1.00;MQM=60	RAD51L3-RFFL,RAD51D	missense	RAD51D:ENST00000590016:missense:MODERATE:exon6/10:c.554G>A:p.Arg185Gln,RAD51D:ENST00000345365:missense:MODERATE:exon6/10:c.494G>A:p.Arg165Gln,RAD51D:ENST00000394589:missense:MODERATE:exon7/11:c.494G>A:p.Arg165Gln,RAD51D:ENST00000360276:missense:MODERATE:exon5/9:c.359G>A:p.Arg120Gln,RAD51D:ENST00000335858:missense:MODERATE:exon3/7:c.158G>A:p.Arg53Gln,RAD51D:ENST00000460118:missense:MODERATE:exon5/9:c.137G>A:p.Arg46Gln		rs4796033	0.0950	0.1593	1568,680,7	0.0343,0.3195,0.0456,0.1606,0.1701	0.1566	1.3260	T,T,T,T,T,T,T	T	B,B,B,B	T,T	16.92	602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4,614291];	142159 [benign/likely benign DISEASE=hereditary_cancer-predisposing_syndrome,breast-ovarian_cancer,_familial_4,not_specified,breast_and_ovarian_cancer_susceptibility]; 	CM172631 [CLASS=DM? MUT=ALT PHEN="Breast cancer" GENE=RAD51D]; 		n/a (AF>5%)	n/a (AF>5%)	1	[1] ahstaea1 08.05.2018: AF 15% in gnomAD und ExAC			RAD51L3-RFFL (inh=n/a pLI=n/a), RAD51D (inh=AD pLI=0.00)
chr17	33445549	33445549	G	A	het	anno_omim	QUAL=1637;DP=132;AF=0.55;MQM=60	RAD51D,RAD51L3-RFFL	synonymous,5'UTR,intron	RAD51D:ENST00000345365:synonymous:LOW:exon3/10:c.234C>T:p.Ser78Ser,RAD51D:ENST00000394589:synonymous:LOW:exon4/11:c.234C>T:p.Ser78Ser,RAD51D:ENST00000360276:synonymous:LOW:exon3/9:c.234C>T:p.Ser78Ser,RAD51D:ENST00000357906:synonymous:LOW:exon3/4:c.234C>T:p.Ser78Ser,RAD51D:ENST00000460118:5'UTR:MODIFIER:exon3/9:c.-42C>T:,RAD51D:ENST00000590016:intron:MODIFIER:exon2/9:c.144+581C>T:,RAD51D:ENST00000335858:intron:MODIFIER:exon2/6:c.144+581C>T:		rs9901455	0.1875	0.1184	1176,263,469	0.3018,0.0999,0.2331,0.0878,0.0839	0.1624							602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4,614291];	183785 [benign/likely benign DISEASE=hereditary_cancer-predisposing_syndrome,breast-ovarian_cancer,_familial_4,not_specified,breast_and_ovarian_cancer_susceptibility]; 			n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD pLI=0.00), RAD51L3-RFFL (inh=n/a pLI=n/a)
chr17	41223094	41223094	T	C	het	pred_pathogenic;anno_omim	QUAL=4395;DP=434;AF=0.47;MQM=60	BRCA1	missense,intron	BRCA1:ENST00000471181:missense:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly,BRCA1:ENST00000357654:missense:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly,BRCA1:ENST00000351666:missense:MODERATE:exon11/19:c.1288A>G:p.Ser430Gly,BRCA1:ENST00000309486:missense:MODERATE:exon14/22:c.3949A>G:p.Ser1317Gly,BRCA1:ENST00000352993:missense:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly,BRCA1:ENST00000468300:missense:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly,BRCA1:ENST00000591534:missense:MODERATE:exon3/11:c.310A>G:p.Ser104Gly,BRCA1:ENST00000493795:missense:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly,BRCA1:ENST00000491747:missense:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly,BRCA1:ENST00000346315:intron:MODIFIER:exon12/18:c.4358-7126A>G:,BRCA1:ENST00000354071:intron:MODIFIER:exon12/17:c.4358-7704A>G:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-7126A>G:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-98-20887A>G:		rs1799966	0.3558	0.3496	7852,3646,290	0.2397,0.3138,0.3805,0.3268,0.5001	0.3546	-0.1120	D,T,D,T,D,T,T,T,D,.,D,D,D	T	B,B,B,B,B,B,B,B	D,D,D,D,D,D,D,D,D,D	0.55	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	41827 [benign DISEASE=hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_1,not_specified,not_provided]; 	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1]; 	COSM3755560, COSM3755559	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	41234470	41234470	A	G	het	anno_omim	QUAL=343;DP=34;AF=0.50;MQM=60	BRCA1	synonymous,intron	BRCA1:ENST00000471181:synonymous:LOW:exon12/24:c.4308T>C:p.Ser1436Ser,BRCA1:ENST00000357654:synonymous:LOW:exon12/23:c.4308T>C:p.Ser1436Ser,BRCA1:ENST00000351666:synonymous:LOW:exon8/19:c.759T>C:p.Ser253Ser,BRCA1:ENST00000309486:synonymous:LOW:exon11/22:c.3420T>C:p.Ser1140Ser,BRCA1:ENST00000346315:synonymous:LOW:exon12/19:c.4308T>C:p.Ser1436Ser,BRCA1:ENST00000352993:synonymous:LOW:exon11/22:c.882T>C:p.Ser294Ser,BRCA1:ENST00000354071:synonymous:LOW:exon12/18:c.4308T>C:p.Ser1436Ser,BRCA1:ENST00000468300:synonymous:LOW:exon12/22:c.999T>C:p.Ser333Ser,BRCA1:ENST00000493795:synonymous:LOW:exon11/22:c.4167T>C:p.Ser1389Ser,BRCA1:ENST00000491747:synonymous:LOW:exon12/23:c.999T>C:p.Ser333Ser,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-18502T>C:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-7932T>C:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-98-32263T>C:		rs1060915	0.3363	0.3431	7653,3619,159	0.1800,0.3088,0.3778,0.3258,0.4993	0.3493	-0.1190		T			4.96	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	125703 [benign DISEASE=hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_1,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	41244000	41244000	T	C	het	anno_omim	QUAL=4694;DP=350;AF=0.49;MQM=60	BRCA1	missense,intron	BRCA1:ENST00000471181:missense:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg,BRCA1:ENST00000357654:missense:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg,BRCA1:ENST00000309486:missense:MODERATE:exon9/22:c.2660A>G:p.Lys887Arg,BRCA1:ENST00000346315:missense:MODERATE:exon10/19:c.3548A>G:p.Lys1183Arg,BRCA1:ENST00000354071:missense:MODERATE:exon10/18:c.3548A>G:p.Lys1183Arg,BRCA1:ENST00000493795:missense:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-951A>G:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.671-951A>G:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.788-951A>G:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-28032A>G:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-17462A>G:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+33288A>G:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.788-951A>G:		rs16942	0.3526	0.3490	7768,3592,284	0.2358,0.3141,0.3827,0.3259,0.4999	0.3534	-0.3650	T,T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	0.01	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	41818 [benign DISEASE=hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_1,not_specified,not_provided]; 	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1]; 	COSM3755561, COSM148277	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	41244435	41244435	T	C	het	pred_pathogenic;anno_omim	QUAL=10833;DP=980;AF=0.49;MQM=60	BRCA1	missense,intron	BRCA1:ENST00000471181:missense:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly,BRCA1:ENST00000357654:missense:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly,BRCA1:ENST00000309486:missense:MODERATE:exon9/22:c.2225A>G:p.Glu742Gly,BRCA1:ENST00000346315:missense:MODERATE:exon10/19:c.3113A>G:p.Glu1038Gly,BRCA1:ENST00000354071:missense:MODERATE:exon10/18:c.3113A>G:p.Glu1038Gly,BRCA1:ENST00000493795:missense:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-1386A>G:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.671-1386A>G:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.788-1386A>G:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-28467A>G:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-17897A>G:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+32853A>G:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.788-1386A>G:		rs16941	0.3357	0.3429	7641,3610,156	0.1798,0.3083,0.3777,0.3254,0.4996	0.3490	-0.4800	D,D,D,D,D,D,D	T	B,B,B,B,P,B	T,T,T,T,T,T	22.20	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	41815 [benign DISEASE=hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_1,not_specified,not_provided]; 	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1]; 	COSM3755563, COSM3755562	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	41244936	41244936	G	A	het	pred_pathogenic;anno_omim	QUAL=2131;DP=132;AF=0.58;MQM=60	BRCA1	missense,intron	BRCA1:ENST00000471181:missense:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu,BRCA1:ENST00000357654:missense:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu,BRCA1:ENST00000309486:missense:MODERATE:exon9/22:c.1724C>T:p.Pro575Leu,BRCA1:ENST00000346315:missense:MODERATE:exon10/19:c.2612C>T:p.Pro871Leu,BRCA1:ENST00000354071:missense:MODERATE:exon10/18:c.2612C>T:p.Pro871Leu,BRCA1:ENST00000493795:missense:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-1887C>T:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.671-1887C>T:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.787+1825C>T:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-28968C>T:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-18398C>T:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+32352C>T:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.787+1825C>T:		rs799917	0.5439	0.4101	11586,3799,3500	0.8193,0.3435,0.3780,0.3341,0.5285	0.4855	4.2460	T,T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	14.03	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	41812 [benign DISEASE=hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_1,not_specified,not_provided]; 	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1]; 	COSM148278, COSM3755564	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	41245237	41245237	A	G	het	anno_omim	QUAL=1538;DP=127;AF=0.46;MQM=60	BRCA1	synonymous,intron	BRCA1:ENST00000471181:synonymous:LOW:exon10/24:c.2311T>C:p.Leu771Leu,BRCA1:ENST00000357654:synonymous:LOW:exon10/23:c.2311T>C:p.Leu771Leu,BRCA1:ENST00000309486:synonymous:LOW:exon9/22:c.1423T>C:p.Leu475Leu,BRCA1:ENST00000346315:synonymous:LOW:exon10/19:c.2311T>C:p.Leu771Leu,BRCA1:ENST00000354071:synonymous:LOW:exon10/18:c.2311T>C:p.Leu771Leu,BRCA1:ENST00000493795:synonymous:LOW:exon9/22:c.2170T>C:p.Leu724Leu,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-2188T>C:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.671-2188T>C:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.787+1524T>C:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-29269T>C:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-18699T>C:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+32051T>C:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.787+1524T>C:		rs16940	0.3353	0.3420	7603,3578,154	0.1792,0.3080,0.3785,0.3239,0.4995	0.3482							113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	125554 [benign DISEASE=hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_1,not_specified]; 		COSM3755566, COSM3755565	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	41245466	41245466	G	A	het	anno_omim	QUAL=460;DP=62;AF=0.44;MQM=60	BRCA1	synonymous,intron	BRCA1:ENST00000471181:synonymous:LOW:exon10/24:c.2082C>T:p.Ser694Ser,BRCA1:ENST00000357654:synonymous:LOW:exon10/23:c.2082C>T:p.Ser694Ser,BRCA1:ENST00000309486:synonymous:LOW:exon9/22:c.1194C>T:p.Ser398Ser,BRCA1:ENST00000346315:synonymous:LOW:exon10/19:c.2082C>T:p.Ser694Ser,BRCA1:ENST00000354071:synonymous:LOW:exon10/18:c.2082C>T:p.Ser694Ser,BRCA1:ENST00000493795:synonymous:LOW:exon9/22:c.1941C>T:p.Ser647Ser,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.548-2417C>T:,BRCA1:ENST00000352993:intron:MODIFIER:exon9/21:c.670+2397C>T:,BRCA1:ENST00000468300:intron:MODIFIER:exon10/21:c.787+1295C>T:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.5-29498C>T:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-18928C>T:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+31822C>T:,BRCA1:ENST00000491747:intron:MODIFIER:exon10/22:c.787+1295C>T:		rs1799949	0.3365	0.3483	7796,3607,286	0.2364,0.3138,0.3783,0.3252,0.5002	0.3533							113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	125536 [benign DISEASE=hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,hereditary_breast_and_ovarian_cancer_syndrome,breast-ovarian_cancer,_familial_1,not_specified]; 		COSM148280, COSM3755567	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	41249364	41249364	A	-	het	off-target;anno_omim	QUAL=594;DP=70;AF=0.39;MQM=60	BRCA1	intron	BRCA1:ENST00000471181:intron:MODIFIER:exon7/23:c.548-58delT:,BRCA1:ENST00000357654:intron:MODIFIER:exon7/22:c.548-58delT:,BRCA1:ENST00000351666:intron:MODIFIER:exon6/18:c.547+2428delT:,BRCA1:ENST00000309486:intron:MODIFIER:exon6/21:c.-341-58delT:,BRCA1:ENST00000346315:intron:MODIFIER:exon7/18:c.548-58delT:,BRCA1:ENST00000352993:intron:MODIFIER:exon7/21:c.548-58delT:,BRCA1:ENST00000354071:intron:MODIFIER:exon7/17:c.548-58delT:,BRCA1:ENST00000468300:intron:MODIFIER:exon7/21:c.548-58delT:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.4+27835delT:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-43-22826delT:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+27924delT:,BRCA1:ENST00000493795:intron:MODIFIER:exon6/21:c.407-58delT:,BRCA1:ENST00000491747:intron:MODIFIER:exon7/22:c.548-58delT:		rs8176144	0.3349	0.0000	0,0,0	0,0,0,0,0	0.3002							113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	125889 [benign DISEASE=breast-ovarian_cancer,_familial_1,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	41256090	41256103	AAAAAAAAGAAAAG	-	het	off-target;low_QUAL;low_DP;anno_omim	QUAL=21;DP=12;AF=0.33;MQM=60	BRCA1	intron	BRCA1:ENST00000471181:intron:MODIFIER:exon6/23:c.441+36_441+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000357654:intron:MODIFIER:exon6/22:c.441+36_441+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000351666:intron:MODIFIER:exon5/18:c.441+36_441+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000309486:intron:MODIFIER:exon5/21:c.-448+36_-448+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000346315:intron:MODIFIER:exon6/18:c.441+36_441+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000352993:intron:MODIFIER:exon6/21:c.441+36_441+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000354071:intron:MODIFIER:exon6/17:c.441+36_441+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000468300:intron:MODIFIER:exon6/21:c.441+36_441+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000586385:intron:MODIFIER:exon1/7:c.4+21096_4+21109delCTTTTCTTTTTTTT:,BRCA1:ENST00000591534:intron:MODIFIER:exon1/10:c.-44+21185_-44+21198delCTTTTCTTTTTTTT:,BRCA1:ENST00000591849:intron:MODIFIER:exon1/4:c.-99+21185_-99+21198delCTTTTCTTTTTTTT:,BRCA1:ENST00000493795:intron:MODIFIER:exon5/21:c.300+36_300+49delCTTTTCTTTTTTTT:,BRCA1:ENST00000491747:intron:MODIFIER:exon6/22:c.441+36_441+49delCTTTTCTTTTTTTT:	Alu:(AAG)n	rs373413425	0.0000	0.3276	5802,2580,203	0.2198,0.2869,0.3490,0.3060,0.4815	0.2780							113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370|Pancreatic cancer,susceptibility to,4,614320|Fanconi anemia,complementation group S,617883];	225705 [benign DISEASE=breast-ovarian_cancer,_familial_1,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AD pLI=0.00)
chr17	56769979	56769979	C	T	het	off-target;anno_omim	QUAL=11259;DP=987;AF=0.46;MQM=60	RAD51C	5'UTR	RAD51C:ENST00000337432:5'UTR:MODIFIER:exon1/9:c.-26C>T:,RAD51C:ENST00000583539:5'UTR:MODIFIER:exon1/8:c.-26C>T:		rs12946397	0.1583	0.1797	2089,1377,92	0.1420,0.1122,0.1719,0.2015,0.1381	0.1954							602774 [RAD51C (provisional) Fanconi anemia,complementation group O,613390|Breast-ovarian cancer,familial,susceptibility to,3,613399];	324173 [likely benign DISEASE=fanconi_anemia,breast_and_ovarian_cancer_susceptibility]; 			n/a (AF>5%)	n/a (AF>5%)					RAD51C (inh=AR+AD pLI=0.00)
chr17	56798207	56798207	T	C	het	off-target;anno_omim	QUAL=203;DP=27;AF=0.44;MQM=60	RAD51C	intron	RAD51C:ENST00000337432:intron:MODIFIER:exon6/8:c.904+34T>C:,RAD51C:ENST00000583539:intron:MODIFIER:exon6/7:c.904+34T>C:		rs28363318	0.2053	0.2800	5250,3988,381	0.2744,0.1757,0.0010,0.3537,0.1930	0.2892							602774 [RAD51C (provisional) Fanconi anemia,complementation group O,613390|Breast-ovarian cancer,familial,susceptibility to,3,613399];				n/a (AF>5%)	n/a (AF>5%)					RAD51C (inh=AR+AD pLI=0.00)
chr17	59760996	59760996	A	G	hom	anno_omim	QUAL=7621;DP=310;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:ENST00000259008:synonymous:LOW:exon20/20:c.3411T>C:p.Tyr1137Tyr		rs4986763	0.6208	0.5941	22043,11338,2201	0.6531,0.8008,0.7230,0.5842,0.4525	0.5973							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	183702 [benign/likely benign DISEASE=neoplasm_of_ovary,neoplasm_of_the_breast,fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,fanconi_anemia,_complementation_group_j,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD pLI=0.00)
chr17	59763347	59763347	A	G	hom	low_DP;anno_omim	QUAL=369;DP=12;AF=1.00;MQM=60	BRIP1	missense	BRIP1:ENST00000259008:missense:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro,BRIP1:ENST00000577598:missense:MODERATE:exon18/18:c.2755T>C:p.Ser919Pro		rs4986764	0.6278	0.5972	22365,11454,2344	0.6702,0.8060,0.7235,0.5861,0.4525	0.5998	0.1360	T	T	B	T	0.20	605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	133756 [benign/likely benign DISEASE=neoplasm_of_ovary,neoplasm_of_the_breast,fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,fanconi_anemia,_complementation_group_j,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD pLI=0.00)
chr17	59763465	59763465	T	C	hom	anno_omim	QUAL=3671;DP=114;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:ENST00000259008:synonymous:LOW:exon19/20:c.2637A>G:p.Glu879Glu,BRIP1:ENST00000577598:synonymous:LOW:exon18/18:c.2637A>G:p.Glu879Glu		rs4986765	0.8151	0.7188	32088,14734,4248	0.9048,0.8760,0.8933,0.6648,0.6981	0.7178							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	183703 [benign/likely benign DISEASE=neoplasm_of_ovary,neoplasm_of_the_breast,fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,fanconi_anemia,_complementation_group_j,not_specified]; 		COSM437064, COSM1479821	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD pLI=0.00)
chr17	59857600	59857600	A	-	het	off-target;low_QUAL;anno_omim	QUAL=14;DP=28;AF=0.21;MQM=60	BRIP1	intron	BRIP1:ENST00000259008:intron:MODIFIER:exon13/19:c.1935+22delT:,BRIP1:ENST00000577598:intron:MODIFIER:exon12/17:c.1935+22delT:		rs763913233	0.0000	0.0160	0,0,0	0.0154,0.0092,0.0127,0.0209,0.0103	0.0079							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];				0	20					BRIP1 (inh=AR+AD pLI=0.00)
chr17	59857809	59857809	C	G	het	off-target;low_DP;anno_omim	QUAL=183;DP=14;AF=0.64;MQM=60	BRIP1	intron	BRIP1:ENST00000259008:intron:MODIFIER:exon12/19:c.1795-47G>C:,BRIP1:ENST00000577598:intron:MODIFIER:exon11/17:c.1795-47G>C:	AluJb	rs4988351	0.7897	0.7476	33638,18248,3568	0.8570,0.4757,0.8267,0.7498,0.7978	0.7917							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	262005 [benign DISEASE=not_specified]; 		COSN165483	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD pLI=0.00)
chr18	19995753	19995753	T	C	hom	low_DP	QUAL=461;DP=19;AF=1.00;MQM=60	CTAGE1	synonymous	CTAGE1:ENST00000391403:synonymous:LOW:exon1/1:c.2022A>G:p.Pro674Pro		rs9946145	0.6855	0.8453	44643,28030,667	0.3568,0.8772,0.8275,0.9168,0.7898	0.8559											n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a pLI=0.00)
chr18	19996011	19996011	G	A	het		QUAL=1512;DP=133;AF=0.46;MQM=60	CTAGE1	synonymous	CTAGE1:ENST00000391403:synonymous:LOW:exon1/1:c.1764C>T:p.Leu588Leu		rs7227477	0.4942	0.4999	15457,8071,1094	0.4711,0.6082,0.6152,0.4902,0.4270	0.5049											n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a pLI=0.00)
chr18	20555219	20555219	T	C	hom	off-target;anno_omim	QUAL=2177;DP=70;AF=1.00;MQM=60	RBBP8	intron	RBBP8:ENST00000360790:intron:MODIFIER:exon6/18:c.428+37T>C:,RBBP8:ENST00000327155:intron:MODIFIER:exon6/18:c.428+37T>C:,RBBP8:ENST00000399722:intron:MODIFIER:exon6/18:c.428+37T>C:,RBBP8:ENST00000399725:intron:MODIFIER:exon6/17:c.428+37T>C:		rs2336916	0.9157	0.9626	54138,30894,3453	0.8544,0.9824,0.9196,0.9840,0.9373	0.9651							604124 [RBBP8 (provisional) Pancreatic carcinoma,somatic|Seckel syndrome 2,606744|Jawad syndrome,251255];				n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR pLI=0.00)
chr18	20564801	20564803	TCA	-	het	off-target;anno_omim	QUAL=362;DP=32;AF=0.47;MQM=60	RBBP8	intron	RBBP8:ENST00000360790:intron:MODIFIER:exon7/18:c.605-41_605-39delCAT:,RBBP8:ENST00000327155:intron:MODIFIER:exon7/18:c.605-41_605-39delCAT:,RBBP8:ENST00000399722:intron:MODIFIER:exon7/18:c.605-41_605-39delCAT:,RBBP8:ENST00000399725:intron:MODIFIER:exon7/17:c.605-41_605-39delCAT:		rs34354995	0.4517	0.5698	18103,12215,199	0.2153,0.5083,0.4739,0.6493,0.5481	0.5690							604124 [RBBP8 (provisional) Pancreatic carcinoma,somatic|Seckel syndrome 2,606744|Jawad syndrome,251255];				n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR pLI=0.00)
chr18	48584855	48584855	-	TT	het	off-target;anno_omim	QUAL=2475;DP=234;AF=0.41;MQM=60	SMAD4	intron	SMAD4:ENST00000342988:intron:MODIFIER:exon7/11:c.904+44_904+45dupTT:,SMAD4:ENST00000398417:intron:MODIFIER:exon7/11:c.904+44_904+45dupTT:,SMAD4:ENST00000588745:intron:MODIFIER:exon4/7:c.667+3507_667+3508dupTT:		rs397686427;rs760402978	0.0118	0.1541	617,388,11	0.0993,0.1582,0.1879,0.1624,0.1214	0.3070							600993 [SMAD4 (confirmed) Pancreatic cancer,somatic,260350|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,175050|Myhre syndrome,139210|Polyposis,juvenile intestinal,174900];				n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD pLI=0.99)
chr18	48584855	48584855	-	T	het	off-target;anno_omim	QUAL=2475;DP=234;AF=0.16;MQM=60	SMAD4	intron	SMAD4:ENST00000342988:intron:MODIFIER:exon7/11:c.904+45dupT:,SMAD4:ENST00000398417:intron:MODIFIER:exon7/11:c.904+45dupT:,SMAD4:ENST00000588745:intron:MODIFIER:exon4/7:c.667+3508dupT:		rs760402978	0.0066	0.1914	355,191,19	0.1770,0.2042,0.2211,0.1927,0.1675	0.1703							600993 [SMAD4 (confirmed) Pancreatic cancer,somatic,260350|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,175050|Myhre syndrome,139210|Polyposis,juvenile intestinal,174900];				n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD pLI=0.99)
chr19	17379558	17379558	C	T	het	off-target	QUAL=1316;DP=109;AF=0.48;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	splice_region&intron,intron	BABAM1:ENST00000359435:splice_region&intron:LOW:exon1/8:c.-51-7C>T:,BABAM1:ENST00000595632:splice_region&intron:LOW:exon1/5:c.-51-7C>T:,BABAM1:ENST00000598188:intron:MODIFIER:exon1/8:c.-13-45C>T:,BABAM1:ENST00000447614:intron:MODIFIER:exon1/8:c.-13-45C>T:,BABAM1:ENST00000601043:intron:MODIFIER:exon1/8:c.-13-45C>T:		rs10424178	0.1727	0.3600	1239,714,323	0.5034,0.2725,0.0023,0.3632,0.3131	0.2340											n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a pLI=0.92), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr19	17382505	17382505	A	T	het	off-target	QUAL=331;DP=49;AF=0.37;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	intron	BABAM1:ENST00000359435:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:ENST00000598188:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:ENST00000447614:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:ENST00000601043:intron:MODIFIER:exon3/8:c.344+41A>T:,BABAM1:ENST00000595632:intron:MODIFIER:exon3/5:c.344+41A>T:		rs10420922	0.4631	0.4367	10978,5948,2038	0.6825,0.3419,0.3188,0.4383,0.3812	0.5065											n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a pLI=0.92), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr19	17387254	17387254	G	A	het	off-target	QUAL=1375;DP=102;AF=0.52;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	intron	BABAM1:ENST00000359435:intron:MODIFIER:exon6/8:c.570-50G>A:,BABAM1:ENST00000598188:intron:MODIFIER:exon6/8:c.570-50G>A:,BABAM1:ENST00000447614:intron:MODIFIER:exon6/8:c.569+37G>A:,BABAM1:ENST00000601043:intron:MODIFIER:exon6/8:c.570-50G>A:,BABAM1:ENST00000595632:intron:MODIFIER:exon3/5:c.345-50G>A:		rs61634114	0.0990	0.2372	483,299,39	0.2149,0.2221,0.0015,0.2891,0.1535	0.1712											n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a pLI=0.92), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr19	17389648	17389648	C	T	het		QUAL=1229;DP=109;AF=0.47;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	splice_region&intron	BABAM1:ENST00000359435:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:ENST00000598188:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:ENST00000447614:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:ENST00000601043:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:ENST00000595632:splice_region&intron:LOW:exon5/5:c.562-6C>T:		rs10406920	0.1118	0.1798	1404,941,140	0.2148,0.1001,0.0008,0.2100,0.1366	0.1840											n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a pLI=0.92), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr19	17389704	17389704	G	A	het		QUAL=6312;DP=539;AF=0.47;MQM=60	BABAM1,CTD-2278I10.6,USHBP1	synonymous	BABAM1:ENST00000359435:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:ENST00000598188:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:ENST00000447614:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:ENST00000601043:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:ENST00000595632:synonymous:LOW:exon6/6:c.612G>A:p.Lys204Lys		rs8170	0.1124	0.1568	1581,1048,168	0.2029,0.0782,0.0007,0.1848,0.1202	0.1859									CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1]; 	COSM438891, COSM438892	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a pLI=0.92), CTD-2278I10.6 (inh=n/a pLI=n/a), USHBP1 (inh=n/a pLI=0.00)
chr20	14167283	14167283	A	G	hom		QUAL=905;DP=31;AF=1.00;MQM=60	MACROD2	intron	MACROD2:ENST00000310348:intron:MODIFIER:exon3/17:c.271+100909A>G:,MACROD2:ENST00000217246:intron:MODIFIER:exon3/16:c.271+100909A>G:	L1PA16	rs6074704	0.4792	0.0000	0,0,0	0,0,0,0,0	0.5388											n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=n/a pLI=0.15)
chr20	48301146	48301146	G	A	hom		QUAL=39629;DP=1210;AF=1.00;MQM=60	B4GALT5	intron	B4GALT5:ENST00000371711:intron:MODIFIER:exon1/8:c.116-27907C>T:		rs6512586	0.4681	0.5201	15518,8865,587	0.3857,0.4491,0.3772,0.5389,0.6480	0.5178											n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a pLI=0.99)
